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Abstract
A multi-faceted approach was applied to the molecular design of substrates for the
selective adhesion, proliferation and differentiation of connective tissue progenitors
(CTPs) from human bone marrow aspirates. The basic premise of the thesis is that
integrin-specific adhesion peptides, when presented in a biophysically appropriate
spatial arrangement against an inert background, allow enrichment of CTPs in vitro.
Comb copolymer comprising a methyl methacrylate backbone with 10-mer
poly(oxyethylene) sidechains was selected as the vehicle to present small adhesion
peptides at the surface. This polymer shows excellent performance in cell resistance
studies and offers sufficient functionalizable sites to create high local densities of
ligands. Methods for preparing comb copolymer substrates with peptides in -300
nm2 clusters with inter-ligand spacings closer than integrins were developed. This
nanometer-scale clustered presentation was favorable to integrin binding. Cells were
more spread on RGD peptide substrates with a higher degree of nanoscale clustering
but of the same overall peptide surface density as comparable substrates with lower
degree of peptide clustering. We evaluated adhesion peptides for their ability to
support CFU formation of marrow-derived CTPs using colony forming unit (CFU)
assay. The results, analyzed with a statistical model implemented to capture
characteristics of CFU assay, showed that while RGD substrates supported a
moderate amount of alkaline phosphatase -positive CFU (CFU-AP) formation, the
bone sialoprotein peptide FHRRII(A, and two 0C4f31 peptides demonstrated the best
performance in promoting CFU-AP formation. Patient variability in CFU data could
be partially explained by the variations in marrow aspirate cell integrin expression,
particularly 0C5 and OCvP3. The high level of ECM protein association seen with aspirate
cells, as revealed by immunoblotting, may inhibit cell adhesion and account for the
fairly low CFU counts observed. Treatments of marrow aspirate with phosphate
saline buffer (PBS) and RGD solution reduced a significant amount of protein
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association. A comprehensive study showed that patients' marrow aspirates were
naturally partitioned into two groups of very different colony formation behavior and
integrin and AP expressions but consistency was observed within each group. Upon
treatment of marrow cells with divalent ion-free PBS, CFU-AP formation on RGD
substrates drastically increased in one group of patients. The designs and assays
developed in this thesis could be applied for the further understanding of marrow
aspirates, such as their interaction with a high-affinity X5s1 peptide, and with that
knowledge, frther optimize the surface design of bone marrow grafts.
Thesis Advisor: Linda Griffith
Title: Professor of Biological and Mechanical Engineering
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Chapter 1
Introduction and background
1.1 Current bone graft technology
Over 1 million bone grafting procedures are performed annually in the United States to
treat acute factures, bone defects, fracture non-union and other problems associated
with bone. Roughly fifty percent of these procedures involve the use of autogenous
bone graft. Autogenous bone has proved to be highly successful due to the transfer of
osteoprogenitor cells, its osteoinductive and osteoconductive capacity, as well as its
mechanical properties (Burwell, 1994a). However, the lack of sufficient material,
difficulties in shaping the bone graft to fill the defect, and the significant morbidity
associated with the harvest of autogenous bone, including blood loss and infection risk,
all preclude the universal use of autogenous bone for orthopaedic applications. As a
result, surgeons turn to allograft bone and synthetic materials for alternatives. The risk
of disease transmission and the potential danger of cell-mediated immune responses of
allografts has led many researchers to search for other methods to repair skeletal defects.
Synthetic polymers such as poly(methyl methacrylate) had been used as grafting material
to fix implants to bone or to graft bone defects but they are not osteoconductive and
non-degradable. Some possess mechanical properties incompatible with those of bone,
leading to stress shielding and bone resorption. Another class of materials, calcium
phosphate ceramics, such as -tricalcium phosphate and hydroxyapatite (HA), provide an
effective scaffold for bone ingrowth but their poor mechanical properties make them
difficult to use for load-bearing applications.
Thoe success of bone graft materials in stimulating new bone formation is highly
dependent on the presence of a sufficient number of cells that possess the potential to
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repopulate the graft, the osteoblastic progenitors. Burwell showed that primitive
osteogenic cells in bone marrow were responsible for much of the biologic efficacy of
cancellous bone graft (Burwell, 1994b). In many cases, the performance of bone grafts is
limited by the scarcity of the local progenitor population and therefore bone grafts
providing an exogenous source of progenitors can improve the grafts' efficacy (Ohgushi
et al., 1989; Muschler et al., 1996). Bone marrow aspirates have proven to be a practical
cell source (Muschler et al., 1997) and the efficacy of a bone marrow graft can be
significantly enhanced by rapid intraoperative concentration of bone marrow derived
cells using allograft or HA matrices as surfaces for attachment (Matsukura et al., 2000;
Muschler et al., 2003).
1.2 Bone marrow as the cell source for bone grafting
The drastic improvement of graft efficacy provided by implanting exogenous bone
marrow at the grafting site is due to the heterogeneous population of stem and
progenitor cells in bone marrow. These progenitor cells possess different potentials to
proliferate and differentiate into osteoblasts which play an important role in bone
formation, such as extracellular matrix (ECM) maturation and mineralization. It had
been demonstrated that some mesenchymal stem cells, also known as marrow stromal
cells, present at a concentration of 200 - 1000 per mL of bone marrow, are pluripotent
and can differentiate, under the appropriate conditions, into the chondrocyte lineage, the
adipocyte lineage, the osteoblast lineage and possibly others (Owen, 1985; Muschler et al.,
1997; Pittenger et al., 1999). In this proposal, the term connective tissue progenitors
(CTPs) refers to these cells, a heterogeneous population of cells including fully
pluripotent as well as undifferentiated progenitors at various stages of commitment to
connective tissue or adipocyte lineages. Progenitors and even mature cells in these three
lineages exhibit some level of plasticity. Some of these cells can be trans-differentiated
into cells of other lineages (Figure 1.1). As a progenitor becomes more differentiated, its
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proliferative ability drastically decreases. As illustrated in Figure 1.2, when a
multipotential stem cell becomes an osteoprogenitor, its self-renewal ability is limited but
it can still undergo extensive proliferation. However, mature osteoblasts and osteocytes
are post-mitotic. Figure 1.2 also shows the sequence of steps of osteoblast
differentiation. A proliferative phase is followed by the upregulation of Type I collagen,
osteopontin, osteonectin, and alkaline phosphatase (AP). Mineralization follows,
accompanied by the downregulation of AP and upregulation of osteocalcin (OC) and
bone sialoprotein (BSP). The expression of these markers permits a rough identification
of the stage of differentiation of the cells. In natural bone formation and remodelling,
osteoprogenitor recruitment is a crucial step in which migration, attachment, and
proliferation play roles just as significant as subsequent differentiation. In addition, once
matured to a late differentiation stage, cell proliferation can no longer occur. In light of
all these models, the attachment of sufficient cells and their proliferation before
differentiation is extremely important in the success of repopulating the grafting site. In
fact, Muschler et al. have shown, using the canine spinal fusion model, a 4-fold
concentration of bone marrow derived connective tissue progenitors could be obtained
when allograft matrices were used as surfaces for selective attachment. The union rate
and quality of spinal fusion were also much improved compared to the use of fresh bone
marrow without concentrating the CTPs (Muschler et al., 2003). The studies showed
that even a modest increase in the number of osteoprogenitors in a bone graft using a
matrix as a surface for attachment could drastically improve the biologic result.
Preliminary data from the Muschler laboratory demonstrated that coralline
hydroxyapatite (HA) and allograft cancellous bone chips (3x3x3 mm3) can provide a 2 to
I selection of CTPs over other marrow cells (-40% of nucleated marrow cells and -80%
of CTPs attached to the matrices). These studies suggested the feasibility of bone
formation enhancement by matrices, although the poor mechanical properties of HA and
the risk of disease transmission and limited supply of allograft cancellous bone make
both materials suboptimal for bone grafting. Therefore, there is a need to develop a
synthetic material that is capable of selecting and concentrating osteoprogenitor cells
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from marrow. This material should have the capability to be easily incorporated to bone
grafting devices as the surface material, making it possible to separate surface and bulk
properties of bone grafts. Utilizing the advantage of the osteoprogenitor cell
concentrating ability of this synthetic coating material as well as the architectural and
mechanical properties of the bulk.
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O -0- ' 0 O0
/ N,
/I
/ ) Postulated osteoblast-chondroblast N \
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O ---O -O 0'- 0
Early Late
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Adipocyteprogenitor . . - -,
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0
Osteocyte
/
0
Adipocyte
Other mesenchymal cells including
myoblasts, fibroblasts
Figure 1.1 Postulated steps in the osteoblast lineage outlining some of the potential
commitment and restriction points and plasticity. (Adapted from Aubin. (Aubin, 1998))
To develop such an osteoprogenitor cell selective material, an understanding of the
mechanistic basis for osteoprogenitor attachment and function via interaction with ECM
molecules would be valuable. The cells of interest are human marrow-derived CTPs
which grow to form clonogenic cell clusters of connective tissue lineage known as colony
forming units (CFUs) in in vitro assays. CTPs have been a challenge to identify from the
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mixed population of marrow. The mean prevalence of these cells is about 1 per 20,000
cells in human bone marrow (Majors et al., 1997; Muschler et al., 1997). In addition, a
marker or a set of markers that can definitively single out only this cell population had
not been identified. STRO-1, an IgM antibody that labels all CTPs, was a marker used to
concentrate (CTPs using fluorescence activated cell sorting (FACS). About 7% of all
human marrow cells express the STRO-1 antigen and of all the colonies formed by
STRO-1+ cells, essentially all exhibit osteoblastic potential. About 50% exhibit
adipocytic potential (Gronthos et al., 1994). Based on the cell surface molecular profile
of human mesenchymal stem cells, researchers had used a combination of molecules
present and absent on these cells in an attempt to identify them, for example,
CD105+CD45- (Meinel et al., 2004), CD105+CD45- with the addition of GlyA- (Lodie et
al., 2002), CD49a+CD45mcdlow (Deschaseaux et al., 2003), STRO-lhighVCAM-1+ (De
Ugarte et al., 2003). However, in many of these studies, the mesenchymal stem cells
assayed had been plated or expanded in culture and therefore their surface molecular
profiles may have changed compared to when they were first isolated. This may be
especially a problem for the expression profile of cell adhesion molecules such as
integrins.
Dccrca.ing Prohlferalion a d Incrcasing Differcntiation
Limited Post-mitotic
proliferation 1 
Limited self-renewal
Extensive proliferation
Unlimited self-rcnewal
Mullipotentia O -- // --
Stem Cell '
Immaturc Mature
ostecoprogenitor stcoprogcnitor
~//'X~
O
Lining Cell
Apoptosis
O0 T
Osteoblast
Progenitors for other mesenchymal
cells including adipocytes, fibroblasts,
and myoblasts
Figure 1.2 Postulated steps in the osteoblast lineage implying recognizable stages of
proliferation and differentiation as detectable from in vitro and in vizvo experiments.
(Adapted from Aubin et al. (Aubin and Heersche, 2000))
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1.3 Integrin-mediated cell adhesion
Integrins constitute the principal class of cell adhesion molecules that mediate cell-matrix
adhesion. These transmembrane receptors are heterodimers that are composed of oa and
3 subunits (Hynes, 1992; Hynes, 2002). In mammals, there exist at least 18 types of oc
subunits and 8 types of P subunits. Permutations of x and subunits generate at least 24
known distinct integrin heterodimers that bind to different ligands. This diversity of
integrins and their ability to bind to various ligands, such as ECM molecules, allow cells
to express a combination of integrins, in order to recognize different adhesion molecules.
This is essential in enabling cells to migrate to their correct location in tissue
morphogenesis. The extracellular binding of integrins to ligands activates these
transmembrane receptors to associate with various cytoplasmic proteins and thereby
initiates multiple signalling pathways that regulate cell functions such as survival, motility,
proliferation and differentiation (Huttenlocher et al., 1996; Palecek et al., 1997;
Bourdoulous et al., 1998; Davey et al., 1999; Scott et al., 2003; Onodera et al., 2005). In
addition, cells that express integrins that bind to the same ligands can selectively regulate
the density and activity of each type to elicit certain cell function through fine-tuning
their interaction with the matrix. For example, a decrease in the number of OC4p1 integrins
at the late stage of hematopoietic cell differentiation is believed to allow mature blood
cells to detach from bone marrow stroma (Kronenwett et al., 2000).
Integrins, however, bind to their ligands at relatively low affinities (dissociation constants
Ki( are typically between 10-6 and 10-8 N) compared to cell-surface hormone receptors
(IKD between 10- 9 to 10-11M) (Lodish et al., 1999). Therefore, biophysical parameters play
an important role in mediating cell-matrix interactions via integrin binding. On one hand,
because individual binding is weak, migrating cells can break individual contacts with the
matrix and cell motility can be regulated through the cell-substratum adhesion by varying
substratum E,CM surface density. On the other hand, due to the multi-hundreds or
thousands of integrins that are present, these weak binding forces can be combined
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together to anchor a cell firmly to the matrix. In fact, upon binding to extracellular
igands, integrins form nanoscale clusters which enable the assembly of multiple
cytoplasmic regulatory and structural proteins at sites of aggregated integrin cytoplasmic
domains, activating intracellular signalling pathways. Structurally, the formation of
integrin clusters strengthens the adhesion of cells to their underlying substrata by
enhancing connection to the cytoskeleton with the formation of actin-rich stress fibers
that are attached through adapter proteins to the subunit of integrins (Schoenwaelder
and Burridge, 1999). On the cell-signaling level, accumulating data show that both ligand
binding and receptor clustering are needed to elicit full cellular responses mediated by
receptor-signaling-protein interactions (Miyamoto et al., 1995a; Miyamoto et al., 1995b).
Previous studies in our lab have shown that clustered presentation of the RGD peptides
was more effective in promoting cell adhesion and migration. (List of abbreviations of
amino acids can be found in Appendix A.) Surfaces coated with synthetic star-
configured polyethylene oxide polymer with more YGRGD peptides grafted on each star
molecule (i.e., more peptides per polymer cluster) were more effective in promoting cell
adhesion. Not only cell attachment but also full spreading and haptokinetic, as well as
chemokinetic, motility was observed. At the same time, even with the same overall
peptide density, fibroblast migration was impaired on unclustered peptide surfaces
(Maheshwari et al., 2000). Koo et al. also showed an increase in adhesion force by
fibroblasts on surfaces with RGD peptides presented as clusters by comb-shaped
copolymer with poly(methyl methacrylate) backbone and poly(oxyethylene) side chains
(P(MMA-r-P EM)) (Koo et al., 2002). Thus, both the biochemical recognition of
ligands by integrins and the biophysical presentation of ligands plays an important role in
eliciting full cellular responses.
In bone marrow biology, reports of integrin expression profile of CTPs are quite
conflicting. T-his may in part be due to the difference in cell source (animal vs. human,
calvarial bone vs. marrow aspiration etc) and in part due to the various methods of
culture and different expansion. As mentioned above, one of the major difficulties is the
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impossibility of analyzing a cell molecular profile while assaying for its ability to form
colonies. Once a cell adheres to a surface in vitro, its molecular profile will likely have
been changed. Mesenchymal stem cells have been shown in culture to express ECM
molecules such as fibronectin, laminin, collagens, hyaluronan (Chichester et al., 1993;
Conget and Minguell, 1999; Minguell et al., 2001) and it is generally believed that they
secrete these matrix molecules in rivo to make up the stroma in bone marrow. In Chapter
6, the ECM and integrin profile of bone marrow aspirates, both the overall as well as
particular subpopulations, is reported in attempt to elucidate an understanding of these
cells. In addition to integrins, there are other transmembrane receptors that mediate cell
adhesion. Cell surface proteoglycans are of particular interest in bone biology.
Proteoglycans consist of a transmembrane core protein and an extracellular domain
containing polysaccharide chains that can also bind to ECM molecules such as
fibronectin and bone sialoprotein. This class of cell adhesion molecules is of growing
interest as proteoglycans such as hyaluronan which is present in marrow can stimulate
the proliferation of bone marrow mesenchymal stem cells (Zou et al., 2004).
1.4 Rational design for in vivo cell-based tissue engineering
In recent years, the discipline of bone regeneration and its related fields have progressed
very rapidly. Bone development biology has provided a better understanding of
mesenchymal stem cells and the cues needed for their cell function, including
differentiation into bone. Cellular engineering to enhance bone graft efficacy utilizing
bone marrow has greatly advanced. Previously, in order to transplant sufficient
mesenchymal stem cells into the grafting site, an ex vivo expansion of mesenchymal stem
cells was considered the principle strategy for the enhancement of CTPs. Now clinical
strategies in intraoperative aspiration and concentration of CTPs as well as delivery of
these cells to the grafting site have been developed. At the same time, the technologies
in tissue engineering have advanced immensely. The use of biomaterials has grown from
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the traditional concept of a bio-inert space-holder to constructs providing an
environment both conductive and inductive to regenerating the original tissue structure
and function. This progress is made feasible by the advance in technologies allowing the
capabilities of manipulating the architectural, mechanical and surface properties of tissue
engineering scaffolds. Rational design of tissue engineering scaffolds is therefore
possible, and much needed to facilitate three- dimensional tissue development. Scaffolds
with the desirable mechanical properties can be achieved by the use of the appropriate
polymer and architecture. A careful architectural design also takes into account all of the
nano-, micro-- and macro-scale aspects which allow spatial control in tissue formation at
the molecular, cellular and tissue-length scale respectively. The scaffold not only
provides a void space for cells to proliferate, vascularize and form new tissues. It
provides a pathway for diffusion and mass transport of oxygen and nutrients. Solid-form
fabrication techniques, such as the Three-Dimensional PrintingTM process (Park et al.,
1998; Griffith, 2002), allow precise control in implementing these architectural designs
and the separation of bulk and surface material properties of tissue engineering scaffolds.
Surface design is crucial for the success of tissue engineering scaffolds as the surface is
the interface at which cells and the scaffold interact. Bio-molecules presented by
covalent-linking to a surface can provide an appropriate chemical environment for the
adhesion and function of specific cell types. In this regard, a comb-shaped polymer
recently developed by our laboratory was shown to be protein- and cell-resistant but
small peptides can be covalently attached to the side-chains of the polymer and be
presented at a surface in submicron clusters to induce specific cell function (Irvine et al.,
2001a; Irvine et al., 2001b). This polymer is discussed in detail in the next chapter.
Despite the development of all these tools in tissue engineering, an integral design of
scaffolds has not been widely applied to in vivo bone tissue engineering. A lot of the
earlier works have been aimed to seed cells in scaffolds and grow them in vitro before
implanting them back to the host and in in vivo studies, only simple scaffolds with
undefined pore size and architecture, such as those made by freeze-drying, have been
used. On the other hand, in developing clinical strategies in enhancing the efficiency of
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bone marrow grafts, the focus on optimizing the acquisition and concentration of CTPs
has allowed the possibility for this procedure to be done intraoperatively. However, so
far, only naturally occurring materials and hydroxyapatite have been used as the carrier of
these progenitor cells and the matrix in which these cells are concentrated and grown.
Bringing the aforementioned technologies in tissue engineering into the design of bone
graft scaffolds would free the development of bone marrow grafts from being precluded
by the limitations of the matrices currently used. Taking the best from both the field of
engineering design and clinical cellular engineering, the rational design of a tissue
engineering scaffold that is tailored for the intraoperative concentration of CTPs from
bone marrow and for the proliferation and differentiation of CTPs into bone would
bring bone graft technology to a new dimension.
1.5 Scope of thesis and objectives
This thesis focuses on the molecular design of bone graft surfaces. While the overall aim
of engineering bone marrow graft is to develop a matrix with defined architecture and
surface chemistry to enhance the rapid intraoperative concentration of connective tissue
progenitors from bone marrow aspirates, the objective of this dissertation is to develop
and implement the design of a synthetic polymer system that is capable of enriching
CTPs from whole bone marrow and can be incorporated into the surface of bone grafts
by 3DP TM . A perfect selectivity for CTPs is not needed, in fact may not be desired due
to the possible co-operative interactions between CTPs and other marrow cells. Thus,
our approach is to use the P(MMA-r-POEM) comb copolymer to strategically present
small adhesion peptides to facilitate a two-fold "enrichment" - the positive concentration
and function of CTPs, and the negative selection of other marrow cells in the aspirate.
In particular, this dissertation encompassed three specific aims:
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1. Design of surfaces for bone grafts by the design of the base surface material, the
biophysical and biochemical presentation of small adhesion peptides. And in
particular,
a. Improving the protein- and cell-resistance of comb copolymer, the base
surface material
b. Preparation of comb copolymer surfaces with covalently-bound peptides
c. Selecting a short list of peptides based on critical literature reviews and
empirically identifying peptide-substrates that enhance the selective colony
formation of CTPs
d. Enhancing the efficacy of peptides in mediating cell functions by
biophysical presentation of peptides
2. Developing and standardizing marrow aspirate assays to evaluate and understand
the colony formation of CTPs.
3. Enhancing the interaction of bone marrow cells and graft surface by cell-
preloading treatments
It is our hope that not only the molecular design of substrates for selective adhesion and
proliferation c)f CTPs in this thesis would be incorporated into the overall design of bone
marrow grafts, but the knowledge gained in this dissertation on marrow cells, especially
the CTPs, provide a better understanding in the behavior and molecular profile of these
cells.
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Chapter 2
Design of Base Material for the Surface of Bone Grafts
2.1 Introduction
To design a suitable surface material that presents biomolecules to target specific cells
and their function in bone grafts, several properties of the material have to be considered.
The stability of the material in an aqueous environment, protein and cell resistance, and
the availability and sufficiency of sites for covalently coupling biomolecules to engender
cell response, are all important design criteria. In addition, another favorable property is
facile incorporation onto the surface of bone grafts, by for example, three-dimensional
printing (3DPTM). In choosing a base material candidate, a biomaterial intrinsically
resistant to protein adsorption and cell adhesion is needed. With a cell and protein
resistant base material, any interactions between cells and the material, such as adhesion
and proliferation, are engendered by specific receptor-mediated interactions with
biomolecules covalently coupled to the material, rather than to proteins non-specifically
adsorbed from the culture or grafting environment, such as serum, cellular secretion,
exogenous factors, etc. In this regard, the class of comb copolymers that consist of a
hydrophobic backbone of poly(methyl methacrylate) (PMMA) and short poly(ethylene
oxide) (PEO) side chains (Figure 2.1) were chosen to test for their protein and cell
resistance ability. One comb copolymer in the class with side chains of 6-9 ethylene
oxide units has been previously tested to be completely resistant to non-specific adhesion
of wtNR6 fibroblasts, even in the presence of serum (Irvine et al., 2001a). The
hydrophobic PMMA backbone imparts stability to the comb polymer surface in contact
with aqueous solution while the hydrophilic PEO side chains are extended and segregate
at the water-polymer interface to provide protein and cell resistance as well as sites for
peptide coupling (Figure 2.2). The segregation of POEM sidechains is due to both
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entropic forces - the enrichment of chain-ends at the surface (Walton and Mayes, 1996),
and enthalpic forces - the formation of hydrogen bonds between POEM sidechains and
water molecules (Irvine et al., 2001b).
Figure 2.1 Basic comb copolymer structure. Repeat units are x- methyl methacrylate
(MMA),3 , - poly(oxyethylene) methacrylate (HPOEM), and g- methoxy-
poly(oxyethylene) methacrylate (MPOEM). Side chain lengths are presented as /n and n.
Several attributes of the comb copolymer play a role in giving the material its protein and
cell resistance - the proportion of PEO in the polymer, length of side chains and side
chain end-groups. These parameters were systematically varied to render the comb
copolymer more effective as a bone graft surface material. Previous work gave us an
idea of the range of PEO content we could vary - comb copolymer (6-9 ethylene oxide
unit side chains) with greater than 30 wt% PEO content is generally NR6 fibroblast
resistant while the same polymer with greater than 40 wt% PEO was soluble in aqueous
solution (Irvine, 2000). We tested a set of comb copolymers within this range of PEO
content to determine what properties yielded the greatest resistance to marrow aspirates,
which consist of various cell types as well as a significant amount of associated proteins
from the marrow environment. Different surface chemical groups of biomaterials have
also been known to impart different degrees of cell inertness (Ratner et al., 2004). For
the comb copolymer, it has been shown that certain combs with more methoxy (-OCH 3)
side chain ends are more resistant than those with more hydroxyl (-OH) chain ends
(Hester, 200(); Irvine, 2000). However, only the hydroxyl side chain ends are
functionalizable for downstream peptide-coupling. Hence, in this study, we varied the
sidechain end--groups to obtain good cell resistance and at the same time maximize the
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amount of functionalizable end-groups. The length of side chains also plays a role in
determining whether the comb polymer is protein and cell resistant. Increasing the
length of the side chains while maintaining the same PEO content would mean fewer
side chains in the comb and hence the average spacing between side chains would
increase (Figure 2.3). Greater spacings may reduce protein resistance, as the PEO side
chain in the PEO brush layer may not be able to fan the underlying PMMA backbones.
Adhesion peptides
gi -s
Surface-
segregated _
POEM side
chains
PMMA
backbone
Figure 2.2 A schematic of comb
copolymer structure at the water-polymer
interface. ydrophilic POEM sidechains
(yellow), being enthalpically and entropically
driven, segregated at the aqueous interface
while the backbone PMMA stays in the bulk.
Figure 2.3 A schematic showing the
relationship between sidechain length and
spacing between sidechains. With the
same POEM content, increasing the length
of POEM sidechains increases the spacing
in between.
The same can. happen when the side chains are too short. In addition, long side chains
provide fewer functional groups in a comb molecule. Therefore, in this chapter, the
objective of the work was to evaluate a set of polymers to identify parameters giving the
maximum functionalizable chain-ends without compromising protein and cell resistance.
This was achieved by varying the PEO content of the comb, side chain lengths and side
chain end-groups, and testing empirically with both wtNR6 fibroblasts, one of the most
adhesive cells in our experience, and human marrow aspirates. Protein adsorption
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studies with 1251 -BSA were conducted to determine if comb copolymers were protein
resistant. The water insoluble comb polymer with the optimal protein and cell resistance
and sufficient functionalizable chain ends will be used as the base polymer for our
subsequent studies.
This work was done in collaboration with William Kuhlman, who synthesized and
provided some of the comb copolymers used in these studies.
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2.2 Materials and Methods
2.2.1 Cells and Culture
2.2.1.1 wt NR6 fibroblast cell line and culture
The wtNR6 fibroblast cell line, obtained from the Wells Lab (University of Pittsburgh), is
a 3T3 variant that lacks endogenous EGF receptors but expresses stably-transfected
human EGFR. Cells were routinely cultured in minimum essential medium-a (MEM- cc)
supplemented with 7.5% fetal bovine serum (FBS), 350 ig/mL Geneticin, 1 mM non-
essential amino acids, 2mM L-glutamine, mM sodium pyruvate and 100 i.u./mL
penicillin and 200 ptg/mL streptomycin. All materials were obtained from Gibco, Grand
Island, NY, U.SA. Cells were cultured at 370 C with 5% CO 2 and split when they were
near 80% confluency.
2.2.1.2 Human bone marrow aspirations
Donors and patients presenting for treatment to Dr. George Muschler were recruited for
assay of bone marrow immediately prior to an elective orthopaedic procedure. All
subjects were enrolled with full informed consent under a protocol which was approved
by the Institutional Review Board of The Cleveland Clinic Foundation. Bone marrow
aspirates were obtained using a procedure described previously (Muschler et al., 2001).
In brief, on the day of surgery, following induction of anesthesia and sterile skin
preparation, a. 3-mm stab incision was made approximately 4 cm posterior and lateral to
the anterior superior iliac spine (ASIS). A bone marrow aspiration needle (Lee-Lok,
Minneapolis, MN, USA) was advanced through this incision into the intramedullary
cavity of the iliac crest approximately 2 cm posterior to the ASIS. A 2-ml sample of bone
marrow was aspirated into a 10-ml plastic syringe containing 1 ml of saline containing
1000 units of heparin. Subsequent aspirates were taken using identical technique through
separate cortical perforations separated by at least 1 cm, moving posteriorly along the
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iliac crest. Four aspirates were harvested from each side, a total of eight aspirates per
patient. The heparinized marrow sample from each site was suspended into 20 ml of
MEMo( containing 2 unit/ml Na-heparin and sealed in a 50-ml test tube for
transportation to the laboratory for cell count and experiments. All samples were
harvested by Dr. Muschler.
2.2.2 Comb copolymer synthesis and surface preparations
Comb copolymer was synthesized using a protocol similar to one previously described
but with some modifications (Irvine, 2000; Irvine et al., 2001a). In summary, comb
copolymer was synthesized by free radical polymerization of methacrylate, polyethylene
glycol methacrylate (HPOEM) and polyethylene glycol methyl ether methacrylate
(MPOEM) in toluene using azo(bis)isobutyronitrile (AIBN, Sigma-Aldrich, St. Louis,
MO, USA) as an initiator. The polymer product was purified several times with ethanol-
hexane (1:8). HPOEM of molecular weight Mn - 360 g/mol (6-mer PEO units) and Mn
526 g/mol (9.7-mer PEO units) and MPOEM with Mn - 475 g/mol (9-mer PEO
units) used in the polymerization were obtained from Aldrich (St. Louis, MO). Other
H-POEM and MPOEM, such as 22-mer and 33-mer HPOEM and 45-mer MPOEM
were synthesized by reacting polyethylene glycol (PEG) of the desired chain lengths
(Aldrich) with methacryloyl-chloride (Aldrich) with triethylamine (TEA) as base. The
products were purified using a C1 8 sephadex column.
The molecular weight and polydispersity index (PDI) of resulting comb polymers were
determined by gel permeation chromatography with inline light scattering (GPC-LS,
Wyatt MiniDawn) based on polystyrene standards. The weight ratio of the three
monomers in the resulting polymer were determined by NMR (Bruker Avance DPX400
proton NMR running at 400 mHz) using 1% copolymer solution in deuterated
chloroform. PDI of all comb polymers were less than 3.5 and other specifications of the
polymers were tabulated in Table 2.1.
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Comb m-mer n-mer wt% wt% Total
HPOEM MPOEM HPOEM MPOEM wt%
m= n= PEO
H6M9_1 6 9 17.7% 16.3% 34.0%
H6M9 2 6 9 25.9% 11.1% 37.0%
H6M9_3 6 9 19.8% 16.2% 36.0%
H6M 6 40.0% ---- 40.0% .
H10M 10 ---- 40.0% ---- 40.0% .
H22M0 22 40.0% ---- 40.0% 
H33M0 33 40.0% ---- 40.0% 
H22M9 22 9 35.0% 5.0% 40.0%
H33M9 33 9 35.0% 5.0% 40.0%
HOM9 9 ---- 39.0% 39.0%
HOM45 45...  50.0% 50.0%
Table 2.1 Specifications of comb copolymers tested
Comb polymer substrates used for subsequent protein and cell resistance testing were
prepared by spincoating 0.2ptm-filtered polymer solution on glass coverslips previously
silanized with methacryloxypropyltrimethoxysilane (MPTS, Gelest Inc, PA) to render the
glass surfaces more hydrophobic. To prepare for silanization, glass coverslips were first
sonicated in 200 proof ethanol for 30 minutes to remove any dust and dirt. After rinsing,
the coverslips were placed in a 4% solution of MPTS in 95% ethanol and 5% water (pH
4 -- 5) with constant agitation for 20 minutes. After five rinses in 200 proof ethanol, the
coverslips were allowed to cure in room temperature for overnight, or at 130°C for one
hour. Spincoating solutions were prepared by dissolving comb copolymer in 3:1 methyl
ethyl ketone to toluene solution at 20 mg/mL. Spincoated coverslips were then placed in
'acuo at room temperature for overnight to allow the evaporation of any remaining
solvents. Ellipsometry measurements indicated that the comb polymer thin films
produced by this method were between 900 - 1000 A.
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2.2.3 Protein resistance experiments
To study protein resistance of comb polymer substrates, bovine serum albumin (BSA)
(Sigma-Aldrich, St. Louis, MO) was used as the model protein. BSA radiolabelled with
iodine-125 using iodobeads (Pierce, Rockford, IL) was used to quantify how much BSA
was adsorbed on comb substrates. Comb copolymer surfaces were placed in contact
with BSA solutions with concentration ranging from 0.01 to 1 mg/mL of phosphate-
buffered saline (PBS) at pH 7-7.5 for 2 hours at room temperature. After 2 hours, the
substrates were washed four times with PBS before gamma activity in counts per minute
(cpm) was measured with the Packard Cobra II Gamma Counter. From cpm, the
amount of BSA adsorbed was calculated from the standard calibration curve set up by
gamma counting a series of BSA solutions with known concentrations.
2.2.4 wtNR6 fibroblast resistance studies
wtNR6 fibroblasts were used as the first pass of cell resistance studies before human
marrow aspirates were used. 12mm glass coverslips spincoated with the comb
copolymer to be tested were fixed in 24 well-plates with silicone rings cut out from
biocompatible and non-fouling silicone tubings. Surfaces were sterilized under UV light
for 30 - 45 mins and then pre-incubated with wtNR6 growth media that contained 7.5%
serum overnight before 14000 cells / cm2 were seeded with the same wtNR6 growth
media. Tissue culture treated polystyrene (TCPS) was used as a positive control.
Surfaces were examined under a microscope (Nikon upright, transmission mode) after 48
hours of seeding and on Day 7 and three images were taken per coverslip. Each comb
polymer substrate was tested in triplicate within the same experiment and the results
were from three sets of separate experiments. Images were processed using the Openlab
software and cells in each image were counted manually. The cell counts from
microscopy were correlated with results from Vybrant MTT assays (Molecular Probes,
CA) performed on Day 7 after the images were taken.
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2.2.5 Human marrow resistance studies
Comb copolymer substrates to be tested were prepared on 18mm x 18mm square glass
coverslips by spincoating. Spincoated coverslips were stored at room temperature prior
to use and coverslips were set in experiments no later than 4 weeks after they were first
prepared. In human marrow resistance studies, coverslips were placed in 2-chamber
Lab-tek glass chamber slides (Nunc, NY), sterilized under UV and were seeded with 0.5
million fresh marrow aspirate cells in DMEM with 10% FBS. Glass coverslips and Lab-
tek glass slides were used as the positive control. Non-adherent cells were transferred to
new Lab-tek slides after 48 hours of seeding and were replenished with new media. On
day 6, all slides were washed with PBS twice and fixed. The number of colonies, defined
as a cluster of 8 or more cells, and sub-colony clusters were counted for each slide and
the amount of single cells were scored as + (0 - 10 cells per slip/chamber), ++ (10 - 100
cells per slip/chamber) and +++ (>100 cells per slip/chamber). Four slips/chambers
were used for each type of comb copolymer surface per marrow sample and three patient
samples were used in this study.
2.2.6 Statistical analysis
Results from cell resistance experiments were analyzed by single-factor analysis of
variance (ANOVA) with MSExcel. Pairwise comparisons were performed by using
Fisher LSD post hoc test. Confidence level was as indicated in the figures.
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2.3 Results
2.3.1 Protein resistance studies - 1251 -BSA adsorption on comb surfaces
To determine the amount of BSA adsorbed onto various comb surfaces, adsorption
isotherms were constructed for each of the comb polymers listed in Table 2.1. Results
are summarized in Figure 2.4 and Figure 2.5. The BSA amounts adsorbed on all comb
copolymer surfaces were substantially less than the amount adsorbed on glass. Even the
highest BSA adsorption observed on comb surface was less than 13% of the amount
adsorbed on glass at the same concentration of BSA solution. In most cases, the relative
percentage of adsorption is less than 8% (Figure 2.5) and below 40ng/cm 2 even at the
highest BSA concentration tested (1 mg/mL).
The actual amount of BSA adsorbed on glass was, however, as high as (94.9 + 2.2)
ng/cm 2 even at 0.01 mg/mL of BSA and increased to (477.5 ± 35.4) ng/cm 2 when the
concentration of BSA solution used for adsorption was 1 mg /mL.
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Figure 2.4 BSA adsorption isotherms for comb copolymers with various
POEM content, sidechain lengths and endgroups. Absorption amount was obtained
using 125I -BSA.
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Figure 2.5 Relative percentage of BSA adsorbed on comb copolymers to that on
glass. Absorption amount was obtained using 1251 -BSA.
Among different types of comb copolymer, there did not seem to be an apparent trend
of BSA adsorption in correlation to the attributes of the comb polymer, such as
sidechain end-groups, sidechain lengths, etc. HOM45 was the comb copolymer that was
the least resistant to BSA adsorption. The amount adsorbed on HOM45 surfaces, (61.8 +
1.54) ng/cm 2 at 1 mg/mL, was significantly higher than all the other comb surfaces
tested while adsorption to H22M9, H33M9 and H6M9_1 was lower than the other
combs. The adsorption isotherms of H6M9_2, H6MO and H1OMO almost coincided
with each other. At 1 mg/mL BSA concentration for adsorption, most comb
copolymers had reached or were approaching an asymptotic maximum of BSA
adsorption, with the exception of H22M9 and H33M9, both of which exhibited the
lowest amount of BSA adsorption compared to the rest of the comb copolymers tested.
2.3.2 wtNR6 fibroblast resistance of comb copolymers
The wtNR6 fibroblast cell line is the most adhesive cell line we have in our experience
and was therefore chosen to be used to empirically test the cell resistance of comb
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copolymers in the presence of serum. All comb copolymer surfaces were inert to cell
attachment even after 24 hours of serum pre-incubation and subsequent seeding with
wtNR6 cells for 7 days. Figure 2.7 shows the relative percentages of wtNR6 fibroblast
adhesion on various comb copolymer surfaces. Here, relative cell adhesion is defined as
the ratio of number of adherent cells on comb surfaces to that on tissue-culture
polystyrene (TCPS) control surfaces. Figure 2.7 showed that all comb copolymers, even
the less cell resistant H22M9, H33M0 and H6M9_2, exhibit a relative cell adhesion of
less than 25/o in 7 days (p <0.001 vs. TCPS control, Fisher LSD post hoc test). Due to
this low relative cell adhesion observed, to obtain statistical significance in cell resistance
performance, each comb copolymer was compared pair-wise with H6M9_1 and H22M9
as reference points. Comb polymers with only methoxy-terminated POEM sidechains,
the 9-mer HOM9 and the 45-mer HOM45, as well as the 10-mer HPOEM sidechain
comb H10M0O were the most cell resistant. Relative cell adhesion was only (1.38 +
0.78)%, (0.52 ± 0.27)% and (2.10 ± 0.68)% respectively. These three comb copolymers
were the only ones that exhibit a lower relative adhesion than H6M9_1 with p < 0.05 and
H22M9 with p < 0.01. The comb polymer with 6-mer HPOEM sidechains, H6MO and
1-16M9_3 (comb copolymer with a mixture of 6-mer HPOEM and 9-mer MPOEM
siclechains) also exhibited excellent NR6 fibroblast cell resistance. ((2.05 + 1.16)%, and
(2.03 + 1.24)% respectively. p < 0.01 vs. H22M9.) When observed under the
microscope, many of these surfaces, particularly the ones that exhibited less than 3% cell
adhesion, had no cells adhered on them in general. For the fibroblasts that were attached,
they were either round and did not spread as they did on TCPS surfaces or they were
found on visible defects on the surface, such as scratches that exposed the underlying
glass to which the cells adhered. Encouraged by these results of inertness of the comb
copolymer with fibroblast cell lines, we proceeded to test these comb copolymers for
their resistance to human marrow aspirates.
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Figure 2.6 Microscopic image of HIOMO
comb surface after wtNR6 has been seeded for 7
days. The image showed no apparent cell
adhesion.
**
** ** ** r
*
** # ** #
H6M9_2 H6M9_1 H6M9_3 H6MO H1OMO H22MO H22M9 H33MO H33M9 HOM9 HOM45
Figure 2.7 Relative ratio of adherent wtNR6 fibroblasts on comb copolymer surfaces
to that on TCPS control after 7 days of culture. Note that all comb copolymers
supported less than 25% of non-specific cell adhesion compared to TCPS control.
H6M9_3. H6MO, H1OMO and MPOEM combs exhibited less than 5% cell adhesion. Cell
adhesion was assessed by countingthe number of adherent cells in microscopic images of
surfaces. Results are mean ± SE of three experiments. (Error from variance of three
experiments, which was larger than the technical error propagated from triplicates of each
experiment (data not shown), was used here to give a more conservative error
measurement.) The differences observed among the comb copolymers were significant,
p < 1x10' °0 (ANOVA). Comb surfaces were compared with H6M9_1 and H22M9 using
the Fisher LSD post hoc test. * p < 0.05 vs. H22M9, ** p < 0.01 vs. H22M9, and p <
0.05 vs. H6M9_1.
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2.3.3 Human marrow aspirate resistance of comb copolymers
To study how resistant comb copolymers were to non-specific adhesion of bone marrow
aspirates, the colony forming unit (CFU) assay was used. The number of cell colonies
(cluster of 8 or more cells) and sub-colony clusters were counted and the number of
single cells on the substrates was recorded on a scale of 1 (+) to 3 (+++), where + (0 -
10 cells per slip/chamber), ++ (10 - 100 cells per slip/chamber) and +++ (>100 cells
per slip/chamber) of 500,000 marrow cells seeded. CFU efficiency, which is defined as
the ratio of colonies formed on a test surface to that on glass or a Lab-tek control, was
used to measure colony formation on comb surfaces. With the exception of H6M9_2,
which supported (38 ± 15) % of CFU efficiency, all comb copolymers showed significant
reduction of colony formation compared to glass control (p < 0.001). However, due to
the lower amount of CFU formation observed, the trend among comb copolymer wasn't
statistically significant. Only H6M9_1 and H6M9_3 showed significantly less CFU
formation than H6M9_2 (p < 0.05, Fisher LSD post hoc test), suggesting good cell
resistance for these two polymers. H6MO and HOM9 seemed to show very good
resistance to non-specific colony forming cell adhesion and colony formation (CFU
efficiency less than 2%). However, due to the smaller sample size for these two
polymers (n = 5, compared to n = 12 for H6M9 comb copolymers), statistical
significance was not observed. The longer chain polymer H33M0, H33M9 and HOM45
did not seem to perform as well (CFU efficiency ranged from 9% to 14%) while the CFU
efficiency of H-16M9_1, H6M9_3, HiOMO, H22MO and H22M9 were less than 6% (Figure
2.8). When subcolony-clusters were taken into consideration, and the ratio of the sum of
colonies and subcolony-clusters on comb surfaces to that on glass controls (%o/o,,,lie,,s+ier
was plotted for each comb copolymer, we found that the longer-sidechain combs were
not as resistant as the shorter sidechain ones (Figure 2.9). H22M9, H33M0 and H33M9
supported over 40% of colony and subcolony-cluster formation when compared to that
on a glass control. H6MO, HlOMO, H22M0 were the most resistant to non-specific
colony and cluster formation (p < 0.05 vs. H22M9) followed by comb with only
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methoxy-terminated POEM sidechains (p < 0.1 vs. H22M9). However, around 20% of
non-specific colony and cluster formation was observed on H6M9 comb copolymers.
The degree of single cell adhesion was very similar for all surfaces, comb copolymers and
glass or Lab--tek slides.
(Table 2.2)
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Figure 2.8 CFU efficiency of comb copolymers and glass. CFU efficiency is
defined as the ratio of adherent colonies on test surfaces to that on glass, the positive
control of the CFU assay. Results are mean ± SE. Statistical significance (p < 1x10-8 ,
ANOVA) was observed in the differences in CFU efficiency of comb copolymer and
glass. However, other than a p < 0.001 vs. glass significance level was observed for
all comb copolymers and a * p < 0.05 for H6M9_1 and H6M9_3 vs. H6M9_2, the
difference in CFU efficiency of the other comb copolymers was not statistically
significant. This may be due to the smaller sample size of the non-H6M9 comb
copolymers. (n = 12 for H6M9's and glass; n = 3 for all others).
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Figure 2.9 Colony and subcolony cluster formation on comb copolymer surfaces.
The ratio of the sum of the colonies and clusters on comb copolymer surfaces to the
sum on glass control was reported here. Data are mean + SE. Statistical significance
(p < 0.0009, ANOVA) was observed in the differences in CFU efficiency of comb
copolymer and glass. Relative colony and cluster formation of all comb copolymers
were lower than that on glass control (p < 0.02, Fisher LSD post hoc). * p < 0.1 vs.
H22M9, ** p < 0.05 vs. H22M9; p < 0.1 vs. H33M0 and H33M9. (n = 5)
Single Cell Adhesion Score
H6M9 1 + q
H6M9 2 +-4
H6M9 3 +-
HMO q -
H10MO t +t
H22MNIO + 4
H22M9 + +
H33NIO ++
H33M9 + -
HO(M9 +
HOM45 +
Glass + +
Table 2.2 Single marrow cell
adhesion on comb copolymers.
+ is assigned to surfaces with 1 -
10 adherent single cells, ++ to 11-
99 cells and +++ to > 100 cells.
(n > 5)
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2.4 Discussion
Bovine serum albumin has been widely used in model investigations of non-specific
protein adsorption. It is chosen in this study on comb copolymer surfaces because of
the high prevalence of albumin in blood. BSA is known to adsorb on a great variety of
both hydrophilic and hydrophobic surfaces due to its low conformation stability, and
therefore is a favorable model protein for studying adsorption on the amphiphilic comb
copolymers. Hence, the first part of the study on bio-inertness of bone graft surface
materials consists of a simplified protein-surface system to measure the adsorption of the
well-characterized protein BSA on comb copolymers in PBS.
BSA has a molecular weight of 66500 Da and an isoelectric point of 4.7. It has been
widely demonstrated in the literature that at neutral pH, BSA takes on its native or "N"
form. The "N" form is a heart-shaped molecule with dimensions of 8.0 nm on the sides
and a depth of 3.0 nm (Peters, 1985; Giacomelli et al., 1997). Based on these dimensions,
the estimated structural area of BSA was calculated to be 27.7 nm2 and therefore,
assuming BSA molecules could be closely-packed into a monolayer, a monolayer would
contain 397 ng/cm 2 of BSA. When taking into consideration the electrostatic repulsion
between adsorbed BSA molecules, with contribution from the double-layer thickness
(1,/Km), the effective area of BSA for adsorption, can be estimated by
Aeff (A + 2 2
where Km is the Debye-Hiickel parameter, which because BSA is a soft molecule
(Giacomelli e: al., 1997), is expressed as
Km = iK(l + ( P )2)42zen-
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where p is the charge density of BSA (- 3.6 x 10-20 C/nm 3) at pH -7-8, e the elementary
electrical charge, ~, and ni the electrolyte solution valence and concentration, respectively
and K, a Debye-Hiickel parameter -
'e2 ni zi
T
where £ is the dielectric constant. The main composition of PBS was NaCl at 120mM.
The Debye-Hlickel parameter, K, is thus, 0.787 nm-1 and the double-layer thickness
(1 /Km) is 0.88nm. Hence the effective area can be estimated to be about 49 nm2. Based
on this effective area of BSA, a monolayer would contain approximately 225 ng/cm 2 of
BSA, which is lower than but in the same order of magnitude as that estimated solely
from the size of a BSA molecule.
Comparing the results from the BSA adsorption study to these estimates of a BSA
monolayer, BSA adsorption on glass surfaces leveled off at an asymptotic value of about
500 ng /cm2. This value, higher than that of the estimated BSA monolayer, could be an
indication that more than a monolayer of BSA was adsorbed on glass surfaces. However,
BSA adsorption for all comb copolymer substrates was lower than that of a BSA
monolayer. Several comb copolymers performed superbly in resisting non-specific BSA
adsorption. Isotherms of H6MO, H1OMO, H6M9_03, H6M9_01 all reached an
asymptotic adsorption value of less than 30 ng/cm2 , which was about one-tenth of the
calculated monolayer. H22M9 and H33M9 also showed less than 30 ng/cm 2 adsorption
up to the highest concentration of BSA tested. However, at that concentration, their
adsorption isotherms were still increasing and thus these two polymers could show an
elevation in BSA adsorption and thus may not be non-fouling at a higher concentration.
The amount of adsorbed BSA measured in this study was likely to be higher than in
reality. Comb copolymer was cast on glass coverslips by spincoating. This technique
created relative smooth films at and near the center of the coverslips, but as the polymer
solution was spun off during the process, residues accumulated near the edge and around
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dust particles on the surface giving rise to irregularities such as small folds and cracks
which increased the surface area and exposed the underlying glass leading to an elevated
amount of BSA adsorption. These irregularies, the result of a shortcoming of
spincoating, were visible under the microscope even at 5X magnification. However,
even with the increased amount of BSA adsorption due to the presence of these surface
defects, comb copolymers, H6M0, HiOMO, H6M9_03, H6M9_01, H22M9 and H33M9
were still non-fouling at high BSA concentrations, as discussed above.
We compared the performance of these "non-fouling" comb copolymers with other
similar BSA adsorption investigations on PEO-grafted polymer or surfaces reported in
the literature. One of the most non-fouling surfaces found in the literature was
polyethylene and polytetrafluoroethylene surfaces deposited with tetraethylene glycol
dimethyl ether (TEGDME) by glow discharge plasma deposition (Lopez et al., 1992).
Lopez et al. performed a series of protein adsorption studies on these surfaces with
Baboon albumin at 0.2 mg/mL concentration. After two hours of adsorption, the
amount of BSA adsorbed on these non-fouling TEGDME surfaces was about 20
ng/cm 2, and our results showed that BSA adsorption on the non-fouling comb
copolymers was in the same range. Our results are also in agreement with previous
investigations by Hester et al. who showed by x-ray photoelectron spectroscopy and BSA
stained with anionic colloidal gold that BSA resistance was imparted by HOM9 comb
copolymer segregated on the surface of poly(vinylidene fluoride) (PVDF) membranes
(Hester et al., 1999).
The BSA adsorption study only gave a rough estimate of how much protein would be
adsorbed onto comb copolymer substrates in an oversimplified scenario, with only one
protein in PBS. Nevertheless, it served to provide a first-pass screening of whether a
given comb copolymer was non-fouling and allowed us to compare its performance with
other model protein adsorption studies in the literature. However, in in vitro culture and
more so in an in vivo grafting site, comb copolymer would be subjected to aqueous
environment with various proteins, including those secreted by cells. With proteins of
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different size, charge, bulk concentration and surface activity, adsorption to surfaces
becomes a lot more complicated as proteins dynamically compete for sites on the surface.
The conformation of the adsorbed protein also could not be predicted by this kind of
protein adsorption study. However, it is the type of adsorbed proteins and their
conformation at the surface that determine whether cells would adhere to the surface
through binding their receptors to the adsorbed proteins. Therefore, to investigate
which comb copolymer is the most inert in in vivo and in vitro situations, empirical studies
were needed to measure the relative amount of non-specific cell adhesion on various
comb copolymers using cells directly relevant to the in vitro and in vivo situations of
interest.
As mentioned before, the wtNR6 fibroblast cell line was used to study the cell resistance
of comb copolymers because of its known strong adhesiveness to attach non-specifically
to surfaces (Maheshwari et al., 2000) and the prevalence of fibroblasts in the body. Our
studies indicated that most comb copolymers tested showed excellent fibroblast
resistance. Less than 5% of the amount of cells adhered to TCPS adhered to H6M9_3,
H6M0, H10AI0, H22M0, HOM9 and HOM45. It needs to be pointed that the amount of
adherent cells measured, whether at 48 hrs or on day 7, reflects the number of fibroblasts
initially adhered as well as the ones proliferated during the course of the experiments.
Results from the study also showed that comb copolymers with methoxy-terminated
sidechains were more fibroblast resistant than those with hydroxyl-terminated sidechains,
or a mixture of both. However, its marrow resistance was similar to that of the most
marrow-resistant HPOEM or H6M9 combs. Previous experimental data from our group
also indicated that comb copolymers with methoxy-sidechains were more wtNR6
resistant than hydroxyl ones (Irvine, 2000). Comb copolymers with longer sidechains
were in general less resistant to non-specific cell adhesion than those with shorter
sidechains. This could be due to the increased average distance between POEM
sidechains exposing the PMMA layer to non-specific adsorption of proteins in the media.
As a consequence, cells could adhere themselves to the adsorbed proteins. Even though
less cell adhesion was observed on H6M9_3 which had 36 wt% total POEM compared
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to the 34 wt%-POEM H6M9_1 ((10.46 + 2.4) % and (2.03 + 1.24) %), the margin
POEM content was too small and the statistical insignificance as analyzed by post hoc
comparison test made it impossible to conclude whether a higher POEM content
contributed to better cell inertness. Note that in both H6M9_1 and H6M9_3, the ratio
of HPOEM to MPOEM was roughly 1:1. The much-higher non-specific cell adhesion
observed on H6M9_2, despite its high POEM content (37 wt/o), was unexpected. Even
the higher HPOEM:MPOEM ratio (2.3:1) compared to the other two H6M9 polymers
could not explain its compromised cell resistance as H6MO had no MPOEM sidechains
at all and contained 40 wt% HPOEM. The results of wtNR6 resistance showed no
correlation with the BSA adsorption studies. For instance, HOM45 substrates, one of the
most cell resistant surfaces, supported the highest amount of BSA adsorption. This
showed that despite the fact that BSA is the main constituent of serum, BSA adsorption
studies were not a good predictor of the total amount of all proteins that would adsorb
onto the surface and/or the amount of non-specific cell adhesion was not only
dependent on the amount of protein adsorption.
The marrow aspirate resistance study was the most direct estimate of how comb
copolymers would behave in bone marrow grafts or in in vitro studies with marrow
aspirates. Bone marrow consists of various cell types and in measuring the number of
colonies, subcolony-clusters and single adherent cells, the investigation hoped to shed
light on how different cells, differentiated by their adhesion and colony-forming
characteristics, would behave on comb substrates. Colonies and subcolony clusters on
surfaces would most likely be populated by colony forming cells such as the connective
tissue progenitors (CTPs). Subcolony clusters indicated the presence of these cells but
probably with a slower proliferation rate than those in the colonies. Single cells found on
test surfaces could be any adherent cell types in bone marrow, such as fibroblasts,
endothelial cells, macrophages or CTPs that have not proliferated to form clusters or
colonies. Further details of the colony forming assay will be discussed in Chapter 5.
Colony formation requires both the initial adhesion of a colony forming cell to the
surface as well as subsequent proliferation of that cell within 6 days to become a colony.
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Thus, failure to support colony formation on an inert surface may be by means of
resisting the initial adhesion of colony forming cells and/or inhibiting or retarding the
proliferation of an adherent colony forming cell. In the case in which proliferation of an
adherent colony forming cell was retarded, one would expect to see an increase in
%0 o/olits+c/us/etr, the ratio of the sum of colonies and subcolony clusters on test surfaces to
that on the glass control and/or the number of single cells on test surfaces. By day 6 in
CFU assays, most colonies that were capable of forming would have formed on glass
surfaces and our data showed that the number of subcolony clusters on glass was very
small compared to the number of colonies. Therefore, increase in %,o/onies+c/,st,, signified
an increase in the number of subcolony clusters on test surfaces. This increase was very
significant in the case of three of the four long sidechain combs, H22M9, H33M0 and
H33M9, as well as all of the three-component combs, H6M9. This showed that there
were a number of non-specifically adhered colony-forming cells on these comb
substrates, but that their proliferation was relatively slow so they did not fully develop
into colonies. Our data showed that the number of adherent single cells on all surfaces
fell in the narrow range of a score of 1.2 to 2.25, i.e., around 10 - 100 single adherent
cells per 2 million marrow cells seeded. The low percentage of cells adhering to the
surfaces indicated that comb copolymers were very inert to non-specific cell adhesion in
bone marrow aspirates.
From the cell resistance studies done empirically as described above, comb copolymers
that were the most resistant to both fibroblasts, a cell type highly present in human
tissues, as well as human marrow aspirates, which would be the cell source to be used for
bone graft and subsequent studies, were identified. Only comb copolymers with
functionalizable sidechains, in this case, the HPOEM sidechains, were chosen here. The
hydroxyl end--groups of HPOEM sidechains could be activated a number of ways, such
as with tresyl chloride, 4-nitrophenylchloroformate (NPC) and p-
maleimidophenylisocyanate (PMPI) for covalent coupling with peptides and small
proteins to engender specific cell response in subsequent studies. In light of that, two
comb candidates, H6MO and H1OMO were identified. Both polymers had excellent cell
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resistance. Calculations from GPC and NMR results showed that each H6MO polymer
molecule had, on average, 86 HPOEM sidechains, ie, 86 functionalizable sites, while 107
HPOEM sidechains were present on each H10M0 molecule. The higher number of
sidechains for the H10M0 polymer was due to the polymer's higher molecular weight
and hence more repeating units. The H10M0 comb copolymer was chosen at the end as
the comb copolymer to be used for subsequent studies due to its higher number of
HPOEM sidechains and longer sidechains which may be preferable due to the higher
flexibility of the sidechains. A large-scale batch of H10M0 comb copolymer was
synthesized as a result. Its cell resistance was re-verified to be similar to the H1OM0
comb copolymer tested previously. Unless otherwise noted, this polymer was used in all
subsequent studies.
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Chapter 3
Functionalization of Comb Polymer, Surface Modification
and Characterization
3.1 Introduction
]n the previous chapter, we identified the comb copolymer, HlOMO, as the choice of
biomaterial to be used for the surface design of bone marrow grafts. This polymer, as
we have shown, was resistant to protein adsorption and non-specific cell adhesion. To
engender specific cell response, the polymer must be functionalized with biomolecules
and be presented to surrounding cells. As the primary interest of this thesis is to
optimize the interaction of bone marrow aspirate cells with the surface of bone grafts to
achieve better efficacy in bone formation, a two-dimensional model to study cell
interactions with surfaces is preferred. Therefore, methods for functionalizing comb
copolymers were developed with this in mind. The objective of work described in this
chapter is to develop methods for coupling small adhesion peptides to the sidechain ends
of comb copolymer at the surface. With small modifications, the protocols could be
easily adapted. to coupling bigger proteins. Small adhesion peptides were focused on due
to their robustness and low risks of undesirable immune response compared to proteins
of bigger size and complicated tertiary structure. Peptides exhibit higher stability towards
pHI-variation (Ito et al., 1991), storage (Boxus et al., 1998) and sterilization conditions
(Weiss et al., 2001). Such stabilities are highly favorable for the fabrication of peptide
surfaces as well as the preparation of them for biological studies. In addition, it has been
shown that cell integrins can bind to small adhesion peptides such as the tri- residue
sequence RGD (Pierschbacher and Ruoslahti, 1984; Ruoslahti and Pierschbacher, 1987).
The reasons for using peptides and the choice of peptides used in these studies are
discussed in greater detail in Chapter 4.
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Two steps of chemical reactions were involved in the functionalization of comb
copolymer. First was the activation of the polymer sidechain ends so that in the second
reaction, peptides can be coupled to them. Peptides can be covalently coupled to the
hydroxyl sidechain ends of comb copolymer via the amine or carboxylic terminal groups
or via the thiol of a cysteine or sidechains of other residues. Here we focus on
developing methods to couple peptides via the amine terminus as it is the most readily
available in all peptides, compared to, for example, cysteine or other sidechain groups in
a particular residue. In activating the comb polymer for peptide coupling via the amine
terminus, numerous reports could be found in the literature in activating polyethylene
glycol (PEG) chains, for example, by alkylation or acylation, for subsequent peptide or
protein conjugation. For instance, hydroxyl-terminated PEG could be activated with
tresyl chloride (Delgado et al., 1990; Sperinde et al., 1999) or carboxylated then activated
with hydroxysuccinimidyl esters (Shah and Watson, 1993). These protocols, however,
could not be transferred directly to activate the comb copolymer. The amphiphilic
nature of the comb presented complications both in activating the polymer as well as in
purification and processing after the activation. Issues such as solubility could be
anticipated. Previous work done in our lab had used N-hydroxylsuccinimide (NHS) to
activate comb copolymer after the hydroxyl chain-ends had been first carboxylated
(Irvine et al., 2001a). Later in this chapter, this method of comb functionalization and its
companion protocol of peptide coupling to NHS-comb in solution will be revisited and
compared with the methods developed in this chapter. In the work presented here, as
we were primarily interested in cellular interactions with peptides presented by the comb
at the surface, peptides are coupled to activated comb copolymer at the surface instead
of in solution. Surface coupling allows a much more economical use of peptides
compared to solution coupling and purification is much easier due to the amphiphilic
nature of the comb polymer and the fact that the addition of peptides could change the
solubility of the polymer after coupling. This chapter describes the development of
methods for activating and peptide-coupling the comb copolymer, and the
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characterization methods that were central to the implementation of the two-dimensional
experimental model for subsequent cell studies. An additional advantage of the comb
copolymer was the possibility to allow easy tuning of peptide surface density, an essential
feature for the experiments directed at determining the effect of peptide density on cell
function. The optimization of the coupling reaction and post-reaction purification, as
well as the quantification of peptide densities on these surfaces is discussed. At the end
of the chapter, peptide-coupled comb surfaces are evaluated on their sturdiness and
stability over a 21-day period.
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3.2 Materials and Methods
3.2.1 NPC activation of comb copolymer, purification and characterization
Comb copolymer was dissolved in benzene and free-dried azeotropically to remove all
the moisture in the polymer. The polymer was then dissolved in dichloromethane and
4.5 times excess of triethylamine (TEA) was added. (Since this procedure was to activate
the hydroxyl- terminal of PEO sidechains of comb copolymer, all stated molar excess
ratios are relative to the number of moles of hydroxyl end-groups to be activated.) The
reaction flask containing the reaction mixture was cooled in an ice bath while the flask
was purged with nitrogen. When the mixture was cooled to 40 C, 2.5 times molar excess
of 4-nitrophenyl chloroformate (NPC) dissolved in dichloromethane, was injected into
the reaction flask. The mixture was allowed to react for 2 hours on ice and overnight at
room temperature or 4 hours on ice.
At the end of the reaction, the product was concentrated by rotary evaporation. TEA
salts were removed by precipitating the mixture in ethyl acetate followed by
centrifugation to separate the salt precipitate from the activated polymer solution. After
a second precipitation, the NPC-activated comb polymer was purified by filtering the
polymer solution into petroleum ether to form precipitates. The amount of petroleum
ether used was more than 8 times the amount of polymer-ethyl acetate solution in order
for the comb copolymer to precipitate. The precipitate was re-dissolved in ethyl acetate,
filtered and re-precipitated in petroleum ether two more times before the polymer was
dried in vacuo. NPC comb polymer was aliquoted and stored at -200 C until use.
NPC-activated comb copolymer was analyzed by gel permeation chromatography with
inline light scattering (GPC-LS, Wyatt MiniDawn) and the percentage conversion of
sidechain hydroxyl-terminal groups to NPC was determined by NMR (Bruker Avance
DPX400 proton NMR running at 400 mHz). 1H NMR spectra were obtained for 1%
copolymer solutions in deuterated chloroform.
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3.2.2 Peptide-coupling to comb substrates and preparation of surfaces with
different peptide densities
To prepare surfaces with various peptide surface densities, a series of comb copolymer
solutions were made by mixing NPC-activated comb copolymer with its non-activated
counterpart in defined proportion. These comb copolymer solutions with various
percentages of NPC-activated comb were then spincoated on glass coverslips, as
described in the previous chapter, to give rise to surfaces with various densities of NPC
comb sidechains. Hence, when peptides were allow to couple to these surfaces, different
peptide surface densities could be obtained.
Peptides were obtained from several sources, the MIT Biopolymers Laboratory, Tufts
University Core Facility or synthesized in our own laboratory. All peptides were purified
by high performance liquid chromatography and analyzed by MALDI mass spectroscopy.
Peptides with free amine terminal groups were dissolved in 0.1 M sodium bicarbonate
(NaHCO 3) buffer (pH 8.3) at - mM, unless otherwise specified. Peptide coupling was
done by placing spincoated surfaces with NPC-activated comb copolymer in contact
with peptide solution for 4 to 5 hours at room temperature. The surfaces were then
rinsed twice with sodium bicarbonate buffer before ethanoamine (EtAm) solution
(0.025M EtAm in 0.25M NaHCO3 buffer) was added to the surfaces to deactivate the
remaining NIPC groups that had not been coupled to peptides. The surfaces were
allowed to incubate in the EtAm solution at 370 C overnight and then rinsed three times
with NaHCO 3 buffer and finally with milliQ water to remove residual bicarbonate salts.
3.2.3 Quantification of side product release
The amount of 4-nitrophenol, side product given off by the reaction of NPC groups,
could be measured by colorimetry. The peptide solution used for coupling was collected
at the end of the experiment. The absorbance of the solution at 400 nm was measured
by a spectrophotometer. Correlating the absorbance with a standard curve of
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absorbance versus known amount of 4-NP, the amount of 4-NP given off by the
reaction of NPC-activated comb was calculated. Note that the amount of 4-NP
measured was the collective amount given off by both the hydrolysis and peptide-
coupling to NPC groups. Since 4-NP is a small molecule that can easily diffuse,
contributions can come from reaction throughout the polymer film, and not just limited
to, the very top surface.
3.2.4 Quantification of peptide surface density
To quantify peptide surface density, peptides were radiolabelled with iodine-125 using a
similar iodobead method as reported by Brown (Brown, 1999) but modified to
accomodocate the peptides used here. In brief, 20 tL of peptides (approximately
2mg/mI in PBS) were allowed to react with an iodobead and 5mCi of 1251 for 15
minutes. The reaction was then quenched with 80 FL of the reducing agent sodium
metabisulfite (12 mg/mL in PBS) followed by cold potassium iodide solution. Peptides
were purified with a C18 Sep-Pak Reverse phase cartridge (Waters, MA). 1251 - peptide
solution was loaded on the cartridge and a series of water-based solutions containing 1%
trifluoroacetic acid (TFA) and an increasing amount of methanol (10% to 80%) were run
through the cartridge to elute the 1251 -bounded peptides and separate them from free 125I.
A gamma counter was used to determine the fractions which contained the most 125 -
peptides. 2 mg of cold peptides were then added to the 125 - peptide fraction and
because of the relatively negligible amount of 125I - peptides in the solution compared to
that of the cold peptides added, the final concentration was based only on the amount of
added cold peptides. The peptide solution was then titrated to approximately pH 8.3.
To quantify peptide surface density, 25I - peptide solution prepared as described above
was diluted to the concentration at which peptide-coupling would usually be done. In
essence, the reaction parameters of peptide-coupling were kept the same as that used in
preparing regular peptide-coupled comb surfaces of which the peptide density was of
interest. After deactivating with ethanoamine and several washes with 0.1M sodium
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bicarbonate buffer, gamma activity of the 12 5I-peptide-coupled coverslips was measured
with a Packard Cobra II Gamma Counter. By correlating gamma activity with the
standard calibration curve of gamma activity versus number of 125 - peptides, obtained
by gamma counting a series of 125I - peptide solutions with known concentrations, overall
peptide surface density on a substrate was calculated.
3.2.5 Surface stability studies
Spincoated surfaces with NPC-activated comb and its non-activated counterpart were
prepared as described in previous sections. Surfaces were coupled with 12 5I-peptides and
de-activated with EtAm as described above. After washing, substrates were placed in 24
well-plates where cell growth media (DMEM with 10% FBS, 2mM L-glutamine, mM
sodium pyruvate, 100 i.u./mL penicillin and 200 tkg/mL streptomycin) were added. The
substrates were incubated in media at 37°C for up to 21 days. During this 21-day period,
a triplicate of substrates were taken out on day 0, day 1, 3, 7, 14 and 21 to assess the
gamma activity on the substrates and in the media.
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3.3 Results
3.3.1 Characterization of NPC-activated polymer
Comb copolymer activated with NPC was characterized by GPC and NMR. Results
from GPC did not show any detectable difference in molecular weight and polydispersity
index before and after the NPC activation. The conversion of hydroxyl sidechain ends
of comb copolymer to NPC was assessed by NMR. The characteristic pair of proton
peaks of 4-nitrophenyl carbonate at 7.4 - 8.4 ppm indicated the successful activation by
NPC (Figure 3.1). The ratio of the proton peak of the ethylene group attached directly
to 4-nitrophenyl carbonate to the proton peak corresponding to the ethylene group
attached to a MMA group gave the percentage of POEM sidechains that were activated.
Without azeotropic freeze-drying of the comb copolymer before the activation, the
percentage of NPC activation, for both the H10M0 and H6M9_3 comb copolymer, was
consistently only around 55%. The percentage of NPC activation drastically increased to
over 80% with freeze-drying preparation of the polymer.
3.3.2 Peptide-coupling to comb polymer surfaces and quantification of
peptide surface density
3.3.2.1 Effect of pH on peptide coupling
In attempt to optimize the peptide-coupling reaction as well as the removal of non-
specifically adsorbed peptides on the substrates, parameters of the peptide-coupling
reaction and the washing procedures were varied. For all the peptide-coupling reactions,
the amount of peptides used was always in excess in order to maximize the amount of
coupling. Thus the main parameter to be varied was the pH of the reaction. Two
different pH conditions were used for peptide coupling, pH 8.3 and pH 10. The results
for coupling the peptide GRGDSPY to the H6M9_3 polymer under these two pH
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Figure 3.1 'H NMR spectra of NPC-activated comb copolymer. e refers to the two
hydrogens immediate to - COO - in all POEM sidechains. The ratio of c to e gives the
percentage of- OH groups to - NPC.
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conditions are shown in Figure 3.2. Peptide densities were obtained by using 125 -
peptides, as outlined in the Methods and Materials section. The peptide density shown
in Figure 3.2 was the per unit area difference in the number of peptides as measured
from the gamma activity on a surface and that on a substrate with no NPC-activated
comb (ie, the non-activated version of the same comb copolymer). The amount of
peptides measured on the non-activated comb surface represented the amount of non-
specifically adsorbed peptides. Coupling efficiency was higher at pH 8.3 than pH 10 and
the same results were observed for other peptides with the same polymer as well as the
3-component polymer H6M9.
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Figure 3.2 Amount of GRGDSPY peptides coupled to surfaces with NPC-
activated comb at pH 8.3 and pH 10. Error bars showed standard errors of substrate
quadruplicates within a representative experiment. The experiment was repeated
twice and. similar results were obtained.
3.3.2.2 Quantification of surfaces with various peptide densities
Spincoated surfaces with 0% to 100% NPC-activated comb in the bulk spincoating
solution were synthesized. Figure 3.3 and Figure 3.4a showed the two general trends of
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peptide densities when 125I - peptides were coupled to surfaces with increasing NPC-
comb densities. When the percentage of NPC-activated comb was increased from 0% to
about 30%, the increase of surface peptide density was linear (R2 > 0.95 for all peptides),
as shown in Figure 3.4b. However, beyond about 30%, the increase in peptide density
started to plateau off or even decreased at the highest percentages of NPC-activated
comb, as in Figure 3.3.
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Figure 3.3 The biphasic trend of peptide surface density with increasing %/
NPC-activated comb on the surface. Peptide surface density decreased at high %
of NPC -activated comb on the surface. Figure 3.4 showed another typical trend in
peptide quantification in which peptide surface density leveled off beyond - 30%
NPC-activated comb on the surface. Error bars showed standard error of technical
triplicates.
As the expected trend was a monotonic increase in peptide density as the ratio of NPC-
comb to non-activated comb on the surface was increased, a number of experiments
were carried out to explain the biphasic variation of peptide density with increasing
NPC-comb. We hypothesized that the side product released from the reaction of NPC
groups may have an effect. A set of experiments was therefore carried out to investigate
the effect of the reaction side product, 4-nitrophenol, which was given off by both the
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coupling and hydrolysis reactions, on peptide density. The amount of 4-NP given off by
NPC-activated comb coverslips were measured by colorimetry. The total amount given
off by a 10mm diameter 100% NPC-activated comb surface was 1.0 jig. Assuming this
amount was concentrated within the couple hundred microns immediately above the
surface before mixing, the concentration of 4-NP near the surface would be
approximately 0.23 ptmol/mL. Exogenous 4-NP, at this concentration, was added to the
peptide coupling buffer to investigate its effect on coupling. Peptide-coupling densities
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on these surfaces were compared to that without the exogenous 4-NP and peptide
density was lower on coupling with exogenous 4-NP, as shown in Figure 3.5. Peptide
surface density was also lower when peptide solution that had been previously used for
coupling to NPC-activated comb was used in the coupling reaction (Figure 3.6). Since
the amount of peptide in the coupling solution was in excess, the only difference
between recycled and new peptide solution was the 4-NP from the previous reaction.
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Figure 3.5 Effect of 4-nitrophenol on surface peptide coupling yield. The
amount of exogenous 4-NP added was comparable to the amount local at the
surface due to the side product released by the reaction of NPC groups. Error bars
showed standard errors of substrate triplicates of a representative experiment. Two
more experiments were performed (one with the same peptide and the other with
GRGESPY) and almost identical trends were obtained.
3.3.3 Surface stability studies
The objective of the surface stability studies was to examine the stability and integrity of
the spincoated thin film and the stability of peptides introduced to the surface after
prolonged immersion in cell culture media. For incubation in culture media at 370 C for
up to 7 days, spincoated thin films remained integral. However, after that, at around day
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14, films started to detach from the coverslips. By day 21, slight disturbance to the films
would cause the film to delaminate from the coverslip.
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Figure 3.6 Effect of 4-nitrophenol on surface peptide coupling yield. GRGESPY
peptide solution that had been used for coupling, and hence contained 4-NP but same
peptide concentration, was recycled for another coupling. Surface peptide density
obtained was lower than when new peptide solution was used. Error bars showed
standard errors of substrate triplicates of a representative experiment. Three
experiments were performed and similar results were obtained
An array of surfaces encompassing three peptides and two different comb copolymers
was tested for the amount of peptides given off by the surface over the course of 21 days.
For each type of comb copolymer, when surfaces with low peptide density (7.5% NPC-
comb in bulk) and high peptide density (22.5% - 30% NPC-comb in bulk) were
compared with non-activated comb control (0% NPC-comb), it was found that the
absolute amount of peptides released for all three types of surfaces were the same, within
experimental error. The amount of peptides released was attained after 7 days of
immersion in media, and the decline in the amount of peptides remaining on the surfaces
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was stabilized after day 7. The amount remained the same, and did not increase between
day 7 and 21 (Figure 3.7a and 3.7b).
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Figure 3.7 Surface stability studies. (a) amount of GRAASPY remained on the
peptide-coupled comb surfaces after immersion in cell growth media. (b) the amount
of GRAASPY released by the surfaces under the same conditions. Error bars showed
standard errors of 6 substrate replicates of a representative experiment. The
experiment was also performed with 2 other peptides and with comb copolymer
H6M9. The same trend was obtained for all cases.
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3.4 Discussion
3.4.1 NPC activation of comb copolymer
Several methods of activating the comb copolymer for functionalization with peptides or
small proteins had been used or developed previously. Irvine et al. had used NHS for
activation after carboxylizing the hydroxyl end-groups of POEM side chains (Irvine et al.,
2001a). This method had worked with solution coupling with peptides. However, we
found that the yield was extremely low due to the extra step needed before NHS
activation could be done. Considerable efforts had been put in activating the comb
copolymer with tresyl chloride and subsequent coupling with peptides. In addition to the
high hydrolysis rate, we found that even after strenuous purification procedures, the
amount of tresyl chloride salts from the activation and still associated with the comb
copolymer caused a significant amount of non-specific cell adhesion, even after the
tresyl-activated chain ends of comb copolymer had been hydrolyzed. Coupling of tresyl-
activated comb with peptides in solution and the further purification of the peptide-
comb product did not alleviate the problem. However, NPC activation of the comb
copolymer was a one step reaction with high yield and as we and others have shown,
hydrolysis rate was low at neutral and acidic pH. NPC activation also proved to be a
much cleaner method - the TEA salts could be removed easily and when tested for cell
resistance, deactivated NPC-comb did not promote the non-specific adhesion of
fibroblasts.
NMR spectra of the NPC-activated comb showed a consistent > 80% conversion of
hydroxyl chain-ends to NPC, when the polymer was freeze-dried prior to the activation
reaction. The NPC-characteristic peaks observed in our NMR spectra of NPC-activated
comb was consistent with the NMR spectra of other NPC-activated polymers reported
in the literature o et al., 2001). The H10M0 comb copolymer shown here contained
40/o hydroxyl-terminated POEM sidechains by weight and had a number average
molecular weight of 142,000. Stoichiometric calculations showed that with 81%
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conversion, per NPC-activated H10M0O molecule, there were 959 repeating units, among
which 852 were MMA, 87.5 were NPC-POEM and 20.5 were unconverted hydroxyl-
terminated POEM. Based on the simulation results by Irvine et al., P(MMA-r-POEM)
comb molecules configured themselves as quasi-2D non-interpenetrating disks at the top
layer of the polymer thin film. The hydrated POEM side chains anchor to the underlying
layer of primarily PMMA backbone. Given this prediction of quasi-2D configuration of
comb copolymer molecules at the very top layer, the radius of gyration of comb
copolymer confined in 2-dimensions, RI2D, can be estimated by
R2D aC
where a is the backbone segment length 6.4 A, C is a constant with an approximate
value of 1.1 --- 1.45 based on simulations (the mean value, CZ 1.27, is used here), N,, is
the number of backbone segments in the chain = 960, and psbb 0.67 is the surface
volume fraction of backbone segments estimated from self-consistent field calculations
(Irvine et al., 2001a). Hence, with the physical data of our comb copolymer as listed
above, R2) is found to be 12.5 nm. Given this dimension, the number of NPC-
activated sidechains per unit area is approximately 180 x 103 per m2. This number is
also an estimation of the maximum possible surface density of peptides per unit area.
The above estimation of radius of gyration gave us an approximation of the size of the
footprint of a comb molecule. However, it did not capture the polydispersity of the
comb copolymer. Recently, Kuhlman et al. in our laboratory was able to observe directly
the conformation of comb copolymer molecules using transmission electron microscopy
and obtained a direct empirical estimation of the number average radius of gyration, R 2D
= 9.2nm, which is on the order of magnitude as the simulated KRD estimated above
(Kuhlman et al., 2005). With this more realistic RD, the number of NPC-activated
sidechains per unit area is roughly 330 x 103 per 1Im2. The maximum surface density of
all the peptides quantified were in the order of 50,000 to 200,000 per im2, except for
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YGGFHRRIIA, a highly positively charged peptide at neutral or slightly basic pH. This
showed that the values obtained by 125 - peptide quantification was in good agreement
with the calculated density of NPC-activated sidechains. The maximum surface density
for YGGFHRRIKA was around 600,000 per [Im 2 which was higher than, but still within
the same order of magnitude as, the maximum possible value as estimated above.
3.4.2 Peptide-coupling to surfaces with NPC-activated comb
In an attempt to optimize the surface coupling of peptides to NPC-activated comb
surface, the pH of the coupling buffer has been varied to determine the effect of pH on
the coupling yield. When the pH of the coupling buffer is higher than the pK of the
peptide's amine terminus, more peptides will exist with deprotonated amine. We assume
the pK of terminal amine in peptides is similar to the pK value ( - 9 - 9.5) of terminal
amnine in most amino acids, even though the value deviates with different sidechains in a
peptide. The more of this deprotonated amine form of peptides is desired in maximizing
the peptide coupling reaction to NPC-activated comb as it is only the deprotonated form,
rather than the protonated one (-NH 3+) reacts with NPC. More peptides exist in their
deprotonated form at higher pH but a basic pH favors the hydrolysis of NPC. NPC
hydrolysis occurred at a much faster rate at basic pH (pH>10) than at acidic (pH 4) or
neutral pH (pH 7) at which hydrolysis occurred very slowly, as measured by the release
of 4-NP from spincoated surfaces of NPC-activated comb (data not shown). Studies by
Veronese et al. on polyethylene glycol activated with a very similar chemistry also showed
a much higher hydrolysis rate at basic pH (Veronese et al., 1985). Therefore, in
optimizing the peptide coupling reaction, an intermediate pH has to be found to
maximize the number of deprotonated amines in peptides while minimizing hydrolysis of
NPC groups. In addition, for peptides with lysine or arginine residues, it is desirable to
run the reaction at a pH much lower than the pKa of the side chains to minimize side
reactions with the amine and amidine groups when deprotonated. (pKa of lysine and
arginine is 12.5 and 10.5 respectively.) In light of all these factors, coupling reactions at
two different pH, pH 8.3 and pH 10 were tested. Coupling yield was higher at pH 8.3
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for both peptides tested, possibly due to the lower hydrolysis rate of NPC groups at that
pH such that more NPC was available for peptide coupling. This finding is consistent
with a previous report on coupling the proteins ribonuclease and superoxide-dismutase
to NPC-activated polyethylene glycol for which the authors also reported an optimal
reaction yield at around pH 8.3 (Veronese et al., 1985).
3.4.3 Removal of non-specifically adsorbed peptides on comb surfaces
A moderate amount of peptides were found to be non-covalently linked but associated
with the comb surfaces, even on substrates without any NPC-activated comb. Although
later it was proven that the amount of adsorbed peptide had no effect on cell adhesion or
function, several approaches had been experimented to remove these non-specifically
adsorbed peptides. A surfactant, sodium dodecyl sulfate (SDS) and different salts and at
various ionic strengths were empirically tested for the ability to remove non-specifically
adsorbed peptides. One possibility that peptides were associated with comb surfaces was
preferential hydrogen bonding between peptides and the POEM chains over between
water molecules and peptides and between POEM and water. Salt has been shown to
modify the interactions between proteins and water and induce the solubility (or
insolubility) of proteins. However, the molecular basis for this effect, in particular the
anionic or cationic interactions with either backbone or side chain groups on the protein
is still speculative. Some researchers showed that the ability of salts to induce or reduce
protein-water interactions follow the lyotropic or Hofmeister series (Kumosinski and
UJnruh, 1994; Curtis et al., 2000). The Hofmeister series is given by SO42 - > CH 3COO- >
tHC(03 > C1- > NO3 > SCN- (Hofmeister, 1888) where salts high in the Hofmeister
series interact strongly with water and thus tend to induce proteins to associate with
themselves and vice versa. The molecular mechanism of this effect is not known and
there exists reports where salt-protein interactions follow a trend opposite to that
predicted by the Hofmeister series (Curtis et al., 2000). Therefore, in this work, an
empirical approach was taken. Three different salts, sodium sulfate Na2SO4, sodium
bicarbonate NaHCO 3, and sodium nitrate NaNO3, high, in the middle of, and low in the
69
Hofmeister series, respectively were tested for their ability to remove peptides by the
hypothesis of inducing peptide-water interactions, hence dissociating peptides from the
polymer surface. At the end of coupling, these buffers with the same ionic strength
(0.3M NaHCO3, 0.1 M Na2SO4 and 0.3M NaNO3) were used to make up the 0.025M
ethanoamine solution to deactivate the remaining surface NPC groups. During the
overnight period of NPC deactivation, the salts in the buffer were allowed to act on the
adsorbed peptides. Buffers with the same ionic strength were used here so the effect
would solely be due to the action of the different anions. No major difference in the
effect of different salt type on non-specific adsorbed peptide removal was observed, as
shown in Figure 3.8a. Sodium bicarbonate solutions of 0.05M, 0.25M and 0.5M were
then used to investigate the effect of ionic strength on adsorbed peptide removal. Again,
no noted effect of ionic strength on peptide removal was observed (Figure 3.8b). The
effect of ionic strength and salt type may not be effective for the salt concentration
tested. However for the comb copolymer, the salt concentration was limited to below
0.775M. When a higher salt concentration was used, the polymer layer disintegrated
within a very short period of time. It was also possible that salt did not have much effect
on inducing peptides to dissociate with the comb copolymer.
Surfactant was used with reservation to remove non-specifically adsorbed peptides due
to the difficulty in removing it at the end of the process and could interfere with cells
that were subsequently seeded onto the surfaces. Therefore, only a 1% SDS solution was
used in attempt to remove non-specifically adsorbed peptides and at this concentration,
no major effect was seen.
The major concern for these non-specifically adsorbed peptides on the surface is if a
significant amount is released from the surface, they may compete with peptides
covalently linked to the surface for binding with cell adhesion receptors and thus may
cause the cells to de-adhere. Fortunately, our long-term cell adhesion experiments
substantiated that the adsorbed peptides had no effect on cell adhesion. This will be
discussed in Section 3.4.5.
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Figure 3.8 Effect of salt types and ionic strength on the removal of non-specifically
adsorbed peptides. (a) Different salt types were used but had no distinguishable effect
on non-specific peptide removal (b) Various ionic strength of NaHCO 3 solutions were
used but no effect on the removal of non-specifically adsorbed peptides. Error bars
showed standard errors of substrate triplicates of the experiment.
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3.4.4 Side-product inhibition in surface peptide-coupling reaction
The most puzzling results in the quantification of peptide surface density were the
biphasic variation of peptide surface density with increasing NPC-activated comb
content on the surface. One would expect the peptide surface density to increase
monotonically with increasing NPC-activated comb at the surface, or at least increase
monotonically till a certain density of NPC-activated comb and level off due to
saturation. The decrease in peptide surface density as observed in our experiments could
only be explained by the inhibition of the coupling reaction by the side product, 4-
nitrophenol that was accumulated at the surface. As NPC-activated POEM side chains
were reacted at the surface, due to peptide-coupling and hydrolysis, 4-NP was given off
as the only side product. As there was no flow during the entire time the reaction
occurred and the reaction was confined to the surface, 4-NP could only be carried away
from the surface by diffusion, a slow process, 4-NP was thus built up at the surface. By
simple Le Chatelier's principle, a significant amount of the side product 4-NP could
possibly shift the equilibrium of the reaction to favor the reactants. In fact, when 0.23
mnnol/mL of exogenous 4-NP, an amount equivalent to that given off by 100% NPC-
activated comb during the time of reaction, was added to the peptide coupling buffer, the
amount of peptide coupling to comb surfaces decreased (Figure 3.5). In addition, when
peptide solution recycled from previous peptide coupling was used to couple to comb
surfaces, the coupling yield was lower (Figure 3.6). Since the amount of peptide in the
coupling solution was in excess, the first coupling reaction would only consume an
insignificant amount of peptides, so the peptide concentration remained essentially
unchanged. The pH of the solution was readjusted when necessary. Thus, the only
difference between the new and recycled peptide solution was the presence of 4-NP.
Note that the concentration of 4-NP in the recycled peptide solution, which has been
mixed with the rest of the solution in bulk, was much lower than that originally confined
at the surface and yet a difference in coupling yield could be observed with this diluted
amount of 4-NP. It is not surprising that for surfaces with a high NPC-activated comb
content, the peptide coupling yield could be quite drastically inhibited by the significant
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amount of 4-NP given off. If the decrease in peptide density at higher NPC-comb
surfaces was indeed due to side product inhibition, the quantification of peptide surface
coupling to comb polymer using a chemistry that did not yield any side product but
water should show a monotonic increase in peptide density with percentage of activated
comb on the surface. Very recently, Ufret et al. in our laboratory quantified the amount
of peptides coupled to surfaces with various densities of comb copolymer activated with
N-(p-Maleimidophenyl)isocyanate (PMPI). Cysteine- containing peptides react with
PMPI-activated comb to form a covalent bond with the PMPI- POEM side chains of the
polymer with water as the only side product. For this reaction, peptide surface density
indeed increased monotonically with increasing PMPI-activated comb on the surface
(Ufret, 2005). Although the results from PMPI coupling were not direct evidence to the
side product inhibition theory, it substantiated that the presence of a side product could
inhibit peptide coupling with NPC-activated comb.
Despite this unexpected side product inhibition that decreased peptide coupling yield at
surfaces with high percentage of NPC-activated comb, the peptide surface density
increased linearly with the percentage of NPC-activated comb from 0% up to 30% of
NPC comb at the surface. The R-squared coefficients for linear regression for that range
were all greater than 0.93 (Figure 3.4b). This span gave us a sufficiently wide range of
peptide density to control cell integrin binding as we will show in Chapter 4.
3.4.5 Surface stability studies
In the surface stability studies in which peptide-coupled comb coverslips were
submerged in cell growth media for up to 21 days, it was found that by day 7 almost all
the peptides that would dissociate from the surface had dissociated by then. The amount
released (in ptg / im2) was the same within experimental error for surfaces with high and
low peptide densities, as well as for plain non-activated comb control that has been in
contact with the peptide solutions under the same condition as coupling. This led us to
believe that the peptides released were ones that were non-specifically adsorbed to the
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polymer surface, rather than those that were covalently bound but being cleaved by
proteases in cell growth media. We compared the results of our surface stability studies
to that performed by Irvine, in which RGD-comb on surfaces were labeled with 30 nm-
diameter fluorescent polystyrene nanospheres and total fluorescence from surfaces was
assessed as a measure of the loss of ligands from the thin film (Irvine, 1999). The results
from their studies showed that only about 10% of ligands on the surface were lost after
immersion in PBS for 21 days. The difference between the amounts of peptides released
between the two studies could be due to a number of reasons: the way the surfaces were
prepared and the way the peptide release was assayed. In the study by Irvine, fluorescent
nanospheres much bigger than the peptides were used for labeling. The size of the
nanospheres used was about the size of the comb copolymer footprint on the surface
and therefore, a nanosphere could bind to multiple peptides within a cluster. So, even
when a peptide that was bound to the nanosphere was released from the surface, the
nanosphere would still be immobilized by other peptides. Thus the amount of peptide
loss as measured by this method was expected to be lower than that measured by
coupling 125I - peptides to comb copolymer surfaces. In fact, the amount of peptides
associated with the comb copolymer but not covalently linked was also expected to be
lower in the degradation studies by Irvine. RGD-comb was prepared by solution
coupling and purified by dialysis in solution for days. Hence it is not surprising that the
amount of peptides non-specifically associated with the polymer was lower than that
from coupling peptides to comb copolymer at the surface.
The major concern for the presence of the non-specifically adsorbed peptides was how
they might affect cell function, especially cell adhesion when the peptides were released
over the time course of the first 7 days in media and could compete with the peptides
still covalently bound to the surface. To elucidate any effect these peptides might have
on cell adhesion, wtNR6 fibroblasts were seeded on comb surfaces coupled with
GRGDSPY and GRGESPY (as negative control) for 8 days and were monitored daily
for any difference in cell adhesion. No detachment was observed on GRGDSPY
surfaces. Fibroblasts that adhered initially continued to spread and proliferate over the
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time course of the experiment, suggesting the non-specifically adsorbed peptides did not
interfere with the adhesion of the cells. On the other hand, nearly no cells adhered to
GRGESPY surfaces, even at the end of the 8-day experiment. This indicated that cell
adhesion on GRGDSPY surfaces was engendered by the peptides and not due to
proteins that adsorbed onto the surfaces over the time-course of the experiment.
By closely examining the system of peptide-coupling to NPC-activated comb surfaces
through all these studies, we came to know the strengths and limitations of this 2-
dimensional model in presenting peptides for interactions with cells. This knowledge is
invaluable in the design of our subsequent cell experiments. Given the constraints of the
stability of the spincoated polymer thin film, long term experiments that extended
beyond 10 days of surfaces in culture would not be reliable. However, the stability and
robustness of surfaces for a week in culture, the characterized peptide surface densities
and the ability to tune the density through varying the ratio of NPC-activated and non-
activated comb and other features of the system opened up numerous opportunities to
study the interactions of cells with surface-bound peptides in a mimicked extracellular
environment. In addition, with modifications of the coupling and quantification
protocols developed, we have also implemented the method of co-coupling two peptides
to the same comb copolymer surface and the methods of tuning the overall peptide
density as well as the relative ratio of the surface density of the two peptides. This was
done by varying the percentage of NPC-activated comb at the surface and the relative
amount of the two peptides in the coupling solution. By using one radiolabeled-peptide
at a time in the coupling and quantification process, peptide surface density for each
peptide was cquantified. In Chapter 4, this co-coupling method was utilized to develop a
2-D model to study the effect of clustered vs. unclustered peptides on fibroblast
spreading. Furthermore, in the next few chapters, we will look at how different cells
interacted with the various peptides presented by this 2-dimensional model and how we
utilize the model to develop a 6-day colony forming assay in which enrichment of
connective tissue progenitors from bone marrow and their ability to form colonies on
these peptides surfaces are investigated.
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Chapter 4
Biophysical and Biochemical Design of Substrates for
Enriching Connective Tissue Progenitors from Bone
Marrow
4.1 Introduction
In Chapter 2, through protein and cell resistance studies and comparison of peptide-
functionalizable sites, the comb copolymer HlOMO was identified as the best base graft
surface material due both to its excellent cell resistance and the high number of
functionalizable sites in the molecule. In Chapter 3, we developed methodologies for
utilizing this comb copolymer as a vehicle to present small adhesion peptides. Methods
for activating hydroxyl chain ends of the comb copolymer with NPC and the subsequent
peptide-coupling were developed. With this foundation, we now explore how the
biophysical and biochemical properties of this system can be used for the selective
adhesion and proliferation of connective tissue progenitors (CTPs) from bone marrow
aspirates.
Small adhesion peptides were chosen to be presented by comb copolymer surfaces for
mediating the selective adhesion and proliferation of CTPs from bone marrow aspirates.
Peptides are relatively chemically robust and non-immunogenic compared to large
proteins. In addition, in Chapter 3, and also later in this chapter, we showed that a high
peptide surface density can be achieved on peptide-immobilized comb surfaces.
Previous studies had shown that integrins bind to extracellular matrix molecules by
recognizing short amino acid motifs in the molecule. The tri-residue RGD sequence
recognized by various integrins is perhaps the most well-known example (Ruoslahti and
Pierschbacher, 1987; Pfaff, 1997). In the next section, through an extensive literature
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search, a short list of peptides was identified for their potential of enhancing the selective
adhesion and proliferation of connective tissue progenitors.
In addition to the biochemical design criterion, the biophysical presentation of peptides
is considered. As mentioned in Chapter 1, previous studies in our lab showed that
peptides presented in a clustered manner was more effective in promoting cell adhesion
and migration. In particular, Koo et al. showed a higher adhesion force by fibroblasts on
comb copolymer surfaces with clustered RGD peptides, compared to unclustered
peptide surfaces of the same density (Koo et al., 2002). These works showed that the
biophysical presentation of peptides is important in elucidating full cellular responses. In
the discussion section of this chapter, various biophysical parameters associated with the
peptide-comb surfaces were evaluated based on experimental results and critically
compared with the dimensions and densities of cell integrins.
The experimental aspect of this chapter focused on validating the biophysical and
biochemical effects on cell adhesion and proliferation with cell lines and primary pig
mesenchymal stem cells (pMSCs). Firstly, surfaces with peptide candidates identified in
Section 4.2 were prepared and the bioactivity of these surfaces was validated with various
cell lines and pMSCs. These cells were chosen because they had been previously
characterized and some were selected as they express certain integrins that would bind to
the peptides on the surfaces to be tested. Through these studies, the bioactivity of
peptides that were immobilized on comb surfaces were validated before the substrates
were set in experiments with human bone marrow. Secondly, the effect of clustered and
unclustered presentation of peptides on cell adhesion was studied by measuring
fibroblast spreading on GRGDSPY surfaces with various degrees of nanoscale clustering.
These cell studies served to validate the biochemical and biophysical design of peptide-
comb substrates so that the finest substrates could be identified and used in experiments
with human marrow aspirates.
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4.2 Biochemical design - strategically identifying peptide
candidates for the selective adhesion and proliferation of
CTPs
Although a few methods have been developed to isolate enriched populations of human
CTPs from bone marrow, the ECM receptor profile of these cells immediately following
isolation has not been described. Indeed, illuminating the adhesion behavior of CTP is
one of the goals of this work. Two complementary sources of literature information
were used to compile a short list of candidate peptides. First, receptors mediating
adhesion of some cell types closely related to primary human CTPs, such as immature
osteoblasts fi-om rat calvariae, have been described. Peptide sequences that target these
receptors were then identified based on their affinity and potential. Second, by reviewing
reports of adhesion assay of CTP or related cells to ECM proteins and their specific
fragments, domains that mediated the selective adhesion, proliferation and differentiation
of CTP related cells were identified. A search for active sequences in those domains was
then conducted to identify possible recognition sites by CTPs. These two approaches
allowed us to combine complementary information in the literature to develop a short set
of peptide candidates, and were especially useful given the relatively scarce information
available in this area and the large number of potential sequences within a fragment of
matrix molecule identified.
ECM molecules that mediate the binding of bone cells to bone extracellular matrix
include collagen I, the major constituent of bone protein, bone sialoprotein, the largest
bone matrix component after collagen, fibronectin, laminin, vitronectin,
thrombospondin, osteopontin as well as hyaluronan and proteoglycans (Horton, 1995;
Robey, 1996; Schaffner and Dard, 2003). Fibronectin, collagens, laminin as well as
proteoglycans have been shown to be expressed by marrow-derived mesenchymal
progenitors (Chichester et al., 1993; Minguell et al., 2001). In addition, using primary
fetal rat calvariae, Roche and co-workers showed that laminin-1 inhibited the adhesion of
non-osteoprogenitor cells but enriched the cell population in osteoprogenitor cells by
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about 5 folds. Tenascin also promoted the enrichment of osteoprogenitor cells but to a
lesser extent while fibronectin, bone sialoprotein, and type I collagen only increased
attachment of all cells (Roche et al., 1999a).
Therefore, laminin-1 is a ECM molecule of particular interest in osteoprogenitor
enrichment. It contains heterotrimeric proteins composed of al, 1i and y chains.
Cellular receptors for laminins include eight different integrins, mostly from the Pi group.
Laminin can induce proliferation of osteoblasts and accelerate differentiation up to the
formation of' nodules (Panayotou et al., 1989). It contains EGF-like repeats, like other
matrix proteins, such as fibronectin and thrombospondin, and can exhibit growth factor
activity on cells which express an EGF receptor (Scutt et al., 1992). According to the
studies by Roche et al. (Roche et al., 1999a), laminin-1 selects osteoprogenitors by
favoring their attachment to the matrix while being anti-adhesive for other rat-calvariae-
derived cells. Laminin-1 also efficiently promoted osteoprogenitor adhesion from early,
undifferentiated calveriae cell populations. When calvariae cells were plated on
increasing amounts of coated laminin-1, overall cell attachment decreased dose-
dependently. However, the number of nodules formed increased concomitantly with the
decrease of overall cell attachment. The increase in the ratio of bone nodules to total
number of cells was a cell attachment effect, as laminin-1 did not significantly stimulate
differentiation and thus bone nodule formation in the studies (Roche et al., 1999a).
More importantly, the El fragment of laminin displayed a similar preferential promotion
of osteoprogenitor adhesion as the whole molecule while the El+ fragment, which
encompasses the entire segment of El as well as the N-terminal short arms, enhanced
the preferential recruitment of osteoprogenitors to an even greater extent than complete
larninin (Roche et al., 1999b). In addition, the N-truncated laminin variant, laminin-5,
did not show any specific affinity for osteoprogenitors. In light of the results of these
studies, laminin became an ECM molecule of particular interest. Later in this section, we
identified active sequences in this molecule that may have the potential in promoting
CTP adhesion and colony formation.
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The very few reports of integrin expression profile of CTPs in the literature are often
contradicting to each other due to the possible reasons outlined in Chapter 1. Integrins
0Cll1, 0(2P1, 0C531, 0631, P3, and p35 have been reported to be expressed on human bone
marrow derived STRO-1+ CFU-F cells although other published data give different
accounts on integrin expression on osteoprogenitor cells, but most reported the presence
of 04, OC5, OCv3, ar35, and f3 (Soligo et al., 1990; Conget and Minguell, 1999; Franceschi,
1999; Gronthos et al., 2001). Osteoprogenitor cells from bone marrow aspirates seem to
share a similar integrin expression pattern with mature bone cell populations (Soligo et al.,
1990; Clover et al., 1992; Hughes et al., 1993; Conget and Minguell, 1999; Gronthos et al.,
2001). Stromal derived osteoprogenitor cells express (a431 transiently and a
subpopulation of differentiated bone cells also express this integrin (Grzesik and Robey,
1994). Based on these reports, we identified 4p31, 05p31, CvP3, to be the integrins of
greatest interest. However, adhesion receptors other than integrins may also be key
players in mediating CTP adhesion and proliferation. Blocking of the i integrin subunit
by incubating rat calvariae cells with anti- i antibodies did not reduce the
osteoprogenitor recruitment ability of laminin-1, an implication that adhesion may not be
mediated by Pi integrins (Roche et al., 1999b). Therefore, in search of peptides that
would mediate the selective adhesion of CTPs, peptides that target proteglycans were
also considered as some studies demonstrated that adhesion was at least partially
mediated by a non-integrin, such as syndecan (Imai et al., 1998; Rezania and Healy, 1999;
Gronthos et al., 2001).
Most of the active motifs from ECM molecules described in the literature were identified
by either sitc-directed mutagenesis of protein fragments or systematic screening of
overlapping peptides covering the protein chain of interest. The affinity of these
peptides to integrins or cells was usually assayed by examining their ability to block
binding of cells to the complete molecule from which the peptide was derived. Very few
studies actually tested whether these peptides alone, when immobilized on a surface,
could support the adhesion and function of the target cells. For some peptides, even
though they can inhibit the adhesion of cells by blocking their target integrins, their
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affinity may not be high enough such that solely the immobilized form of the peptide
itself can support cell adhesion. Moreover, some integrin binding requires the presence
of a synergy site or only with the binding to both the primary and synergy sites elicit full
cell response (Garcia et al., 2002). Blocking of the primary site can reverse binding but
the presence of the primary sequence alone may support very little or even no adhesion
at all. Therefore, in identifying peptide candidates for supporting cell adhesion via a
particular integrin or on a particular ECM protein of interest, peptides that had been
shown in the literature to support adhesion via the particular integrin were first
considered. As very few peptides had been tested for their ability to support adhesion,
active motif sequences that could block cell adhesion were considered next, although the
success in supporting adhesion was not guaranteed. However, their affinity may be
improved by the appropriate biophysical presentation.
RGD Peptides
Since the identification of the RGD sequence in 1986 as a critical determinant of
integrin-mediated cell adhesion (Ruoslahti and Pierschbacher, 1987), RGD-containing
peptides have been widely studied for both promotion and inhibition of cell adhesion
(Maheshwari et al., 2000; Koo et al., 2002). The RGD sequence is found in the
fibronectin 10 domain and is conserved in vitronectin, laminin, collagen, bone
sialoprotein and many other ECM molecules (Yamada and Ileinman, 1992; Hubbell,
1995; Stubbs et al., 1997). RGD was chosen as the first peptide to be screened as it is the
most well-characterized adhesion peptide. In addition, colony forming cells derived
from human marrow have been shown to co-express 0(5s1 and (Xo3. with STRO-1
(Gronthos et al., 2001). Both C5pl1, ave3 are primary receptors for RGD but other
integrins, X3f31, 8ap1, o1Ib3, apl, XcvP5, ,P6, av36, cv8, and to a small extent under
particular condition, a2p1 and X431, have also been shown to bind to ECM molecules in a
RGD dependent manner (Pfaff, 1997). RGD was chosen also because of its interactions
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with osteoblastic cells. Rezania and Healy also showed that the amino acid sequence
CGGNGEPRGDTYRAY enables adhesion and focal contact formation mediated by
.:!p1i and 0X,3 integrins of osteoblastic cells derived from primary adult human tissue
(Rezania and Healy, 1999). Fibronectin, which contains the RGD motifs, mediates
osteoprogenitor adhesion (Gronthos et al., 2001). The sequence GRGDSPY is chosen
for our studies instead of the minimal RGD sequence due to its higher affinity. It has
been shown that cells could adhere to surface-immobilized GRGDSP via c,-3 (Massia
and Hubbell., 1991) and 5P1 (Dillow et al., 2001; Massia and Stark, 2001). A tyrosine
residue was added to the sequence for 1251-labelling for peptide quantification purpose.
GRGESPY and GRAASPY, inactive analogs for GRGDSPY, were used as negative
control peptides. Two inactive negative controls were chosen as there were a few reports
that showed cell response to RGE and RAD control (Olbrich et al., 1996; Bearinger et al.,
1998; Massia and Stark, 2001) and there was no explanation for this phenomenon.
Interaction might occur due to residual peptide affinity or changed surface properties
during the processing in which peptides were immobilized in those reports.
Bone sialoprotein peptide FHRRIKA
The peptide FHRRIIKA was derived from the heparin-binding domain of bone
sialoprotein (BSP). Some studies reported in the literature suggested that human bone
cells may have an attachment mechanism for the heparin-binding region of ECM
proteins. Attachment to this region is probably mediated by cell surface proteoglycans
(Dalton et al., 1995). BSP is the major non-collagenous ECM molecule found in bone
matrix and it has been shown to be primarily localized in newly synthesized bone matrix
(Rezania and Healy, 1998). In addition, BSP, which has been shown to be osteoinductive
(Wang et al., 1998), exhibits to a certain extent specificity in osteoblast-like cell
attachment. Moreover, endogenous protease degraded BSP fragments have been shown
to mediate attachment of primary human osteoblast-like cells (Bianco et al., 1991; Mintz
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et al., 1993). Even though most of the studies reported here were between osteoblasts
and BSP, some recent reports suggested the role of proteoglycans in regulating cell
functions in bone marrow mesenchymal stem cells (Zou et al., 2004). Therefore, a
peptide derived from the heparin-binding domain of BSP was of high interest to be
tested for its ability to mediate CTP adhesion and function. In identifying such an active
sequence from BSP, the fact that attachment to heparin-binding domains of ECM
proteins is largely electrostatic-based was considered. The positively-charged basic amino
acids of the heparin-binding domain interact with the negatively-charged carboxylate and
sulfate groups found in the glycosaminoglycans associated with the proteoglycans found
in the cell membrane (Massia and Hubbell, 1992a). Cardin et al. identified the consensus
amino acid sequences such as [-X-B-B-X-B-X] (X = hydrophobic residue, B = positively
charged basic residue) in heparin-binding domains of adhesive proteins and showed that
the sequence is involved in heparin binding (Cardin and Weintraub, 1989; Bober-
Barkalow and Schwarzbauer, 1991). The BSP peptide FHRRIKIA chosen is a motif that
follows this consensus amino acid sequence.
X4fllpeptides
Sequences that are recognized by (C4p1 were selected for screening because a
subpopulation of STRO-1+ human bone marrow derived cells, as well as expanded
human marrow mesenchymal stromal cells, have been shown to express 4(4p1 (Conget
and Minguell. 1999; Gronthos et al., 2001). In Chapter 6, our own FACS results showed
a significant level of 0(41pl expression in CD45-CD105+ marrow aspirate cells, at a level
higher than the rest of the population. In addition, C4pl1 has been detected in osteoblasts
obtained from rat calvariae (Rezania et al., 1997). There are a number of motif sequences
derived from ECM molecules that are recognized by the (X4P1 integrin. However, other
than REDV (Massia and Hubbell, 1992b), none of these peptides have been shown to
have the ability to mediate adhesion when immobilized on the surface. The other
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peptide sequences, such as ILDV from the CS-1 region of fibronectin, IDS from
VCAM-1, had only been shown to block cell adhesion to ECM proteins via X4P1
(Clements et al., 1994; Hodde et al., 2002). Therefore, multiple peptides that target OC4P1
were chosen to be set in cell experiments. In addition to the two peptides that contain
key sequence identified from ECM molecules, namely ILDV and REDV, a 59-mer X41
peptide identified from bacterial display with two binding domains, EHSDV and LDSAS,
fanned by a :sequence of 45 amino acids (Ashkar, 2001), was also chosen as a potential
peptide candidate.
Collagen Ipeptide DGEA
The motif DGEA from type I collagen (Staatz et al., 1991) was chosen as it has been
shown to be specific for the 2P1 integrin on osteoblasts-like cells, including the MC3T3-
El1 rat calvarial cell lines (Xiao et al., 1998; Gilbert et al., 2003). Human bone marrow
STRO-1+ cells have been shown to express C(2P1 as discussed above.
XB9g1 EIDGIEL peptide
Tenascin-C is one of the few known ligands for the integrin ac93i. It also binds integrins
0(5f31, C0vf3, aCvi36, and tp81, all via the fibronectin type III repeat (Yokosaki et al., 1996;
Mackie and Tucker, 1999; Jones and Jones, 2000). The integrin, c9f31, binds to the
minimal sequence EIDGIEL in that region (Schneider et al., 1998; Yokosaki et al., 1998).
Tenascin-C, a multimeric ECM glycoprotein, has been shown to enrich the
osteoprogenitor population of fetal rat calvaria cells (Roche et al., 1999a). Its
upregulation is also observed in many physiological situations including wound healing,
cancer and embryonic development (Machie, 1997; Shrestha et al., 1997). The peptide
sequence chosen here contains a motif, IDG, homologous to other known OC4P1 binding
motifs, such as the vascular cell adhesion molecule-1 (VCAM-1) C4P31 binding motif IDS
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(('lements et al., 1994) and the fibronectin LDV active site (Komoriya et al., 1991),
underscoring the similarities in structure, function and specificity of a4dl and acsl. We
therefore selected the sequence PLAEIDGIELTY in the peptide-screening list.
Laminin peptides
Two laminin peptides were chosen to be screened, YIGSR and C16. Laminin peptides
were of special interest because of the role of laminin in mediating the preferential
adhesion of fetal rat calvarial cells and supporting the enrichment of bone marrow-
derived colony forming cells (Roche et al., 1999b; Gronthos et al., 2001). Laminin is also
a major component in the bone marrow environment with which bone marrow
mesenchymal cells, including the CTPs, would interact directly. Therefore, it is
reasonable to believe that these cells express receptors that mediate adhesion to laminin.
C16 is an active sequence in the globular domain of the yl chain in laminin-1. Its activity
was identified by the systematic screening of synthetic peptides covering the entire yl
chain (Nozinmu et al., 1997). The globular domains are of particular interest as they are
part of the El+ fragment of laminin-1 but not El. As mentioned earlier, the El+ but to
a much lesser extent the El fragment enhanced the selective adhesion of osteoprogenitor
cells from fetal rat calvariae. Therefore, the affinity to osteoprogenitor cells can be
attributed to motifs found in the globular domains. C16 was chosen because of its
highest potency among the few active sequences in the globular domains of the yl chain.
Cell attachment has been demonstrated on C16-conjugated sepharose beads. Adhesion
could only be partially inhibited by ethylenediaminetetraacetic acid (EDTA) and even
though as5 i and a,33 were identified as receptors for C16, a cyclic-RGD peptide did not
block C16 adhesion, suggesting that adhesion could be oc5s1 or non-integrin mediated
(Ponce et al., 1999; Ponce et al., 2001; Ponce and I(leinman, 2003). C16 was thus chosen
as a peptide candidate for its potency as a laminin El+ peptide, a a.V3 and as3i peptide
and its probable non-integrin binding activity.
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Figure 4.1 Diagram of laminin-1 molecule showing its different domains and
approximate position of various known active binding motifs. The El fragment
encompasses all the green regions in the diagram and the red regions depict E1 +
fragment. (The red-and-green global domains and parallel red and green lines
showed regions common to both El and El+ fragments.)
YIGSR is another active peptide sequence found in the E1 /El + fragment of laminin. It
is a sequence in the 1 chain, known for its ability to promote neurite growth and
migration. Adhesion has been shown to be mediated by the 67kD laminin receptor and
possibly other receptors. Although YIGSR is not a peptide candidate as compelling as
the other peptides discussed above, the mediation of laminin on osteoclast differentiation
was inhibited by YIGSR (Kukita et al., 1998). This peptide also inhibited the attachment
of osteosarcoma cells on laminin (Yudoh et al., 1996).
Based on the above findings, the peptide candidates chosen to be screened for their
ability to mediate the selective adhesive and function of CTPs are listed in Table 4.1.
GRGESPY and GRAASPY were used as inactive controls.
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Peptide Source Sequence
RGD FN and other ECM molecules GRGDSPY
BSP-H BSP heparin-binding domain YGGFHRRIKA
CS-1 FN CS-1 region YLHPGEILDVPST
REDV FN CS-5 region GREDVY
59-mer Bacterial Display EHSDVIDSQELSIKVSREFHSHEFHS
a41i HEDMLVVDPKSKEEDKHLKFRISH
ELDSASSEVN
C16 LN y1 globular domain YGGAFDITYVRLK
DGEA Collagen I YPDGEA
EIDGIEL Tenascin-C FN III repeat PLAEIDGIELTY
YIGSR LN 31 E1/El + YIGSR
Table 4.1 List of peptide candidates chosen for screening for their ability to promote
selective adhesion and proliferation of CTPs. Residues in bold are key residues of the sequence.
(abbreviations used: FN, fibronectin; BSP, bone sialoprotein, LN, laminin)
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4.3 Materials and Methods
4.3.1 Cell line and primary cell isolation and culture
Several cell lines were used to assess the ability of peptide-comb surfaces to support
integrin-mediated adhesion. The WT NR6 fibroblast cell line was generated and
maintained as described in Chapter 2. All cell lines were obtained from the American
Type Culture Collection (ATCC) unless otherwise indicated. The human osteosarcoma
(HOS) cell line was routinely cultured in minimum essential medium-ac (MEMoc)
supplemented with 10% FBS, 200 i.u./mL penicillin, 400 Fig/mL streptomycin, 2mM L-
glutamine, lrnM non-essential amino acids and mM sodium pyruvate. The rat calvarial
osteoblast cell line (MC3T3-E1) was also routinely cultured in MEMoC supplemented with
10% FBS but with 100 i.u./mL penicillin, 200 pFg/mL streptomycin and 1mM sodium
pyruvate. M-IMo with ascorbic acid was used in cases where osteoblastic phenotype of
the cells was; desired. The parental Chinese hamster ovary (CHO-K1) cell line was
routinely cultured in medium of composition similar to that of WT NR6, but with
Dulbecco's Modified Eagle medium (DMEM). All cell lines were maintained at 37oC in
50//5% CO 2 .
Pig mesenchymal stem cells (pMSCs) were harvested and isolated by the Vacanti
laboratory in the Massachusetts General Hospital. The procedure is outlined by
Abukawa et al. (Abukawa et al., 2004). In brief, 6-month old female Yucatan minipigs
were used for bone marrow aspiration. The procedure was performed in accordance
with the regulations and approval of the Institutional Animal Care and Use Committee
of the Massachusets General Hospital and conformed to the standards of the Associated
for Assessment and Accreditation of Laboratory Animal Care. Bone marrow was
aspirated from the ilium crest using an 11-gauge bone marrow aspiration needle while the
minipig was under general anesthesia. 10 mL of bone marrow aspirates was collected
into a syringe containing 6000 units of heparin. After the aspirate has been washed with
high-glucose DMEM (Gibco, NY), it is centrifuged at 900 x g. Cell pellets were
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resuspended in DMEM and loaded on 70% Percoll (Sigma-Aldrich, St. Louis, MO)
gradient. These gradients were centrifuged at 1100 x g for 30 minutes and the pMSC-
enriched density fraction was collected. Cells were then cultured by resuspending in
culture media (DMEM with 10% FBS) and seeding into 75 mm2 cell culture flasks
(Corning, Corning, NY) at a density of 1.6 x 106 cells per cm2. The media were changed
every 3 days and the non-adherent cells containing mostly the hematopoietic cells were
removed at each media change. The cells in culture usually became near-confluent in
around 10 days, at which point the cells are detached by 1X trypsin solution (Sigma-
Alrich, St. Louis, MO) and split into new flasks. Cells up to the third passage were used
in our studies.
Rat hepatocytes were isolated from 150g - 2 30g male Fischer rats by a collagenase
perfusion procedure, as described in Hwa et al. (Hwa et al., 2005). In brief, the liver was
perfused with calcium-free HEPES buffer and digestive enzyme mix. The liver was then
removed, submerged in DMEM supplemented with 1% FBS and Penicillin-streptomycin
at 4°C, and the capsule membrane was removed with surgical forceps. Cells were
released by agitating the liver in the buffer. The cell solution was filtered and purified by
multiple centrifugation and suspensions.
4.3.2 Preparation of peptide-comb surfaces
Peptides were obtained and purified according to the procedures described in Chapter 3,
except for the 59-mer 0O4p1 peptide which was a generous gift from Dr. Samy Ashkar. All
peptides, except for C16 and the 59-mer t4pl1 peptide, were coupled to comb copolymer
surfaces and characterized as outlined in Chapter 3. The peptide C16, due to its
insolubility in sodium bicarbonate buffer, was dissolved in milliQ water with pH adjusted
to 8.3 with triethylamine. For the 59-mer 4pl1 peptide, a peptide solution of 0.4 mg/mL
in 0.1M sodium bicarbonate buffer was used for coupling. The surface peptide density
of each type of peptide surfaces used was quantified with 125 1-labelled peptides using the
methodology described in the previous chapter.
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RGD surfaces with different degrees of RGD clustering were prepared by mixing various
ratios of NPC-activated comb and its non-activated counterpart. Further, the average
overall ligand density was stoichiometrically varied by mixing the active peptide
GRGDSPY with the inactive peptide GRGESPY. RGD surfaces with a maximal degree
of clustering were prepared by spincoating on glass surfaces polymer solutions of 0/100,
5/95, 15/85 and 25/75 of NPC-activated comb / non-activated comb and subsequently
reacted with mM GRGDSPY solution to yield surfaces with peptide surface densities of
(0 + 500) peptides / ym 2, (4150 + 450) peptides / im 2 , (9300 + 900) peptides / m 2,
and (14000 : 450) peptides / m 2 respectively. The average number of peptides in each
cluster was the same while the cluster spacing increased as peptide density decreased
(IKuhlman et al., 2005). RGD surfaces with comparable average RGD densities but a
lower degree of clustering were prepared by coupling peptide solutions of 0/100, 20/80,
60/40, 100/0 GRGDSPY/GRGESPY to substrates spincoated with 25% NPC-activated
comb solution. GRGDSPY and GRGESPY have almost identical reactivity towards
NPC-comb surfaces, as shown by quantification studies with 125I-labelled peptides, using
the method outlined in the previous chapter on co-coupling two peptides. This yielded
surfaces with peptide densities comparable to that of the RGD surfaces with maximal
degree of clustering listed above, but the number of peptides in a cluster was less on
surfaces with lower overall peptide densities and visa versa. Note that at the highest
overall peptide surface density, the "less-clustered" RGD surfaces became the same as
the maximally-clustered RGD surfaces. Refer to Figure 4.10 for a graphical explanation.
4.3.3 Cell adhesion experiments
GRGDSPY, GRGESPY and GRAASPY surfaces of peptide surface densities up to
-20,000 peptides / yim2 were tested for their ability to support cell adhesion and
proliferation with wtNR6 fibroblasts, MC3T3-E1 rat calvarial osteoblasts and primary
pig mesenchymal stem cells. Peptide-coupled substrates were placed in 24-well plates
and fixed in place with rings cut out from protein-resistant, biocompatible medical
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silicone tubing (Nalgene). 10,000 cells per cm2 were seeded on these peptide surfaces, in
the presence of serum-containing media free of phenol red, and incubated for 16 - 18
hours. Microscopy and MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrozolium
bromide) assay were then performed on these surfaces to quantify the amount of cell
adhesion and to examine cell morphology. MTT assays were performed using the
Vybrant MTT cell proliferation assay kit (Molecular Probes, Eugene, OR). After culture,
surfaces were gently washed twice with media before MTT solution (12mM) was added
and incubated with the cells for 4 hours. The solution was then removed and dimethyl
sulfoxide (DMSO) was added for 10 minutes to solubilize the formazan crystals formed.
Solutions were taken out for absorbance reading at 540 nm. The amount of cells on each
surface relative to tissue culture polystyrene (TCPS) control was calculated by the ratio of
absorbance of the two surfaces. Results from MTT assay were correlated with that from
microscopy, the method of which was outlined in Chapter 2. Three experiments were
carried out for each cell type, and for each experiment, triplicates of each type of surface
were used. The same methodology was used to quantify the number of adherent cells
(MC3T3-E1 or primary pMSCs) on surfaces with various densities of the peptide
-FHRRIIA.
Substrates presenting the Ot2p1 peptide YPDGEA were tested for their ability to support
cell adhesion using MC3T3-E1 osteoblasts, which express 2p1 (Gilbert et al., 2003). The
cX4P1 peptides, CS-1 and the 59-mer OC4p1 peptide from bacterial display were tested with
HOS osteosarcoma cells and pMSCs. In antibody-blocking experiments where adhesion
of pMSCs was tested on surfaces with the 59-mer 0O4pl peptide identified from bacterial
display, cells were pre-blocked with the anti-oc4pl blocking antibody P4G9 (Chemicon,
Temecula, CA) prior to seeding on the peptide-coupled surfaces. GREDVY was
validated with human umbilical vein endothelial cell line (HUVEC) by graduate
researcher David Yin but only little adhesion was observed (Yin, 2004). CHO-KI1 and
wtNR6 were used to test surfaces with the peptide C16, as well as GRGDSPY and its
inactive analogs GRGESPY and GRAASPY.
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Adhesion experiments on clustered and unclustered GRGDSPY surfaces were
performed by seeding wtNR6 fibroblasts at 10,000 cells / cm2 on surfaces for 16 - 18
hours. Three to five microscopy images were taken for each surface, avoiding the edges
or irregularities of the substrates. Cell counting, tracing and calculation of cell spreading
area were performed using the NIH image software. Student t-tests were employed to
determine whether the difference in cell spreading area between clustered and
unclustered surfaces were significant. 99% confidence levels were reported.
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4.4 Results
4.4.1 Cell adhesion on substrates with various peptide surface densities
When wtNR6 fibroblasts were seeded on GRGDSPY, GRGESPY, and GRAASPY of
density range up to -20,000 peptides / tm2, an increase in the number of adherent cells
was observed on GRGDSPY surfaces with increasing peptide density but the number of
adherent cells remained minimal for surfaces with GRGESPY and GRAASPY for the
entire peptide density range tested (Figure 4.2). When primary pig mesenchymal stem
cells were seeded on the same surfaces, the same trend was observed (Figure 4.3a). In
addition to cell adhesion, colony formation was also seen on the GRGDSPY surfaces
(Figure 4.3b).
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Figure 4.2 wtNR6 adhesion on GRGDSPY, GRGESPY and GRAASPY
surfaces with various peptide surface densities. After 16-18 hours of seeding, surfaces
were rinsed before MTT assay was performed. Relative adhesion on peptide surfaces
to glass control was reported. Error bars show standard errors associated with 3
technical triplicates of 3 separate experiments.
95
?
4n1o%/IOU7/o
Ce
C)
I--
C 100%0
C.4
a
X 50%
0
6
0%
0 5000 10000 15000 20000
Surface peptide density (peptides / pm2)
Figure 4.3a Adhesion of primary pMSCs on GRGDSPY, GRGESPY and
GRAASPY surfaces with various peptide surface densities. After 16-18 hours of
seeding, surfaces were rinsed before MTT assay was performed. Relative adhesion on
peptide surfaces to TCPS control was reported. Error bars show standard errors
associated with 3 technical triplicates of 3 separate experiments.
Figure 4.3b Primary pMSCs on
GRGDSPY-coupled comb substrate
of average surface density 14000
peptides / Fm2. In addition to cell
adhesion, colony formation was also
seen on GRGDSPY surfaces.
Almost no adhesion was observed on
GRGESPY and GRAASPY surfaces.
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MC3T3-E1 rat calvarial osteoblasts and primary pMSCs were seeded on surfaces with
various surface densities of the bone sialoprotein peptide FHRRIKA. An increase in cell
adhesion was observed for MC3T3-E1 on surfaces with higher surface FHRRIKA
density. However, very little pMSC adhesion was seen even on surfaces with the highest
FHRRIKA density tested (Figure 4.4).
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Figure 4.4 MC3T3-E1 rat calvarial osteoblasts and primary pMSC adhesion on
surfaces with various peptide surface densities of the BSP peptide FHRRIKA. The
ratio of number of adherent cells on FHRRIKA surfaces to that on TCPS surfaces was
reported. MC3T3-E1 adhesion increased with increasing peptide density up to (327 +
9) x 103 peptides / [m 2 while little pMSC adhesion was observed even at the highest
peptide density. Error bars show standard deviations associated with 3 technical
triplicates of a representative experiment. 3 experiments were carried out and similar
results were obtained.
4.4.2 Validation of various peptide-comb substrates
The bioactivity of the 0o4r1 peptides, CS-i1 and the 59-mer from bacterial display, was
validated using HOS cells and primary pMSCs. Excellent cell adhesion was observed on
surfaces with the 59-mer 0C4P1 peptides for both cell types. pMSC adhesion on this
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peptide surface is shown in Figure 4.5a. Adhesion to surfaces with the 59-mer 0C4p1
peptides was significantly reduced by pre-incubating the cells with anti- c41i antibodies
before seeding (Figure 4.5b). HOS which expresses 04P1 integrins (Tiisala et al., 1993)
also showed excellent adhesion on 59-mer oa41i surfaces and inhibition of adhesion when
cells were pre-incubated with OC4p1 antibodies. On the other hand, CS-1 supported only a
moderate level of HOS adhesion, as shown in Figure 4.6.
Figure 4.5 Primary pMSC adhesion on surfaces coupled with 59-mer c43p,
peptides identified from bacterial display. Left (a) pMSC adhesion. Right (b)
Adhesion of pMSCs pre-incubated with x431 monoclonal antibodies before seeding
on peptide-surfaces.
Figure 4.6 HOS adhesion on CS-1
peptide surface. (Average peptide density
of the surface shown here was (36.6 +
3.9) x 10 3 peptides / [tm 2.
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Surfaces with laminin peptides C16 supported the adhesion of both wtNR6 fibroblasts
and CHO-KI cells, as shown in Figure 4.7a and b. Freshly isolated rat hepatocytes were
used to validate the ocs91 EIDGIEL substrates. However, only little adhesion was
observed (Figure 4.8).
Figure 4.7 Left (a) wtNR6 adhesion on C1G6 surfaces. Right (b) CHO-K1
adhesion on C16 surfaces. Peptide density of the surfaces tested here was (260 ± 15)
x 103 peptides / tm2.
Figure 4.8 Primary rat hepatocytes,
which were believed to express c91, did
not adhere well on EIDGIEL surfaces.
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When MC3T3-E1 were seeded on surfaces with the collagen I peptide DGEA, no
adhesion was seen even at a peptide surface density up to (141 22) x 103 peptides/Lm 2
even after 24 hours of incubation.
4.4.3 Cell adhesion on peptide surfaces with different degrees of clustering
A noted difference in cell spreading was observed between wtNR6 fibroblast adhesion
on RGD surfaces with different degrees of clustering (Figure 4.9). Fibroblasts were
more spread on RGD surfaces with a higher degree of clustering than the less clustered
ones of the same overall RGD surface density and the difference was more pronounced
at higher overall surface peptide density. For both types of clustered surfaces, as
expected, the ratio of adherent cells to that on TCPS increased with increasing peptide
density. Figure 4.10 showed the difference between the two types of clustered surfaces.
--. - RGD with a lesser
deg. of clustering
* RGD with max deg.
of clustering
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Figure 4.9 wtNR6 fibroblast spreading on RGD surfaces with different degree of
clustering. Cell spreading area was quantified by cell-area tracing of microscopy images. See
Figure 4.10 for the number of peptides per cluster for both surfaces at each peptide density.
* p < 0.001 between cell spreading area on RGD surfaces of different degree of clustering of
that particular overall peptide density
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4.5 Discussion
4.5.1 Biophysical considerations of peptide-comb substrates
The comb copolymer was chosen as the base graft surface material for its ability to
present peptides in a clustered manner, as shown previously by our lab. Since peptides
were presented as clusters on the surface, there were two associated surface densities -
the overall average peptide surface density and the local peptide surface density within a
cluster. The peptide densities measured from 12 5I-peptide quantification yielded the
overall average peptide density of a surface. Assuming that there was no preferential
segregation between NPC-activated sidechains and its non-activated counterpart at the
surface, given peptides were coupled to only NPC-activated comb, the local peptide
density within a cluster can be calculated by the ratio of the average surface peptide
density to the percentage of NPC-activated comb used in the bulk solution in surface
preparation. Taking the example of GRGDSPY-coupling to substrates spincoated with a
polymer solution of 16% NPC-activated comb (i.e., 84% non-activated), the average
surface density determined from 251-peptide quantification was (10,300 ± 900) peptides
/ 1pm2. Therefore, within a cluster, the local peptide surface density was (64,400 ± 7100)
peptides / im2. In Section 3.4.1, we mentioned that recent work in our lab has obtained
an empirical estimation of the radius of gyration of the H10M0 polymer, which was -
9.2nm (Kuhlman et al., 2005). The size of the cluster was thus - 266 nm2. Based on this
dimension and the local peptide density, the spacing between peptides within a cluster
was -4 nm. Comparing this inter-ligand spacing to integrin size, which is about 6 - 9
nm, the spacing of peptides presented by comb copolymer at the surface is estimated to
be appropriate for integrin binding. The number of peptides on these peptide-comb
copolymer surfaces was also more than sufficient for integrin binding. For a typical cell
with an area of about 200 m 2, there would be - 2 x 106 peptides under that area
available for binding, which is in excess compared to the number of integrins possessed
by the cells (on the order of 105 per cell). The peptide surface density of these substrates
was approximately 20 times higher than the highest concentration of fibronectin used in
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most cell studies (10tg/mL fibronectin coating solution, equivalent to a density of 3700
absorbed fibronectin molecules per m2 (Asthagiri et al., 1999)) Due to the low affinity
of GRGDSPY, 10- to 100-fold less active than that of fibronectin in competition assays
(Pierschbacher and Ruoslahti, 1984; Akiyama and Yamada, 1985), a higher RGD density
was needed to compensate this difference in affinity. Therefore, a local peptide density
of (64,400 7100) peptides / m2, which was about 20 times that of the fibronectin
density used in most adhesion studies, was a reasonable density to be used.
Substrates with a
maximal degree of
peptide clustering
Substrates with a
lower degree of
peptide clustering
Average peptide 4140 430 9660 + 880 14000 ± 440
density (peptide / pm2)
Maximal
# of degree of 18.0 18.0 18.0
peptide clustering
in cluster
Lower
degree of 3.5 10.6 15.0
clustering
Figure 4.10 Schematics to illustrate peptide densities and clustering on surfaces
with maximal degree and lower degree of peptide clustering. Each circle represents a
peptide cluster and the number inside the circle indicates the estimated number of
peptides per cluster. These surfaces were used to determine the effect of clustering
on fibroblast spreading, as shown in Figure 4.9.
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'The number of peptides per cluster on these peptide-comb surfaces was sufficient to
enhance cell adhesion. With the Rg2 D 9.2 nm which yielded an average comb molecule
footprint area of 266 nm2 with - 18.0 peptides per cluster for RGD surfaces with
maximal degree of clustering, regardless of the overall average peptide density. For the
case of low-clustering peptide surfaces, at an overall average peptide density of (4140 +
.310) peptides / yim2 and (9660 + 720) peptides / yLm2 , the number of peptides per
cluster was 3.5 and 10.6 respectively. Our results with wtNR6 fibroblasts showed that
cell spreading was enhanced on surfaces with higher degree of clustering even at the
same overall peptide density. The difference was more pronounced on surfaces with
higher average peptide density ((9660 ± 720) peptides / tm2) even though the difference
in the degree of clustering was larger on the lower average peptide density one. (18.0 vs.
10.6 peptides per cluster for overall peptide density of (9660 + 720) peptides / ym2 and
18.0 vs. 3.5 peptides per cluster for overall density of (4140 + 310) peptides / yim2.) This
is in agreement with a previous report from our lab, in which a more pronounced effect
on the increase in fibroblast adhesion strength with increasing degree of peptide
clustering (1.7, 3.6 and 5.4 peptides per cluster) was observed on surfaces with higher
overall peptide density (Koo et al., 2002). In this study, we have confirmed that the
biophysical presentation of ligands played an important role in cell adhesion, and
consistent with previous studies, cell adhesion can be enhanced by nanoclustering of
peptides. The biophysical enhancement through nanoclustering is important to engender
adhesion response from peptides with relatively low affinity. As discussed above, some
of the peptides selected for screening may have affinity sufficient to reverse adhesion on
that parent protein counterpart by competition but its affinity may not be high enough to
support cell adhesion on its own when immobilized. As in the case of the peptide
YGRGD, to support cell adhesion when immobilized on a surface, RGD sequences
required at least one extra amino acid after the aspartic acid residue. However,
Maheshwari and co-workers demonstrated cell adhesion on YGRGD surfaces by
clustering peptides using star-PEO molecules (Maheshwari et al., 2000).
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4.5.2 Cell behavior mediated by various peptide surfaces
When pMSCs were seeded on surfaces with increasing GRGDSPY surface density, not
only an increase in cell adhesion but also colony formation was observed. Colony
formation was an indication that GRGDSPY surfaces supported not only cell adhesion,
but also subsequent proliferation over a period of days, such that the colonies were
formed. As very little adhesion was observed on the inactive analog GRGESPY and
GRAASPY surfaces over the period of the experiments, it showed that adhesion and
proliferation on GRGDSPY surfaces were solely mediated by the peptides and not by
proteins non--specifically adsorbed to the protein- and cell-resistant comb substrates. It
also confirmed that the coupling of peptides to comb surfaces did not engender addition
protein adsorption sufficient to lead to non-specific cell adhesion.
MC3T3-E1 rat calvarial osteoblasts showed an increase in adhesion on surfaces with a
higher density of the bone sialoprotein peptide FHRRIIKA. Even though MC3T3
adhered and spreaded well on these FHRRII(A substrates, primary pMSCs showed very
little cell adhesion. Since adhesion receptors are highly conserved among species, the
difference in adhesion behavior was probably not due to the difference of cell species.
In addition, Rezania and Healy have previously shown human osteoblasts-like cell
adhesion to surfaces with FHRRIKA. Thus, the only other explanation was the
receptors for this BSP protein were only expressed by mature osteoblasts but not
mesenchymal stem cells that had not been differentiated. The peptide FHRRIIKA is
quite highly charged. The two arginine and the lysine residues all carry a positive charge
and histidine is also slightly charged at neutral pH. (The calculated isoelectric point was
11.0.) The fact that pMSCs did not adhere to the surfaces even at the highest peptide
density implied that the adhesion of MC3T3-E1 was specific and not due to the electric
attraction between the positive charged surface and the slightly-negative charged cell
membrane.
Surfaces with the 59-mer (4P1 peptides identified from bacterial display performed very
well in supporting cell adhesion via OC4f1 integrins, as shown by our studies with pMSCs
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and HOS. Intrigued by the stellar performance, we investigated whether both the
binding domains, EHSDV and LDSAS were required to support cell adhesion. Comb
copolymer substrates were coupled with only YEHSDV, only YLDSASSE and at 25:75,
50:50, 75:25 YEHSDV:YLDSASSE, using a method similar to that described in Section
4.3.2. No adhesion was observed when pMSCs and HOS were seeded on these surfaces,
suggesting that both domains were required for integrin binding or the domains need to
be a certain distance apart or in a particular spatial configuration, as given by the 59-mer,
for integrin binding. We also noted the homology between the second binding domain
and other known active (4P1 sequences, such as IDS on VCAM-1 and LDV on
fibronectin. The LDS in the second binding domain and the known 4p1 sequences all
contained aspartic acid as the second residue and a hydrophobic amino acid as the first.
This may explain why the other C4P1 peptide, CS-1, containing only a single motif LDV
in the sequence, supported only a moderate amount of cell adhesion.
Since CHO-K1, which expressed primarily c5p1 but not OC433, adhered to both the C16
and GRGDSPY surfaces fairly well, it showed, but not exclusively, 51 integrins,
mediated cell adhesion on these surfaces. No adhesion to collagen I peptide DGEA
surfaces was observed when MC3T3 osteoblasts, which expressed Oc2p1 integrins, were
seeded. It is unclear whether the little adhesion was because a particular spatial
configuration or mechanical requisite of DGEA was required for Oc2p1 to bind to, or the
affinity of the peptide was not high enough to support cell adhesion. It is unclear which
was the case in our studies as the only report in the literature that showed binding of
MC3T3-E1 cells to an immobilized form of DGEA was with a DGEA peptide linked to
the hydroxyapatite-binding domain of statherin which bind to hydroapatite surfaces on
which MC3T3-E1 cells were seeded (Gilbert et al., 2003). Even though these DGEA
peptides clearly played a role in cell adhesion, it is unclear whether these peptides alone
could support adhesion since the background, hydroxyapatite, was not an inert surface.
The addition of the statherin fragment might have given the peptide a particular
configuration favorable for 2P1t binding.
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Table 4.2 Order of peptide candidates to be screened with human marrow aspirates for
their ability to promote selective adhesion and proliferation of CTPs. GRGESPY and
GRAASPY are used as negative control peptides in screening.
Very little hepatocyte adhesion was observed EIDGIEL surfaces. EIDGIEL is an (gpl
peptide and is one of the integrins expressed by primary hepatocytes. However, there
were no published reports on the level of a91 expression by hepatocytes. Therefore, it is
difficult to conclude whether the little hepatocyte adhesion was due to the small number
of c93pl expressed by the cells, or the low affinity of the peptide. In addition, the low
degree of adhesion observed may be due to the de-adhesive effect of Oc91. The integrin
has been shown to disrupt focal adhesion (Murphy-Ullrich et al., 1991). Nevertheless, in
this chapter, we have validated the bioactivity of other peptide surfaces and confirmed
that cell adhesion and function can be mediated biochemically by the choice of peptide
presented by comb copolymer on the surface. We have also confirmed that adhesion
can be enhanced biophysically, by nanoclustering the peptides. These knowledge and the
identified and validated peptide surface candidates allowed us to screen these peptide
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Order of Sequence Notes
screening
RGD GRGDSPY s,5P1 & v3 peptide; also as active
control
BSP-H YGGFHRRIKA possibly proteoglycan binding
59-mer EHSDVIDSQELSKVSREFHSH a4,31 peptide from bacterial display.
a0,4 1 EFHSHEDMLVVDPKSKEED High affinity as shown by validation
KHLKFRISH ELDSASSEVN experiments.
C16 YGGAFDITYVRLK LN peptide; binds to aft3 , ct,.33 & non-
integrins
CS-1 YLHPGEILDVPST a4 1 peptide from FN CS-1
Petides of oly seconda imortance to be screened:
DGEA YPDGEA 2cP3 peptide (but no activity with
MC3T3-E1 in validation expts)
YIGSR YIGSR LN 1 E1/E1 +
EIDGIEL PLAEIDGIELTY c9,p peptide. Low affinity?
REDV GREDVY a d , peptide from FN CS-5. Low
potency?
candidates with human bone marrow aspirates for their ability to engender the selective
adhesion, proliferation and differentiation of CTPs. In light of the results from this
chapter, peptide candidates are screened in the following order with marrow aspirates in
the next chapter (Table 4.2).
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Chapter 5
Adhesion and Colony Formation of Connective Tissue
Progenitors from Bone Marrow Aspirates
5.1 Introduction
In the previous chapter, a priority list of peptide candidates with the potential to mediate
the selective adhesion and proliferation of connective tissue progenitors from bone
marrow aspirates was critically chosen from the literature. These peptides were
immobilized on the otherwise inert comb-copolymer substrates and the bioactivity of
these peptide--surfaces was validated with various cell lines or primary cells that expressed
integrins or receptors that recognize the peptides to be tested. In this chapter, these
validated peptide surfaces were set in experiments with human marrow aspirates to
screen for their potential to promote the adhesion and proliferation of CTPs, as well as
the differentiation of CTPs to cells of osteoblastic lineage. A critical evaluation of the
CTP assay was also performed.
rTo evaluate the potential of each peptide in targeting CTPs, the colony forming unit
(CFU) assay was developed to measure colony formation of CTPs in a two-dimensional
model. This functional assay was needed to evaluate empirically the adhesion and colony
formation of CTPs on these peptide surfaces in order to correlate with any molecular
profile of marrow cells, as shown in Chapter 6. With the integrin expression profile
alone, it is impossible to tell whether an expressed receptor actually mediates the process
of CTP adhesion and proliferation. Moreover, to date, markers that target only CTPs
have not been identified. Thus, one can at best assay the adhesion receptor profile of an
enriched but not pure population of CTPs. It is also impossible to analyze the adhesion
receptor profile of a marrow cell while assaying its ability to form colonies. Once a
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marrow cell adheres to a surface in vitro, its molecular profile will likely have been
changed. C)n the other hand, assaying CTP colony formation directly on peptide
substrates allowed us to explore peptides that have the potential of enhancing CTP
adhesion and proliferation but the adhesion receptors which the cells utilized to mediate
the process were not known. Therefore, CTP adhesion measurements were first
performed in this chapter before we examined the integrin expression profile of marrow
aspirate cells in Chapter 6. The CFU assay was developed based on the one reported by
Muschler et al. (Muschler et al., 2001) but modified to assay colony formation on
peptide-comb substrates. Previous studies by Muschler et al., showed that the mean
prevalence of CTPs in bone marrow was about 1 in 23,000. However, the number
varied greatly with patients' age, gender, disease states and other factors (Majors et al.,
1997; Muschler et al., 2001). It has been established that CTPs from bone marrow, when
given the right condition, formed colonies when cultured. Colony expression of alkaline
phosphatase (AP), an early marker for osteoblastic differentiation (Turksen and Aubin,
1991; Bianco et al., 1993; Lee et al., 1993), is an indication that they are progenitors of
osteoblasts. Therefore, the formation of colony (also denoted as CFU from here on) and
the expression of AP by these colonies gives a lumped measure of how well peptide
substrates supported the initial adhesion of CTPs, the subsequent proliferation so a
colony of cells was formed, as well as the differentiation of these progenitors into
osteoblastic lineage. Failure to support any one of the above three aspects would not
lead to the formation of osteoblastic colonies.
In this chapter, in addition to examining the ability of the peptide candidates identified in
the previous chapter for their ability to promote CTP colony formation using the CFU
assay, a statistical model that captured the unique characteristics of the CFU assay was
developed to analyze the findings of the experiments. Lastly, we evaluated glass on its
performance as the "gold standard control" of the CFU assay and from the studies,
revealed the extent of patient-to-patient variability.
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5.2 Materials and methods
5.2.1 Surface preparation for Colony forming unit assay
Peptide-coupled comb copolymer substrates were prepared using a protocol similar to
that developed in Chapter 3, with slight modifications. Instead of round coverslips,
comb copolymer was spincoated on silanized 18 x 18 cm2 square glass coverslips (VWR
International) such that they could fit well in 2-well Lab-tek chambers for CFU assays.
The same glass coverslips, non-silanized but treated by sonicating in 200 proof ethanol,
was used as glass control surfaces in the CFU assay. Plain non-activated comb substrates
were prepared to be used as the negative control of the CFU assay. All surfaces were
stored at room temperature after preparation and drying in vacuo. Substrates were used
within a month of preparation. For marrow experiments, surfaces were placed in 2-well
4-cm2 Lab-tek glass chamber slides (Labtech, Nagle Nunc International, Naperville, IL,
USA) and sterilized by UV light for 30 minutes prior to marrow experiments.
5.2.2 Colony forming unit (CFU) Assay
Bcone marrow was aspirated from human subjects as described in Chapter 2. Marrow
aspirates were heparinized and suspended in complete media (MEM-o with 10% fetal
bovine serum (BioWhittaker, Walkersville, MD, USA), 200 i.u./mL penicillin, 400
btg/mL streptomycin (Gibco)). After the number of nucleated cells in the marrow sample
was counted, a density of 2X106 nucleated cells, unless otherwise noted, was seeded in
each of the two 4-cm2 wells on a glass Lab-tek chamber containing either peptide-comb
substrates or glass coverslip control. Quadruplicates of peptide-comb substrates or glass
coverslips were plated for each patient sample. Cultures were maintained at 370 C in a
humidified atmosphere of 5% CO 2 in air. Medium was first changed after 48 hours of
plating at which point the non-adherent cells from each chamber were removed and
replated on Lab-tek slides. After the media change and the non-adherent cells removed,
the substrates were continued to be cultured for another 4 days before harvest. The
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surfaces were then washed and fixed and the number of colonies formed on these
substrates were counted. These colonies were defined as "early adherent colonies" for
they originated from cells that adhered to the test surfaces within 48 hours of plating.
Subcolony clusters and single adherent cells were also counted. The non-adherent cells
replated on I,ab-tek slides were cultured for 6 days after the replate. Colonies formed on
Lab-tek from the replate were defined as "late adherent colonies" for they were formed
from cells that did not adhere to the first test surfaces within 48 hours of plating but
adhered and formed colonies after they were replated. Figure 5.1 shows the schematic of
C]U assay.
Cells and colonies on substrates were stained for alkaline phosphataste (AP) expression
by first rinsing the substrates with Hanks balanced salt solution and then incubating the
with 120 ml\ Tris buffer, pH 8.4, containing 0.9 mM Naphtol AS-MX Phosphate and
1.8 mM Fast Red TR. Naphtol AS-MX Phosphate was solubilized with N,N-
dimethylformamide (Curtis Matheson Scientific, Houston, TX, USA) prior to dilution
with the Tris buffer. After 30 min at 370C, the cultures were washed with deionized
water. Any CFU that was AP-positive was denoted as CFU-AP.
* 0 0
48 hrs 4 days
Seed BM 8 4 day Count CFUs
,°" . *0* Early adherent CFUs
2x1 6cels/CM2 Test surfaces Replate non- Stained for alk phosphatase
2x1 6cells!cm2 ~ orlss adherent cells Also counted: subcolony
clusters, single cells
0 6days; e 6 d Count CFUs
Late adherent CFUsLabtek chamberLabtek chamber (CFUs of CTPs that failed
slides to adhere on test surface
within the first 48 hours)
Figure 5.1 Schematic showing the flow of marrow aspirate CFU assay.
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5.3 Statistical model for colony formation
In presenting and comparing biological data, statistical analysis techniques such as those
utilizing the Gaussian distribution, student t-test and fisher test were often employed.
Often the mean and standard deviation of data based on the Gaussian distribution
worked sufficiently well in capturing the expected value and variance of data due to the
central limit theorem when the sample size is large even though in reality the data do not
follow a Gaussian distribution due to characteristics inherent to the experiment.
However, the assumption that experimental data follow the Gaussian distribution
became problematic when the sample size is small and when some of the assumptions
behind the Gaussian distribution were clearly flawed for the particular experiments. The
statistics are often skewed by outlying data points and fail to capture the real physical
situation. When dealing with such clinical data, researchers often end up presenting the
data from each patient or sample separately, or use various rank tests to compare only
the trend from each patient. These approaches avoid the misleading presentation of the
data but can at best compare only trends but not the magnitude of the difference within
the trend. There were a number of aspects in the CFU assay and the process of colony
formation itself that were inconsistent with the assumptions behind the Gaussian
distribution. The discrete process of colony formation as discussed below, the small
number of patient marrow samples we could test on each peptide substrates and the
small number of colonies formed on surfaces also made the use of Gaussian distribution
unsuitable for analyzing CFU data. In light of that, a statistical model that captures key
characteristics of CFU formation was developed.
Distinctive characteristics of the process of colony formation in the CFU assay were first
identified in order to build a model that captures this distinctiveness. As we defined a
colony as a cluster of more than 8 cells, the number of colonies on a surface was by
definition a natural discrete number. In addition, it was valid to assume that the
formation of a colony on a surface was independent of, and not determined by whether
another colony formed on the same peptide surface or another peptide surface. The
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discreteness of the number of colonies, the independence of colony formation, and the
process of cell adhesion and colony formation itself can be best described by the poisson
process, a discrete distribution for which one of the requirements, in statistical terms, is
the number of changes in nonoverlapping intervals is independent for all intervals. On
the other hand, since the number of CTPs in a patient sample was reflected by the
number of colonies formed on glass positive control, the number of colonies formed on
a peptide surface was correlated with how many colonies were formed on glass. In
statistical terms, the observed likelihood of colony formation on a peptide surface, i.e.,
the likelihood that was measured in the assay, was the probability of a colony formed on
the peptide-surface given a colony formed on glass. For peptide substrate i assayed with
marrow aspirate from patientj, this probability can be denoted by P(MlI Nj) where M is
the number of CFUs formed on substrate i for patientj and N is the number of CFUs
formed on glass control with patientj sample. Given the poisson process, the probability
of obtaining exactly My CFUs with N total available CTPs (as reflected by the number of
CFUs formed on glass) is given by the limit of a binomial distribution:
P(M I Nj) N -NM M.
where P(MilI N), as defined above, is a discrete probability distribution and Pi is the
probability of: a colony forming on substrate i. Considering all n patient samples that had
been tested for substrate i, the overall probability of the model is the product of the
probabilities of colony formation given a colony formed on glass:
N/I
I7IP(Mij INj = N 1 -MM)!M P -)NM j=1 (Nj M )!M ij!
where Pi, the probability of colony formation on substrate i, is independent of the
number of colonies formed on glass. The Pi that maximizes the overall probability of the
model, Pi,,,,,, is the probability of interest. Pi,,,,, is a true measure of probability of colony
formation on substrate i, independent of colony formation on glass. Therefore, despite
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large variability of colony formation on glass due to the use of different patient samples,
the model takes a fair contribution from each patient data. Owing to this independence,
unlike rank tests in which only patient sample sets tested with all peptide substrates can
be used, this model allows us to consider data in which different patient samples were
used to test different substrates.
The statistical model was programmed and probabilities were calculated and maximized
using Microsoft Excel. Each peptide substrate composition considered in the model was
assayed with three to eight different patient marrow samples. Standard deviation (66%
confidence interval) and 90% confidence level were also determined for each probability
by building the probability distribution curve and calculating the Pi interval around Pi,.
for which the area under the probability curve is 66% and 90% to that of the total area.
Increment of: 0.0025 of Pi was used in this calculation. The results of the model were
presented in Whiskers diagrams. This statistical model was applied to analyze both the
CFU and CFU-AP data of peptide-comb substrates.
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5.4 Results
5.4.1 Colony formation in CFU assay and statistical analysis
Seven marrow samples were plated on GRGDSPY, GRGESPY and GRAASPY
substrates of a range of peptide surface densities to see if there is a peptide dose-
response behavior on CFU formation, similar to that on cell adhesion seen in the
previous chapter. For these experiments, only 5 x 105 nucleated marrow cells, instead of
2 x 106, were plated in each of the two 4-cm2 wells on a glass Lab-tek chamber. Data
from one set of marrow samples had to be discarded due to the extremely low CFU
formation even on glass. (Only 5 early adherent colonies were formed on glass for that
individual sample.) Results are shown in Figure 5.2. Despite the apparent increase in
CFU efficiency (ratio of the number of early adherent CFUs on test surface to that on
glass) with increasing GRGDSPY density, the difference in CFU efficiency between
GRGDSPY and GRGESPY surfaces was not statistically different (p=0.1) due to the
failure of colony formation on GRGDSPY surfaces with samples that had very few
CTPs, as reflected by the low number of CFUs on glass control. Hence a large variance
was associated with the mean CFU efficiency.
"-o/1 /0-
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Figure 5.2 CFU efficiency on GRGDSPY and inactive peptide analog surfaces.
(data from 6 patients) Student t-test was used to compare the difference in CFU
efficiency of GRGDSPY and GRGESPY for the medium and high peptide densities
(p=0.087 and 0.1 respectively). The differences were statistically insignificant.
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In light of the large variations which made the study of dose-response inconclusive, only
surfaces with the highest peptide density was assayed and compared subsequently.
GRGDSPY, GRGESPY and GRAASPY substrates were prepared by coupling these
peptides to surfaces spincoated with 25% NPC-activated comb, yielding substrates with
surface densities of (14000 ± 440) / tm2, (15330 ± 1040) / m2, and (27440 ± 3540) /
inm2 respectively. Figure 5.3a and b show the results when marrow aspirate samples
from seven individuals (different from the ones used in the dose-response studies above
and at a seeding density of 2x10 6 nucleated cells in each of the two 4-cm2 wells of Lab-
tek chamber slides) were plated on these substrates. For five out of the seven samples
tested, C(FU formation was enhanced on GRGDSPY surfaces compared to its inactive
peptide analog and non-activated comb control. This is reflected by the higher CFU
efficiency, defined as the ratio of the number of CFUs on test surface to that on glass
control. Almost no subcolony clusters were found on the peptide surfaces and less than
100 single adherent cells were observed. In many cases, less than 10 single cells were
found on the substrates. The only exception was the patient sample CL where more
than 100 single cells were adherent on all the "early adherent" substrates respectively. All
CFUs on GRGDSPY, GRGESPY and GRAASPY substrates and comb surfaces were
stained positive for AP, except for 30% of the CFUs on GRGESPY surfaces with
patient sample RIW. Even though GRGDSPY enhanced the formation of CFU-AP
(ratio of the number of AP+ CFU on test surface to that on glass) in five out of seven
marrow samples screened, the degree of enhancement varied widely among patients. In
addition, the number of colonies formed on the same peptide or control surface by
different patient samples varied greatly. This is due to the variation observed on glass
control surfaces. The number of early adherent CFUs formed on glass from the 7
patients' marrow aspirate ranged from 10 to 70 and the total number of CFUs (sum of
the number of adherent CFU and non-adherent CFU) also showed a 4-fold variation
among the 7 patients. However, the ratio of CFU-AP to all CFU on glass control
showed a much smaller variation ((91.3 ± 4.8) %).
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Bone sialoprotein peptide FHRRIKA and the 59-mer a4P1 peptide showed a significantly
higher CFU efficiency in comparison with the negative control GRAASPY and comb
control (Figure 5.4). For the peptide FHRRIAK, CFU efficiency was consistently
between 22%°/, and 30% for four out of five marrow samples tested. The fifth sample, CL,
which did not support any colony formation on FHRRIIA surfaces, was the same
sample that showed little colony formation even on GRGDSPY surfaces. The 59-mer
C4P31 peptide was highly potent in promoting colony formation. CFU efficiency was over
30% for all three marrow samples tested.
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Figure 5.3 Top (a) CFU efficiency of GRGDSPY, inactive analog peptide and non-
activated comb surfaces. Bottom (b) CFU-AP efficiency. Marrow aspirates from 7
individuals were used in the experiment. Patient classifiers were denoted on the x axes.
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Figure 5.4 CFU efficiency of FHRRIKA and 59-mer CX431 substrates. 5 marrow
aspirate samples were used to assay colony formation on FHRRIKA surfaces and 3
were used on 59-mer 41 substrates. Patient classifiers were denoted on the x axes.
The CFU assay statistical model was used to analyze all the colony formation data from
screening peptide substrates using the CFU assay. Figure 5.5 shows the Whiskers
diagram of the probability of CFU formation on all the candidate peptide substrates.
Peptide candidates that are potent in enhancing colony formation were defined as those
with a probability of CFU formation higher than that of the negative control peptides
RGE (0.129 0.19) and RAA (0.140, +0.275/-0.225). (Standard deviation was reported
as the variance here.) The peptides RGD, CS-1, FHRRIIKA and 59-mer a041 supported
colony formation to various extents. The probability of colony formation on 59-mer
OC4P3 substrates was 0.424, higher than RGE and RAA with 95% confidence interval.
The probability of CFU formation for CS-1, another c4f31 peptide, FHRRIIKA, and RGD
was 0.24, 0.23, and 0.185 respectively, all higher than that of RGE and RAA by at least
one standard deviation. The probability of colony formation on all peptide surfaces,
except for YIGSR, was higher than that on plain comb copolymer substrates (0.064,
+()0.0135/-0.0115) by at least one standard deviation.
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Figure 5.5 Whiskers diagram showing the probability of CFU formation on
various substrates with x 1 standard deviation (66% confidence interval) and +
90%GO confidence interval. The probability reported here is the P,,,,a in the
statistical model developed in Section 5.3.
When the CFU assay statistical model was used to analyze CFU-AP data from CFU
assays, a similar trend was observed (Figure 5.6). The 59-mer peptide remained to be the
surface with the highest probability of AP+ colony formation (probability = 0.42 ± 0.06),
followed by FHRRII(A and CS-1 (probability = 0.25 0.03 and 0.23 +0.04/-0.03
respectively). Substrates with these two peptides, as well as RGD, showed a significantly
higher probability of supporting CFU-AP than the negative control peptide RGE with
90% confidence interval. C16 peptide showed a probability of CFU-AP formation of
(0.197, +0.028/-0.025), one standard deviation interval higher than RGE. All other
peptides showed no significant probability of CFU-AP formation. As a negative control,
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the probability of CFU-AP formation on RAA surfaces was slightly high, the reason for
which is unknown.
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Figure 5.6 Whiskers diagram showing the probability of CFU-AP
formation on various substrates with x 1 standard deviation (66%
confidence level) and + 90% confidence interval. The probability reported
is the Pi,,, in the statistical model developed in Section 5.3
5.4.2 Evaluation of glass as the gold standard control
As mentioned briefly in the previous section, a large patient variability in colony
formation was observed in CFU assay, even on glass controls. To understand more of
this phenomenon, marrow aspirates were seeded on glass coverslip control and Lab-tek
chamber glass slides at a density of 2x10 6 nucleated cells in each of the two 4-cm2 wells
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on a glass Lab-tek chamber (i.e., at 5x105 cells / cm2 seeding density). The performance
of these two surfaces in supporting colony formation is compared in Figure 5.7. Huge
variations in the total number of CFUs (the sum of early and late adherent CFUs) and in
CFU efficiency (the ratio of the number of early adherent to total CFU) were observed.
The median total number of CFUs formed on glass and Lab-tek was only (36.0 ± 8.9)
and (34.7 ± 5.5) respectively. The median CFU efficiency was also low, (44.4 ± 6.3)%
and (47.8 + 4.3)% for glass and Lab-tek respectively. The percentage of CFUs that were
CFU-APs at this seeding density was (90.7 ± 5.3)%.
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Figure 5.7 CFU formation on glass coverslips and Lab-tek glass chamber
slides at 5x105 cells / cm2 seeding density. For each point, a total of 8 x106
cells were seeded. Large patient variability was observed. The number of
CFUs on glass and Lab-tek was normalized to the area of the respective
surface. The same symbols (different colors) in the graph denote substrates
plated with marrow sample from the same individual.
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At a quarter of the original marrow seeding density, 1.25x105 cells / cm2 , significant
patient variability in the performance of glass coverslip and Lab-tek in supporting CFU
was also observed (Figure 5.8). However, to our surprise, even though only one quarter
of the original seeding density was used, the median total number of CFUs on both glass
and Lab-tek, (34.0 ± 7.2) and (34.3 ± 5.8) respectively, remained approximately the same
as when four times more marrow cells were seeded. The median ratio of early adherent
CFUs to the total number of CFUs on glass coverslips increased by about 30% to (56.6
± 4.5)% as the seeding density decreased. The median ratio increased drastically from
(47.8 ± 4.3)c/o to (79.1 ± 4.8)% for Lab-tek as the seeding density was decreased to one
quarter of the original.
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Figure 5.8 CFU formation by each marrow sample on glass coverslips and
Lab-tek glass chamber slides at 1.25x105 cells / cm2 seeding density. Large patient
variability was observed. However, the median total number of CFU on both
glass and Lab-tek remained approximately the same as when the 4-times higher
seeding density was used (i.e., 4X higher total cells seeded). In addition, the
median ratio of the number of early adherent to total CFU increased significantly
at this lower seeding density.
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5.5 Discussion
5.5.1 CFU formation and statistical analysis
Patient variability is a major issue in analyzing data obtained from CFU assay in which
fresh human marrow aspirates were used. The variation observed on peptide substrates
was not unusual, as such variation was seen even on glass, the "gold standard control" of
the CFU assay. Traditionally, glass has been established to be the gold standard control
for its exceptional ability to promote colony formation from CTPs in marrow aspirates.
However, at the seeding density (5 x 105 nucleated marrow cells / cm2 ) that was used, a
6--fold variation in the total number of CFUs and a 4-fold variation in the ratio of early
adherent CFUs to the total number of CFUs was observed over all the patients. The
latter observation suggests a variation in the adhesion receptor profile of CTPs.
Therefore, it was not surprising to see a large fluctuation of CFU efficiency for even the
same type of peptide substrates but tested with different marrow samples. This inherent
patient variability created difficulties in comparing CFU data collected with different
patient marrow samples. The CFU assay statistical model was implemented to alleviate
some of the contribution by this patient variability by considering each entry of colony
formation measured on peptide substrate as the likelihood of a colony forming on the
substrate given a colony formed on glass using the same patient sample. With the model,
the overall probability of colony formation on a given substrate was computed as a
parameter independent of whether colony formation is high or sparse on glass control
for the marrow samples tested. Based on the analysis on CFU data using this statistical
model, the 59-mer a4pl peptide has the highest ability in promoting CFU formation and
CFU-AP formation, indicating that the peptide has exceptional ability in supporting the
adhesion, proliferation and differentiation of CTPs into osteoblastic lineage.
Interestingly, the other 0c4P1 peptide CS-1 was among the second highest in supporting
both CFU and CFU-AP formation. Thus, OC4P1 may be one of the integrins utilized by
CTPs to mediate adhesion and proliferation. Previous reports in the literature showed
that a portion of osteoblastic progenitor cells expressed 0(4pl and that (X4P1 was expressed
130
transiently by stromal-derived osteoprogenitors (Grzesik and Robey, 1994; Gronthos et
al., 2001). Therefore, the C(4l1 substrates might be capturing a subpopulation of CTPs
that were of osteoblastic lineage and was at a certain differentiating state in which ca41l
was expressed. We could rule out the possibility that the colonies on the substrates were
macrophages even though hematopoietic cells in marrow aspirates, such as most
lymphocytes (except neutrophils) and granulocytes, are known to express c4pl3 (VLA-4)
since almost all the CFUs captured on these O4P1 substrates were AP+. The third a4pl
peptide, REDV, did not promote colony formation probably because the peptide itself
might not be potent enough to support significant cell adhesion. As pointed out in
Chapter 4, surfaces with REDV peptides only supported little adhesion of HUVEC.
The bone sialoprotein peptide FHRRIKIA also promoted the formation of CFU-AP,
with a similar efficiency to that of the CS-1 peptide. In Chapter 4, we showed that
FHRRIKA supported the adhesion of MC3T3-E1 osteoblasts but not primary pMSCs,
leading us to hypothesize that the more differentiated osteoblastic cells and MSCs
expressed different adhesion receptors and hence the different adhesion behavior on
FHRRIKA. If this hypothesis were correct, and bearing in mind that CTP is a term that
collectively refers to all progenitors that have the potential to differentiate into
connective tissue lineage, from the pluripotent mesenchymal stem cells to preosteoblasts,
then the CTP colonies captured on FHRRIKA surfaces could be derived from CTPs that
were more differentiated than the truly mesenchymal stem cells. This could be possible
as the CFUs formed on FHRRIIKA surfaces were all AP +, indicative that their
differentiation states were somewhere along the osteoblastic lineage. However, more
experiments were needed to reveal how differentiated these CFUs were in relation to
CFUs on other peptide surfaces or glass.
The likelihood of colony formation and AP+ colony formation on RGD surfaces were
higher than that on RGE as expected, with 90% confidence interval. The laminin C16
peptide, which has been shown to bind to aspl, Cavf3, but at a lower affinity, and possibly
other adhesion receptors, showed a probability of CFU formation similar to, but slightly
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lower than that of RGD. The increase in the relative likelihood of CFU-AP formation
on RGD and even more on C16 to that of RGE was due to their higher ratio of CFU-
AP to CFU than that of glass and RGE. Other peptides, YIGSR, EIDGIEL and DGEA,
did not support significant CFU formation, as indicated by the low probability of CFU or
CFU-AP formation. This could be a result of the low affinity of the peptides as
validation results with various cell lines or primary hepatocytes in the previous chapter
on these peptide substrates showed only a small degree of adhesion.
The number of subcolony clusters and single adherent cells found on all surfaces in the
CFU assay was surprisingly low and the number of single cells adhering was often less
than 10 even when 2 million nucleated marrow aspirate cells were seeded. This was
unexpected as bone marrow aspirates contain at least some endothelial cells and
fibroblasts which express receptors that would bind to, for instance, RGD surfaces. The
amount of single cell adhesion was also not substrate-dependent but more dependent on
which patient sample was used. These observations led us to hypothesize that marrow
cells were shrouded by extracellular matrix proteins as they were aspirated and hence,
preventing their receptors to bind to the peptide substrates, thus leading to the small
amount of adhesion observed. This issue of matrix protein shrouding is explored and
discussed in detail in the next chapter.
5.5.2 Patient variability and evaluation of glass as the gold standard control
of CFU assay
As mentioned in previous sections, large patient-to-patient variations were observed in
C TP prevalence in marrow and CTP adhesion state even on glass standard control.
Previous reports by Muschler et al. showed that the prevalence of potentially osteoblastic
C TP in bone marrow aspirate was about 1 in 23,000 nucleated cells (Majors et al., 1997).
So when 5 x 105 nucleated marrow cells per cm2 was seeded on a total of 16 cm 2 of glass
substrate in our experiments, there should ideally be -348 CFU-APs. However, from
our studies, at this seeding density, the total number of CFU on glass coverslips ranged
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from 20 to 80 with a median of only 36.0 8.9. Surprisingly, the median number of
CFU stayed approximately the same when the seeding density was reduced to one-
quarter of the previous seeding density. Steric hindrance and nutrient consumption
might limit the number of CTPs that could adhere and subsequently form colonies on
the substrate. Assuming the average size of marrow cells to be 10 m in diameter, 5 x
105 closely packed cells would occupy about 0.5 cm2. Even though not all the nucleated
cells were adherent cells, steric hindrance could still contribute to the saturated number
of CTPs when a higher seeding density was used. At the lower seeding density, 1.25 x
105 nucleated marrow cells per cm2, the efficiency of early adherent CFU formation to
the total number of CFUs on glass coverslips was 30% higher than when the 4-fold
seeding density was used. The increase in efficiency was more than 2 fold for Lab-tek.
The total number of CFU captured in the early and late adherent fraction at this lower
seeding density was about 40% of the ideal number of CFU-APs based on the prevalence
reported by Muschler et al.. Even though the number of CFUs reported in our studies
included both AP+ and AP- CFUs, the drastic increase in the efficiency of CTP capture
was still apparent when the seeding density was decreased from 5 x 105 per cm2 to at 1.25
x 105 per cm2. The lower total number of CFUs and CFU efficiency observed on glass in
our experiments could be partially explained by the use of marrow samples from a pool
of older patients in comparison to the studies by Muschler and co-workers. The subjects
in our pool were dominated by older patients with arthroplasty and an age-related decline
in the number of CTPs in marrow has been demonstrated in the literature (Bergman et
al., 1996; Muschler et al., 2001). According to the same report by Muschler et al., the
number of colonies was the maximum number of CFU-AP counted between day 6 and 9
so more colonies might have been formed. In addition to age-dependence, the variation
observed in CTP prevalence and adhesion characteristics among patients may be due to
factors such as gender, tobacco use and menopausal status (Muschler et al., 2001).
These CFU assay evaluation studies showed that glass coverslips did not perform up to
expectation as a "gold standard control" in CFU assay. When glass coverslips were
compared side-by-side with Lab-tek chamber slides, the median total number of CFUs
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per unit area and the median ratio of early adherent CFUs to the total number of CFUs
were essentially the same for the two surfaces at the higher seeding density (5 x 105 per
cm2). However, at the lower seeding density, the significantly higher ratio of early
adherent to total number of CFUs on Lab-tek but similar total number of CFUs for the
two surfaces showed that Lab-tek was much more capable than glass coverslips in
capturing CTP colony formation. This drastic difference was likely due to the difference
in the type of glass that glass coverslips and Lab-tek slides were made of. The glass
coverslips used in this study were made of borosilicate glass, composed mainly of silica
(70-80%), boric oxide (7-13%) with a small amount of sodium, potassium and aluminum
oxide. On the other hand, Lab-tek chamber slides, according to the manufacturer, were
made of soda-lime glass that composed of 71-75% SiO2 , 12-16% soda, and 10-15% lime
(calcium oxide from limestone or calcium carbonate). The last constituent calcium
carbonate itself had been shown to be osteoconductive, as under hydrothermal exchange
reaction, calcium carbonate, CaCO3 can be changed to hydroxyapatite, Calo(PO4)6(OH) 2,
the main mineral of bone (Roy and Linnehan, 1974). In fact, several studies have shown
that bone marrow seeded on coralline calcium carbonate consistently showed new bone
formation (C)kumura et al., 1991; Vuola et al., 1996). Thus, the presence of calcium
carbonate in Lab-tek chamber glass slides might have contributed to its enhanced ability
in capturing CTP colony formation through unknown mechanisms. From these
evaluation and optimization studies of glass as the positive control in CFU assays, we
have identified 1.25 x 105 nucleated marrow cells per cm2 to be a more optimal seeding
density and Lab-tek glass slide to be a better positive standard control for the CFU assay.
These findings of assay optimization were applied to the CFU studies in Chapter 6.
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Chapter 6
Design of Bone Marrow Aspirate Treatments to Enhance
the Efficacy of Colony Formation
6.1 Introduction
In Chapter 5, peptides that possess the ability to promote osteoblastic colony formation
of CTPs from bone marrow were identified using the CFU assay. However, the amount
of adherent cells in general was much lower than expected, given the millions of cells per
cm 2 seeding density. The lower-than-expected number of colonies and single adherent
cells on even RGD surfaces and glass control was a surprise to us since bone marrow
aspirates contained cells such as fibroblasts and endothelial cells that express c-51 and/or
OC,P3 that recognize the RGD sequence. In fact, in Chapter 4, we have extensively
demonstrated that peptide substrates like GRGDSPY supported the adhesion of several
cell lines very well, such as wtNR6 fibroblasts and HOS osteosarcoma cells, as well as
primary pig MSCs. Therefore, the bioactivity of the substrates was not in question. We
thus hypothesized that the small amount of cell adhesion was due to the shrouding of
bone marrow aspirate cells by the extracellular matrix proteins they were associated with
in their natural microenvironment rich in ECM proteins such as fibronectin, laminin and
collagen IV. We hypothesized that when marrow cells were aspirated, the ECM proteins
associated with them remained attached, preventing them from recognizing and attaching
to the peptides on the test substrates.
Therefore, in this chapter, our first goal was to test the hypothesis of protein shrouding.
Fluorescence-activated cell sorting (FACS) was used to assess the profile of ECM
proteins association with marrow aspirate cells. The level of ECM protein association of
marrow aspirates was compared with cells from cell lines using immunoblotting. As
mentioned in previous chapters, since there were very few reports on integrin expression
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profile of human marrow connective tissue lineage cells, illuminating the integrin profile
of different populations of marrow aspirates is one of the goals here. A single marker
that delineates CTPs had not been identified to date, because of the lack of consensus of
CTP or MSC phenotype (Gronthos et al., 1994; Pittenger et al., 1999; Minguell et al.,
2001; Tocci and Forte, 2003), the broad spectrum of progenitor cells defined as CTPs
(Aubin and Heersche, 2000), and the highly variable profile of cell surface antigens Jiang
et al., 2002; Vogel et al., 2003). The combination of CD45- and CD105 + was chosen due
to the general agreement that MSCs lack typical hematopoietic antigen such as CD45.
CD45 is a transmembrane protein phosphatase marker for all cells of hematopoietic
origin except erythoid cells, platelets and their precursor cells (Thomas, 1989;
Trowbridge and Thomas, 1994). Therefore, CD45- cells were gated to exclude cells of
hcmatopoietic lineage in our analysis. On the other hand, CD105, also known as
endoglin, has been quite extensively used as a mesenchymal stem cell marker (Barry et al.,
1999; Majumdar et al., 2000). When CD105 is used in combination with other markers,
and in particular CD45, it has been demonstrated by several reports to obtain an
enriched population of mesenchymal stem cells (Lodie et al., 2002; Meinel et al., 2004),
even though CD105 is not specific only to MSCs but also expressed by angiogenic
endothelial cells (Duff et al., 2003; Fujiyama et al., 2003). Interestingly, CD105 itself, a
receptor for the transforming growth factor-n (TGF-f), had been shown to play a role in
mediating cell adhesion, spreading, growth, and proliferation in a RGD-dependent
manner (Guo et al., 2004). Even though there were some successes in enriching
marrow-derived osteoprogenitors using STRO-1, the surface antigen itself has not been
characterized and understood to date. In light of all these, CD45 and CD105 were used
in our study to identify an enriched population of CTPs.
Our second objective in this chapter was to design marrow aspirate cell treatments to
reduce the amount of matrix molecule association, and thus enhance interactions
between marrow aspirates and substrates. The treatments had to be mild so as not to
disrupt the adhesion potential of the cells. Simple treatment protocols are also favorable
considering the procedure will eventually be done intraoperatively when peptide-comb is
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incorporated into scaffolds to be used as bone implants. At that point, marrow
aspiration, cell-preloading protein reduction treatments, and marrow cell loading will all
be performed in the operation room. Based on these design criteria, three protein
reduction treatments were designed. The CFU assay, incorporating the new optimized
cell seeding density and gold standard control identified in Chapter 5, was used to
evaluate the effectiveness of various treatments on marrow aspirate cells. GRGDSPY
substrates were used in this model study. The results of these experiments revealed a
partitioning of patient marrow samples into two groups with distinctive CTP behavior
and cell integrin expression profile. One of the cell-preloading protein reduction
treatments was identified to be effective in one of the two patient groups.
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6.2 Materials and methods
6.2.1 Human mesenchymal stem cell (hMSC) line culture and preparation of
human marrow aspirates for FACS and immunoblotting
PoieticsTM human mesenchymal stem cells, a cell line of normal adult hMSCs, was a gift
from the Wells Lab (University of Pittsburgh). The cells were used to validate antibodies
used in FACS and for comparison with human marrow aspirates in Western blotting.
hMSCs were routinely cultured and maintained in DMEM with 10% FBS, mM non-
essential amino acids, 2mM L-glutamine, 1mM sodium pyruvate and 100 i.u./mL
penicillin and 200 [pg/mL streptomycin. Cells were cultured at 37°C with 5% C0 2, fed
every 3-4 days and split when they were near confluency after 5 -7 days of seeding. Cells
up to passage 10 were used. To prepare cells for FACS or Western blotting, hMSCs
were detached from culture plates by trypsin (Sigma) and re-suspended in culture media
before centrifugation. The cell pellet collected was then ready for FACS or Western
blotting.
Frozen bone marrow aspirates were used for FACS and Western blotting. Bone marrow
was aspirated according to the procedure described in Chapter 2 and frozen down in
media containing 10% DMSO on the same day of aspiration. Right before FACS or
Western blot preparation, cells were quick-thawed and re-suspended in culture media
containing 2 units/mL of heparin. For FACS, Buffy coat was isolated by centrifuging
marrow cells at 1600 rpm for 10 minutes. After removing the media on the top, the
buffy coat was slowly and carefully aspirated into a Pasteur pipette, leaving the red cells
behind at the bottom of the tube. The buffy coat was then re-suspended in DMEM
containing 0.3% BSA and 2 units/mL of heparin and cell clumps were broken up by
passing the cell suspension through a 21G needle multiple times and twice with cell
sieves (Falcon). The cells were then processed further for FACS according to the
procedures described in the next section.
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6.2.2 Fluorescent-activated cell sorting (FACS) analysis of bone marrow
aspirates
Buffy coat cells were re-suspended in FACS buffer (Dulbecco's phosphate buffer saline
with Ca2+ and Mg 2+ and 0.2% BSA) for staining with antibodies. In brief, cells were
stained with the appropriate antibodies for 15 minutes on ice and re-suspended in excess
FACS buffer before the cells were pelleted by centrifugation. After FACS buffer was
removed, cells were subjected to the next round of staining either with a secondary
antibody or the next primary antibody. The staining process was repeated until cells
were stained with all the antibodies planned to be tested. CD45 (Cat. # 555481, BD
Bioscience, San Jose, CA) and CD105 (Cat. # CBL418, Chemicon, Temecula, CA)
antigens were used to define an enriched population of CTPs. Polyclonal antibodies
were used to recognize ECM molecules as they were made against whole proteins instead
of specific epitopes that may not be available for binding. Anti- ECM protein polyclonal
antibodies and anti- integrin monoclonal antibodies used in this study, as well as
fluorochrome-conjugated secondary antibodies used for detection were listed in Table
6.1. The activity of all the antibodies towards human ECM proteins and integrins were
validated with hMSC cell line. 6-color FACS analyses were performed on marrow cells
using a BD FACSCanto flow cytometer. Compensation was done using anti-mouse Ig,
x/negative control compensation particles set (BD Bioscience) and the appropriate
antibodies used in this study. Negative controls (cells incubated only with fluorochrome-
conjugated secondary antibodies, i.e., with the omission of primary antibodies) were used
to set up fluorescence gates. 100,000 events were collected for each sample. Cell
clusters and debris were excluded from the analyses by gating on mostly single cells in
the forward scatter width (FSC-W) versus height (FSC-H) and side scatter width (SSC-W)
versus height (SSC-H) plots. Cells were gated on CD45-CD105 + and NOT(CD45-
C(I)105+). Cells in both populations were analysed for their expression of ECM proteins
and integrins. Data analysis was carried out using the BD FACS Diva software.
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Antibodies against ECM molecules Binding epitope information, if
known
FN Rabbit anti- human fibronectin (Chemicon Polyclonal antibodies - target the entire
AB1945) protein.
LN Rabbit anti- laminin (Chemicon AB19012)
VN Rabbit anti- human vitronectin (Chemicon
AB19014)
Col I (I;oat anti- collagen I biotin (Chemicon
AB758B)
Antibodies against integrin subunits Binding epitope information, if
known
0(2 R-phycoerythrin (PE) anti-human CD49b Binds to (2I, the principle binding
nmAb clone 12F1-H6 (BD Cat. # 555669) domain to collagen but no information
on whether they bind to the same
residues within the 200 a.a. domain.
Blocking effect has not been tested
(Cruz et al., 2005)
x03 Fluorescein isothiocyanate (FITC) mouse Binding epitope and whether it blocks
anti-human CD49c mAb clone 17C6 (MCA X3 binding to its ligand is unknown.
1'948F, Serotec, Raleigh, NC)
x04 PE anti-human CD49d mAb clone 9F10 Binding epitope and blocking effect
(BD 555503) unknown.
(5 CD49e clone IIA1 Biotin-conjugated Inhibits sli binding to its ligands
mouse anti-human mAb (BD 555616) (Nhieu and Isberg, 1991; VanNhieu
and Isberg, 1993).
0(6 FITC anti-human CD49f mAb clone May block binding of to laminin P1 and
GoH3 (BD 555735) E8 fragments (Sonnenberg et al., 1986;
Aumailley et al., 1990).
(XT33 PE anti-human CD51/61 mAb clone 23C6 Inhibitory effects on binding to
(BD 550037) vitronectin (Chuntharapai et al., 1993).
Pi biotin-conjugated anti-human CD29 mAb Binding epitope has not been mapped.
clone TDM29 (Chemicon CBL481B) Blocking effect unknown.
Secondary fluorochrome-conjugated antibodies
streptavidin--PE-Cy7 conjugate (BD 557598)
streptavidin--Alexa 700 conjugate (Molecular Probes Cat. # S21383)
Alexa 700 gcoat anti-rabbit IgG (H+L) (Molecular Probes A21038)
allophycocyanin (APC)-conjugated rat anti-mouse IgM monoclonal antibody (BD 550676)
FITC Goat anti-rabbit Ig (BD 554020)
Streptavidin PE-Cy5.5 conjugate (Cat. # SA 1018, Caltag Lab, Burlingame, CA)
streptavidin FITC conjugate (BD 554060)
streptavidin PE conjugate (BD 554061)
Table 6.1 Primary antibodies against ECM molecules and integrins and secondary
fluorochrome-conjugated antibodies used in FACS. Binding epitope information was
obtained from the literature or from the supplier.
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6.2.3 Western blot analysis of protein association
Whole cell lysates of hMSCs or bone marrow aspirates were prepared by lysing a known
number of cells prepared as described above in 150mM sodium chloride with 50 mM f-
glycerophosphate (pH 7.3), 10 mM sodium pyrophosphate, 30mM NaF, 50mM Tris (pH
7.5), 1% Triton X-100, 2mM EGTA, 100 tM sodium orthovanadate, 1 mM of each of
DTT, benzamidine and PMSF, 10 btg/mL aprotinin and leupeptin and 1 tg/mL of
pepstatin. Protein concentration of each sample was determined by the bicinchoninic
acid assay (MicroBCAT M protein assay kit, Pierce, Rockfield, IL). 5% polyacrylamide gels
were polymerized and prepared in house using BIO-RAD's Mini-PROTEAN 3 Cell
Assembly kit with Protogel diluted with Protogel resolving buffer (both from National
Diagnostics, Atlanta, GA) with Temed (Invitrogen, Carlsbad, CA) and ammonium
persulphate (Pharmacia Biotech, Uppsala, Sweden) as the initiator. The stacking gel was
prepared with Protogel diluted with Protogel stacking buffer (National Diagnostics) and
polymerized with ammonium persulphate. Since the goal was to compare the level of
ECM protein associated with different cells or cells subjected to different treatment (as
described in the next section), protein lysed from the same number of cells for each
sample was loaded on the gel for assay. Prior to loading, cell lysates were boiled in
sample buffer to ensure antibody-binding regions were exposed. Approximately 25-40
[xg of protein lysate, as well as molecular marker solution (Precision Plus Protein
Standards, BIO-RAD), was loaded onto the gel and separated by SDS-PAGE. Proteins
on the gel were then transferred to sequi-blot PVDF membranes in Ready Gel blotting
sandwiches (BIO-RAD). After blocking with blotto (5% non-fat dry milk) for one hour
at room temperature, blots were probed overnight at 4°C in primary rabbit anti-human
fibronectin or laminin polyclonal antibodies (Chemicon Cat. # AB1945, AB 19012) at
1:1000 and 1:5000 dilution respectively. Both antibodies were validated for their ability
to bind to human fibronectin and laminin. Blots were washed 3 times in TBS-T (20 mM
Tris-HCl pH 7.5, 137 mM NaCl and 0.1% Tween 20 (BIO-RAD)) for 5 minutes and
then incubated with the secondary antibody ECLTM anti-rabbit IgG, horseradish
peroxidase linked whole antibody (1:10000 in blotto, Amersham Biosciences,
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Buckinghamshire, England), and finally washed 3 times in TBS-T for 5 minutes. Blots
were developed with either Western Lightning Chemiluminescence Reagent Plus (Perkin
Elmer, Boston, MA) or ECL AdvanceTM WB Detection Kit (Amersham Biosciences)
and imaged on a Kodak Imagestation 1000 and analysed with the Kodak 1D software.
6.2.4 Cell-preloading protein reduction treatments and CFU assay
Marrow aspirates were prepared as outlined in Section 6.2.1. After preparation, the
marrow aspirate cell pellet was divided into five groups for treatments to reduce the
amount of cell-associated matrix molecules. Cells in Group A received no treatment.
Cells in Group A' were incubated in DMEM containing 0.3% BSA. Group B and C
were incubated in PBS with and without divalent ions respectively. 200 FLM GRGDSP
solution (in PBS with divalent ions) was added to cells in Group D. Each group was
incubated in their respective solution for 30 minutes. Afterwards, cells were spun down
and the supernatant removed. The pellets were washed again by re-suspending in culture
media and then centrifuged. After the second wash, cells were re-suspended and
counted using a coulter counter or hemocytometer.
Marrow aspirate samples from four individuals were used to examine the effect of these
cell-preloading treatments on protein reduction and colony formation. Freshly aspirated
cells were treated with Treatments A, B, C and D as described above. After counting,
cells from each group were plated on Lab-tek surfaces, GRGDSPY and plain comb
copolymer substrates at 1.25 x 105 cells / cm2 and assayed the same way as the regular
CFU assay described in Chapter 5, except at this lower cell seeding density and with Lab-
tek as the positive control (Figure 6.1). Frozen marrow samples from the same four
individuals were treated with Treatments A, A', B, C and D as described above and the
level of fibronectin and laminin associated with the same number of cells from each
group was analyzed with Western blotting. Frozen marrow aspirates from Patient 1 and 2
were also analyzed with FACS to compare their ECM protein and integrin expression
profile. FACS was performed on fresh aspirate samples from Patient 3 and 4.
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Seed BM --
1 .25x1 cells cm
1.25xl 05 cells/ cm2
I I
Cell
preloadinc
treatment
Iwash
wash
Cell pre-loading treatments
A - No treatments
B- PBS with Ca2+ , Mg2 +
C - PBS without Ca2 + , Mg2 +
D - 200 pM GRGDSP solution
48 hrs 4 days Early adherent
- -- , CFUs
Stained for AP
Test surfaces non- Also counted:
or Lab-tek adhP elels clusters, single cells
control
6 days
'~ Late adherent
A ^ CFUs
Lab-tek
(standard control)
Figure 6.1 Schematics showing the flow of marrow pre-loading treatment and
subsequent CFU assay. Marrow aspirates were subjected to various pre-loading
treatment in attempt to identify one that could effectively reduce the amount of
matrix proteins associated with aspirate cells.
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6.3 Results
6.3.1 ECM protein and integrin profile of marrow aspirate cells by FACS
SSC-H vs. FSC-H plots from FACS showed variations in cells in marrow aspirate from
different patients. In some patient samples, the lymphocyte and granulocyte populations
were more distinct (Figure 6.2a) whereas for some aspirate samples, no clearly-defined
population was found (Figure 6.2b). Both of these profiles were normal but their
difference showed a large variation in cell sizes and granularities among patient samples
as reflected by the different shapes of SSC-H vs. FSC-H plots.
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Figure 6.2 Two typical SSC-H vs. SSC-H plots of marrow aspirate cells
demonstrated patient variability. Left (a) shows distinctive populations of
lymphocyte (circle in red) and granulocyte (dotted circle in green), whereas in (b),
right, there was only one large cell population that was not well defined and with
a lot of debris.
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Figure 6.3 An example of how FACS analysis was performed on marrow
aspirate cells. The analysis of c, expression of CD45-CD105 + of one patient
sample is shown here. Cells incubated with only the secondary antibody (i.e., with
the omission of primary antibody) was used as negative controls to set up gates.
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CD45- CD105 + cells only made up of (0.40 0.11) % of the entire marrow aspirate
population. This small population was believed to represent an enriched population of
CTPs (Lodie et al., 2002; Meinel et al., 2004) and thus matrix molecule and integrin
expression of both the CTP-enriched CD45- CD105+ and non-CD45- CD105 +
populations were compared. Figure 6.4 shows the ECM molecule association profile of
marrow aspirate cells. ECM protein association was generally the same for the CD45-
CD105+ and non-CD45- CD105+ population except for fibronectin, the amount of
association of which by CD45- CD105+ cells ((49.1 11.8) O/o) were likely to be higher
than non- CI-)45- CD105+ cells ((28.9 + 8.25) %) (p<0.1).
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Figure 6.4 ECM association profile of marrow aspirate cells from FACS.
Only fibronectin was expressed by a slightly statistically higher amount in the
CD45(- D105 + population compared to non- CD45-CD105+ cells (* p<0.1,
student t-test). The difference in association between the two populations was
insignificant for other ECM proteins tested. Data are mean + SE. n = 6 for FN
and LN. n = 3 for VN and Col I.
Like ECM protein association, expression of most integrin subunits was about the same
for both the CD45- CD105+ and non- CD45- CD105 + populations, except for the Xc4
subunit. 0a4 was the only integrin subunit that was much highly expressed by CD45-
CL)105+ cells than non- CD45- CD105+ (Figure 6.5). (61.2 + 8.25) % of CD45- CD105+
cells expressed Oc4 while only (28.9 + 8.25) % of non- CD45- CD105+ was 4+ (p<0.005).
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High expression of Pi (> 60%) was detected in both the CD45- CD105+ and non-CD45-
CD105 + populations. Although 20-30% of cells express O5 and CVfP3, large variations in
expression of both integrins were observed (Figure 6.5). Expression of Oc3 and c6 in both
cell populations was negligible.
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Figure 6.5 Integrin expression profile of marrow aspirate cells from FACS.
Data are mean ± SE. a4 expression was higher in the CD45-CD105 + population
(*p<O.(I)05). The difference in expression between CD45-CD105 + and non-CD45-
CD105' populations was insignificant for other integrins. n = 6 for cx4, ao, a,,33
and 31. n = 3 for 02, %c3, and a6.
6.3.2 Western blotting showed fibronectin and laminin association with
marrow aspirate cells
The level of fibronectin and laminin associated with marrow aspirate cells was compared
to that of hMSC cell line. When protein lysates from the same number of cells from
both types were compared by Western blotting, we saw a much higher level of
fibronectin and laminin with marrow aspirate cells. Treatment of marrow aspirate cells
with 0.6X trypsin solution (0.3 g/L porcine trypsin and 0.012 % EDTA 4Na in PBS)
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significantly reduced the amount of fibronectin and laminin to a level even lower than
that of hMSC cell line (Figure 6.6a and b).
FN LN
kDa A B C ctrl A B C ctrl
250
150
100 -
kDa
250 -
150 -*
Figure 6.6 Western blot results showed a higher level of matrix molecules
associated with marrow aspirate cells than hMSC cells. Left (a) fibronectin
probed. Right (b) laminin probed. Protein lysates from the same amount of
cells were loaded and analyzed. Lane A - untreated marrow aspirates. B -
marroxv aspirates treated with 0.6X trypsin. C - untreated hMSCs. FN ctrl and
LN ctrl were commercially available FN and LN proteins. Results of a
representative experiment (one of three independent experiments with similar
results) are shown here.
6.3.3 Comprehensive study of integrin expression, protein reduction and
colony formation of marrow aspirates from four individuals
The effectiveness of the proposed cell pre-loading protein reduction treatments was
critically evaluated by their ability to reduce matrix molecules associated with cells and
hence increase colony formation in CFU assays. Bone marrow aspirate samples from
four individuals were used in this study. Western blots showed that just by washing,
matrix molecules associated with aspirate cells could be reduced by a moderate amount.
Washing aspirate cells with PBS or GRGDSP solution further reduced the level of
fibronectin and laminin (Figure 6.7a). In half of the patient samples tested, the level of
fibronectin and laminin was visibily the lowest for cells treated with PBS without divalent
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ions (Figure 6.7b) while for the other half of the patients, this further reduction effect
was not visible to the eye after the image of the blot was developed.
A A' B C D
Figure 6.7 Fibronectin level of marrow aspirates treated with various
treatments. Top (a) The amount of fibronectin associated with marrow aspirates
was reduced to a different extent after washing. Letters beside each lane denotes
what treatment the cells received before they were lysed. Bottom (b) Higher
contrast image of Lanes B to D of the image shown in (a). All lanes were loaded
with protein lysates from the same number of cells. Blot with laminin also
showed a similar trend (data not shown).
CFU assay revealed two different colony formation behavior when marrow aspirate cells
handled with various treatments were seeded onto Lab-tek, GRGDSPY and comb
substrates. Marrow samples from patient 1 and 3 showed much fewer colony formation
than patient 2 and 4 on Lab-tek glass slides (Table 6.1). However, treatment with PBS
without divalent ions enhanced CFU formation on RGD surfaces compared to untreated
ones for patient 1 and 3. On the other hand, CFU formation decreased after any
treatments for patient 2 and 4. Large variation in single cell adhesion but no particular
trend was seen for all patients. (data not shown.) Alkaline phophatase expression also
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A - no treatment
A' - treated with DMEM with BSA
B - treated with PBS with Ca2 + , Mg2+
C - treated with PBS without Ca2 + , Mg2 +
D - treated with 200 pM GRGDSP
partitioned patient 1 and 3 into the group in which all except one CFUs on Lab-tek
surfaces were weak AP+, while two subpopulations of CFUs, strong AP+ and weak AP+
or AP, were observed on patient 2 and 4 (Figure 6.9). In addition, CFUs formed on
RGD surfaces from patient 1 and 3 marrow cells treated with divalent-ion free PBS were
all AP+. On the other hand, CFUs of patient 2 and 4 on RGD surfaces were all AP-. A
correlation of colony size and AP expression was also observed. CFUs that are AR were
colonies of smaller size. Strong AP+ CFUs were usually larger colonies. Some of these
strong AP+ C FUs showed stronger AP staining at the center of the colony and fainter as
one goes towards the periphery (Figure 6.8).
Early adherent colonies Early adherent colonies
A B C D A B C D
Pt 1 Lab-tek 14 10 7 8 Pt 2 Lab-tek 36 44 42 43
RGD 2 0 8 O RGD 4 O 0 0
comb 0 0 O 0 comb 1 0 1 0
Pt 3 Lab-tek 4 1 3 0 Pt 4 Lab-tek 31 25 18 10
RGD 0 0 3 0 RGD 7 0 2 0
comb 1 1 0 0 comb O 2 0 0
Table 6.1 CFU formation from marrow aspirates pre-treated with PBS with Ca2+
and Mg2+ (B), PBS without Ca2+ and Mg2+(C) and 200 FM GRGDSP solution (D). No
treatments were performed on A. Counts of early adherent CFUs from marrow samples
from all 4 patients used in this comprehensive study is shown here.
Interestingly, FACS analysis showed a higher percentage of cells that express c(5 and 0,x33
in the CD45- CD105+ and non- CD45- CD105+ populations for patient 1 and 3 than
patient 2 and 4 (Figure 6.10). The higher expression corresponds to the patients with
higher early adherent CFU counts on RGD surfaces after divalent-ion free PBS
treatment. No significant difference in the percentage of CD45 CD105+ cells to all
marrow cells was observed among the 4 patients. Similar to the FACS results shown in
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the previous section, 0(4 expression was higher for CD45- CD105 + cells in 3 out of 4
patients. Table 6.2 summaries all the differences observed between Group I (patients 1
and 3) and Group II patients (patients 2 and 4). However, these trends and differences
showed no correlation with patients' age, gender and race (Table 6.3).
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Figure 6.8 Representative images of CFU-AP on Lab-tek surfaces. Top left (a)
fluorescence image of a typical CFU-AP. AP expression was even across the colony.
Top right (b) a CFU-AP stained strongly with AP. AP expression was very strong at
the center of the colony and fainter as one moved towards the periphery. Bottom left
(c) bright field image of a large strong-AP+ CFU. A small colony on the same surface
was AP-. (Bottom right (d))
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Figure 6.9 CFU-AP
formation of marrow
samples from all 4
patients after aspirate
cells had been treated
with divalent ion-
containing PBS (B),
divalent ion-free PBS (C),
and 200 FM GRGDSP
solution (D). No
treatments were received
by the control cells (A) .
The total height of each
bar shows the total
number of CFU formed
on that surface and the
height of each color
showed the AP
expression of the
colonies as indicated in
the legend.
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Figure 6.10 Comparison of Patient 1 and Patient 2 ECM protein and integrin
expression. Top (a) CD45- CD105+ population. Bottom (b) All non- CD45
CD105' cells. In each set of 2 bars, all bars on the left (pink) indicate results
from Patient 1 and bars on the right (blue) Patient 2. 0a5 and 0cv33 expression of
CD45 CD105 + cells was about 10-fold higher in Patient 1 than Patient 2.
Comparison of Patient 3 and Patient 4 showed similar trend. (Also see Table 6.2)
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Table 6.2 Marrow aspirates from the 4 individuals tested partitioned into two
groups of different CFU formation behavior, integrin expression and AP expression.
Table 6.3 Age, gender and race information of the four individuals whose marrow
aspirates were used in this comprehensive study. All 4 patients were diagnosed with
osteoarthritis. No correlation between colony formation experimental results and
patient profile was observed.
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Group I (Patient 1 & 3) Group II (Patient 2 & 4)
Number of CFUs on Lab- Low (< 15) High (20 - 40)
tek
Effect of divalent ion-free Drastically increased CFU Decreased CFU formation
PBS treatment on colony formation
formation on RGD
surfaces
Ratio of marrow cells - Expression of both integrins on Pt 1 cells higher
expressing 0%5 and o0vt3 than Pt 2
- %05 expression on Pt 3 > that on Pt 4 but similar
expression of a,P3 by both patient samples
CFU AP expression on All CFUs (except one) were 2 populations of CFUs for
Lab-tek homogeneously weak AP' each patient:
- weak AP+ or AP
- strong AP+
CFU AP expression on All CFUs are AP+ All CFUs are AP
RGD surfaces
Age Gender Race
Patient 1 56 F African American
Patient 2 74 M Caucasian
Patient 3 78 M Caucasian
Patient 4 73 F Caucasian
6.4 Discussion
To understand adhesion and colony formation behavior of CTPs from bone marrow
aspirates, FACS analysis was employed to reveal first, what ECM molecules were
associated with CTPs and other marrow cells, and second, what integrins these cells
express. The CD45- CD105 + gating was used to identify an enriched population of
mesenchymal stem cells or CTPs for reasons described in Section 6.1. Comparing the
percentage of marrow aspirate cells that were CD45- CD105+ ((0.40 ± 0.11) %) with the
prevalence of CFU-APs (55 per 1 million nucleated marrow cells) as reported by the
Muschler group and the ratio of CFU-APs to CFUs from our data (- 90%),
approximately 1 in 65 CD45- CD105 + cells might form CFU on Lab-tek surfaces. If
indeed as claimed by numerous reports in the literature that CTPs are CD45- CD105 + as
discussed above, the CD45- CD105 + population provided a significant enrichment of
CTPs with colony formation ability (1 in - 65 CD45- CD105+ cells).
A fair portion of both CD45- CD105+ and non- CD45- CD105 + populations expresses
C(4, (as, ,P43 and i integrins. Even though large variation in (5 and as433 expression was
observed, the expression of the 4, as5, vP33 and Pi subunits was consistent with previous
reports on integrin expression by marrow mesenchymal stem cells or marrow-derived
osteoprogenitors (Conget and Minguell, 1999; Gronthos et al., 2001). The large variation
in as5 and 0,43 expression observed was also consistent with the partitioning of marrow
samples of the 4 individuals in the comprehensive study. The large difference in the
percentage of cells expressing 0(5 and 0v3 between in Group I and II patients' marrow
cells demonstrated such variability. The variation in as and (X,433 expression was also
consistent with the variation in the amount of CFU formation on RGD surfaces.
The Ca4 subunit is an adhesion-related antigen of which expression by marrow-derived
MSCs or progenitors differed among reports (Soligo et al., 1990; Conget and Minguell,
1999; Franceschi, 1999; Gronthos et al., 2001; Minguell et al., 2001). Our FACS results,
however, showed 0C4 as the integrin subunit expressed by the highest percentage of
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CD45- CD105+ cells compared to other integrins. (61.2 + 8.25) % of CD45- CD105 +
cells were at+ and it was the only integrin subunit that showed a significantly higher
percentage of positive cells in the CD45- CD105 + population than non- CD45- CD105+.
Interestingly, in Chapter 5, results from CFU assays showed that two of the three
substrates that were the most potent in supporting CFU-AP formation were made of
(4i31 peptides. Even though the stellar performance by the 59-mer 0(431 peptide in
promoting CFU-AP formation could be due to the higher affinity of the peptide to c(431
integrins than GRGDSPY to 0531 or 0,433, the enhancement in CFU-AP formation by the
low affinity CX4p1 CS-1 peptide still points to the possibility that 4 may be one of the
predominant integrins utilized by CTPs to mediate osteoblastic colony formation.
Consistent with the report by Gronthos et al. (Gronthos et al., 2001), our study showed
no measurable level of 0a3 on the cell surface of CTPs. However, in contrast to the same
report, no expression of 0a6 was detected. The expression of (04, C(5, vP33 and P by
marrow cells in our FACS analysis confirmed our previous choice in Chapter 4 in
focusing on 014P1, 0(51, 0(43 as potential integrins to be targeted for the selective adhesion
and colony formation of CTPs.
Immunoblotting showed a much higher level of fibronectin and laminin association with
marrow aspirate cells than hMSC cell line. These proteins were likely from the
microenvironment the marrow cells resided. Collagen IV, fibronectin, laminin had been
shown to be in abundance in bone marrow fibrous tissue (Klein, 1995; Lucena et al.,
1997). Therefore, when bone marrow was aspirated, these proteins in which bone
marrow cells were once embedded were drawn into the aspirate along with the cells. As
a result, marrow cells were still in their proteins after they were aspirated. Since our
hypothesis was that the small amount of marrow cell adhesion observed was due to the
shrouding of bone marrow aspirate cells by a large amount of ECM proteins, the amount
of protein associated with marrow aspirate cells and hMSC cell line immediately before
seeding onto peptide substrates was assessed. Therefore, protein level of marrow cells
was compared with hMSCs detached from culture plates by trypsinizing and re-
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suspended in culture media. Although our studies showed that incubation of marrow
aspirates with trypsin was effective in reducing the amount of associated fibronectin and
laminin, protein-reduction treatments less detrimental were needed to avoid the
disruption of the adhesion and differentiation potential of progenitor cells due to their
sensitivity to external cues. Therefore, 30-minute incubation of marrow aspirate cells
with PBS (with and without divalent ions) and RGD solution was experimented to
reduce matrix molecule association with marrow cells. Incubation with RGD solution
reduced the amount of fibronectin and laminin associated with aspirate cells to a level
similar to the action of trypsin. (data not shown.) Since the level of reduction by RGD
and PBS was also similar (and in half of the patients, reduction was even visibly greater
when treated with divalent ion-free PBS), we concluded that washing with PBS or RGD
solution, but not BSA-containing DMEM, were effective in matrix molecule reduction.
The most striking results from the 4-patient comprehensive study of CFU formation and
ECM and integrin expression of marrow aspirate was the partitioning of the 4 patients
into two groups with very different cell behavior and expression, but within each group,
remarkable consistency was observed. The increase in CFU formation on RGD surfaces
by cells treated with divalent ion-free PBS in only Group I patients could be attributed by
the higher percentage of 05 and 0t43 expressing cells in Group I, in particular the CD45-
CD105+ cells. Incubation with divalent ion-free PBS reversed integrin binding to the
matrix molecule shroud and therefore, for samples with more cells expressing 05 and 0cv3 3,
more cells would have exposed integrins available for binding after washing. Hence, the
increase in adhesion and CFU formation on RGD surfaces was greater for Group I
patients. CTP adhesion and colony formation on RGD surfaces could be mediated by a
combination of C5 and vfP3 integrins. GRGDSP has been extensively shown to mediate
vP3 adhesion and validation of GRGDSPY surfaces with CHO-K1 cells which
expressed only OC5p1 but not OvC,3 showed that C5sl1 could also mediate adhesion on
GRGDSPY surfaces (Figure 6.9). There might be a difference in whether a5 or 0433
were utilized by CTPs from each group of patients to mediate adhesion or colony
formation, and therefore leading to a difference in AP expression by CFUs on
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GRGDSPY surfaces between the two patient groups. (All CFUs on RGD surfaces are
AP + for Group I and all AP- for Group II.) In fact, Keselowsky et al. showed that
mineralization of MC3T3-E1 immature osteoblasts on fibronectin was inhibited by
blocking with 3i but not 3 antibodies, suggesting that even though both c51l and Xvp3
integrins could mediate the adhesion of immature osteoblasts, only o5spl could mediate
the differentiation of these cells (Keselowsky et al., 2005). The possible difference in
integrins utilized by marrow cells in mediating adhesion may also contribute to the
difference in AP expression by CFUs on Lab-tek by the two patient groups. However,
the reasons for the consistent differences observed between the two groups of patients
were not known. The difference might be inherent to patient variability.
Treatment of marrow aspirate cells with GRGDSP solution prior to plating on substrates
did not enhance CFU formation on RGD surfaces in any marrow samples. RGD
peptide solution was effective in reducing the amount of fibronectin and laminin
associated with aspirate cells, as shown by immunoblotting. However, even though the
two washes after the RGD solution treatment would have removed RGD remaining in
the cell media, cell integrins might still be occupied by RGD peptides when the cells were
plated on the substrates and thus were inhibited to bind to RGD substrates. All pre-
plating treatment of marrow aspirate cells actually decreased CFU formation on Lab-teks
for three out of the four patient samples tested. This was likely a result of the reduced
protein level after pre-loading treatments. As a result, less protein was adsorbed to Lab-
tek surfaces to support the adhesion and colony formation of CTPs. In fact, for three
out of four patients, the number of CFUs formed on Lab-tek from marrow aspirates
treated with divalent ion-free PBS and GRGDSP solution was lower than that of marrow
aspirates treated with divalent ion-containing PBS, implying a higher capability in
reducing ECMI proteins using divalent ion-free PBS and GRGDSP solution.
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Figure 6.9 Adhesion of CHO-K1
cells on GRGDSPY surfaces.
Adhesion on GRGDSPY surface was
mediated by 0c5f3 as CHO-K1
expressed only s lcp, but not x,p,3.
In summary, in this chapter, we found that a portion of CTP-enriched CD45- CD105 +
population as well as a portion of all other marrow cells were C4+, 5as+, aX33+ and Pi+ ,
even though we observed a large patient-to-patient variation in as and OaC33 expression. A
significant portion of CD45- CD105+ population was 4 +, statistically much higher than
that of the non- CD45- CD105+ population. High level of ECM proteins were
associated with marrow aspirate cells but various washing treatments could reduce the
amount of protein to various extents. Experimental data on integrin expression and
CFU-AP formation partitioned patient marrow samples into two groups that showed
very different cell behavior and integrin expressions. In one group, the treatment of
marrow aspirate cells with divalent ion-free PBS did increase CFU formation as we
hypothesized. The consistency within each group of patients suggested that patient
variability might not be totally stochastic and could be accounted for.
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Chapter 7
Conclusions and Future Directions
7.1 Conclusions
In in vivo connective tissue engineering, the presence of a substrate and an environment
inductive to cell adhesion and function is crucial to the success in engineering tissues. In
this dissertation, a multi-dimensional approach was taken in an attempt to optimize the
molecular design of substrates for the selective adhesion, proliferation and differentiation
of connective tissue progenitors from human bone marrow aspirates. We optimized the
base substrate material by the critical choice of a highly cell-resistant comb copolymer
with sufficient functionalizable sites. When biophysical design was applied to the
clustered presentation of peptides, we observed an enhancement of cell adhesion as cell
spreading increased on more peptide substrates with a higher degree of clustering. The
biochemical design showed that with the right choice of peptides, CFU-AP formation, an
indication of CTP adhesion, proliferation and differentiation, could be enhanced. The
bone sialoprotein peptide FHRRIIKA and peptides that target 0(4pl integrins promoted
CFU-AP formation. Through a critical evaluation of the CFU assay, we standardized the
assay with the better positive control Lab-tek and a lower but more optimal seeding
density. The evaluation also revealed the extent of patient variability even on standard
controls. In spite of the multi-faceted design of CTP-selective substrates, it was the
understanding of marrow aspirate cells through cell studies that led us to explore the
possibility of further enhancing colony formation from the angle of marrow aspirate cell
manipulation. FACS elucidated bone marrow integrin profile and immunoblotting
showed that the high level of matrix molecule association with marrow aspirate cells that
could be reduced by washing with PBS and RGD solution. On the other hand, peptide
substrates designed earlier in turn allowed us to test whether matrix molecule shrouding
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of marrow cells prohibited CTP colony formation. RGD substrates, when used in CFU
assays, also revealed the natural partition phenomemon of patient marrow samples
according to the expression of marrow cells and colony formation behavior. This could
shed light on possible trends in accounting for the huge patient variations observed with
bone marrow aspirates. Therefore, this work is an example of how in the optimization
of substrates for tissue engineering applications, substrate design and the understanding
of the target cells go hand-in-hand. The understanding of cells contributes to the
improvement of the design of tissue engineering substrates, which in turn serves as tools
to provide a further and more in-depth understanding of the cells of interest. It is our
hope that not only the knowledge gained in this dissertation on marrow cells, CTPs in
particular, provides a better understanding in this behavior and molecular profile, but the
design of the optimized CFU assay with clustered-peptide substrates offers a set of tools
for further understanding human bone marrow cells.
7.2 Future directions
The set of tools developed in this dissertation could be applied to study the effect of
other adhesion molecules on CTP adhesion, proliferation and differentiation. Adhesion
peptides that showed high preferentiality in binding to 05spl integrins were of particular
interest. A recent report showed that blocking MC3T3-E1 immature osteoblasts with 31
but not 33 antibodies inhibited the mineralization of the cells on fibronectin, suggesting
that even though both C5fsi and V(433 integrins could mediate the adhesion of immature
osteoblasts, only 0C5P1 could mediate the differentiation of these cells (Keselowsky et al.,
2005). A branched sX5p1 eptide that consists of both the RGD and PHSRN synergy site
from fibronectin, separated by a spacer that consists of 5 glycine and a lysine, has
recently been developed in our lab (Ufret et al., 2005). With our FACS data showing a
fair portion of CTP-enriched cell population expressing 0cs and the availability of this
recently developed peptide with high binding affinity to (5s31, the assays developed in this
thesis could be applied to see whether 05s31 substrates could support more colony
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formation and osteoblastic differentiation
GRGDSPY surfaces that have higher affinity towards vr33 than 5s1pl. This proposed
study is one of the many possibilities that the tools and assays developed in this thesis
can be used to study the function and behavior of CTPs and marrow aspirate cells.
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Appendix
IUPAC Amino Acids Abbreviations
Alanine Ala A
Arginine Arg R
Asparagine Asn N
Aspartic acid Asp D
Cysteine Cys C
Glutamine Gln Q
Glutamic acid Glu E
Glycine Gly G
Histidine His H
Isoleucine Ile I
Leucine Leu L
Lysine Lys K
Methionine Met M
Phenylalanine Phe F
Proline Pro P
Serine Ser S
Threonine Thr T
Tryptophan Trp W
Tyrosine Tyr Y
Valine Val V
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